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1 SUMMARY 
 
Protein folding is a crucial process for cell survival. Only natively structured proteins can 
perform their essential biological functions. Although all structure-relevant information is 
principally encoded in the amino acid sequence of a protein, the efficient folding of many 
larger proteins depends on the assistance of molecular chaperones. These proteins bind 
reversibly to exposed hydrophobic sequences in folding intermediates, thereby preventing 
aggregation and supporting effective folding.  
The Hsp70 family proteins constitute key components of the cellular chaperone network 
in eukaryotes and bacteria. They are involved in diverse protein processing reactions, 
reaching from folding and assembly of nascent polypeptides to protein transport across 
membranes. Regular Hsp70s consist of an N-terminal nucleotide binding domain (NBD) and 
an allosterically coupled C-terminal substrate binding domain, which is further divided into a 
β-sandwich domain and a three helix bundle domain (3HBD). Hsp70s perform their cellular 
functions through ATP-driven cycles of substrate binding and release: In the ATP state, 
peptide binding is dynamic. ATP hydrolysis results in a dramatic structural rearrangement, 
leading to a conformation in which hydrophobic peptide segments are locked between 3HBD 
and β-sandwich domain. Thus, substrate proteins are stably bound in the ADP and apo state. 
This Hsp70 folding cycle is tightly controlled by a large complement of cochaperones. 
Whereas J-domain proteins recruit substrates and trigger ATP hydrolysis, nucleotide 
exchange factors (NEFs) accelerate ADP release. In eukaryotes, four evolutionarily unrelated 
classes of Hsp70 NEFs have been identified, among which Hsp110 homologs are most 
abundant. As judged by their conserved domain composition, Hsp110s derive from canonical 
Hsp70s, but have evolved into NEFs, preserving the ability to stabilize misfolded proteins in 
solution.  
In the present study, the cooperation of Hsp70 and Hsp110 molecular chaperones in 
protein folding was investigated. First, the crystal structure of a functional complex between 
the yeast Hsp110 homolog Sse1p and the NBD of human Hsp70 was determined. The 
structure was solved by selenium multiple wavelength anomalous diffraction and refined at 
2.3 Å resolution to a crystallographic R-factor of 19.7 %. The structure of Sse1p is 
characterized by extended domain-domain interactions. β-sandwich domain and 3HBD are 
arranged along the NBD and point into opposite directions. Importantly, Sse1p has ATP 
bound, a prerequisite for efficient complex formation with Hsp70. In the complex, the NBD 
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and 3HBD of Sse1p embrace the Hsp70 NBD, thereby opening the nucleotide binding cleft of 
Hsp70 and releasing ADP.  
In a subsequent mutational analysis, key features of the chaperone complex were 
targeted. Specifically, amino acid exchanges were introduced (i) in the areas of close surface 
contacts between Sse1p and Hsp70N, (ii) at the interfaces between individual Sse1p domains, 
(iii) in the nucleotide binding pocket of Sse1p, and (iv) at the putative substrate binding site in 
the β-sandwich domain of Sse1p.  
Sse1p mutations affecting the interaction between the Hsp70 NBD and the Sse1p 3HBD 
strongly impaired Hsp70 complex formation and nucleotide exchange. Consistently, these 
Sse1p variants were less effective than wildtype (wt) Sse1p in supporting substrate release 
from Hsp70 and Hsp70-mediated refolding of thermally denatured firefly luciferase. In vivo, 
the respective sse1 mutations caused severe stress and a pronounced growth defect, likely 
because of reduced substrate flux through the Hsp70 machinery. Taken together, these results 
define nucleotide exchange on Hsp70 as the main function of Sse1p. Furthermore, they 
highlight the importance of the interaction between the Hsp70 NBD and the Sse1p 3HBD for 
the nucleotide exchange activity of Sse1p.  
No evidence was found for an ATP-driven, Hsp70-like conformational cycle of Sse1p. 
Mutations targeting the Sse1p inter-domain communication and the ATPase activity did not 
impair Sse1p function in vitro and in vivo.  
Mutations at the putative substrate binding cleft of Sse1p aggravated the functional 
defect of partially NEF-deficient Sse1p mutants in vitro and in vivo. Thus, direct substrate 
interactions mediated by the β-sandwich domain may support Hsp70-assisted protein folding 
in addition to the nucleotide exchange function of Sse1p.  
According to our mutational analysis, Hsp110s contribute to Hsp70-assisted protein 
folding in two ways: Their major function is the acceleration of ADP dissociation from Hsp70 
by stabilizing the Hsp70 NBD in an open conformation with low affinity for the nucleotide. 
Consequently, Hsp110s support the rapid conformational cycling of Hsp70 and thus efficient 
substrate binding and release. In addition, Hsp110s may directly interact with the unfolded 
substrate upon binding to Hsp70. By holding the misfolded protein chain, Hsp110s might 
cooperatively aid Hsp70 in remodeling the substrate via large-scale thermal motions of the 
Hsp70 PBD. 
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2 INTRODUCTION 
 
Proteins (derived from proteios (Greek), meaning "of the first rank") are the most abundant 
molecules in biology other than water. Forming the most versatile group of macromolecules 
in living cells, they play essential roles in virtually all biological processes: For example, they 
work as enzymes, assume structural and transport functions, allow motion and are key 
components in immune defense, signal transduction and regulation. 
 
2.1 The protein folding problem 
 
Proteins are built up from 20 α-L-amino acids, which vary in size, shape, charge, hydrogen-
bonding capacity, and chemical reactivity and thus allow these molecules to mediate a wide 
range of functions. As encoded in the genomic sequence, the amino acid residues are 
connected to a linear polymer (primary structure) via planar, rigid, and kinetically stable 
amide bonds. The spatial arrangement of amino acid residues which are adjacent in the linear 
sequence is referred to as secondary structure. The most commonly observed elements of 
secondary structure are α-helix, β-sheet, and β-turn. The tertiary structure of a protein 
designates the spatial arrangement of amino acid residues that are distant from each other in 
the primary structure. Large proteins often consist of several distinct polypeptide chains, so-
called subunits. The three-dimensional arrangement of these subunits is termed quaternary 
structure. 
In the early 1960s, Anfinsen and coworkers proved in refolding experiments with 
RNase A the reversibility of protein unfolding. This implies that the native state of a protein is 
thermodynamically the most stable one under physiological conditions. Moreover, all 
information needed to specify the three-dimensional structure of a protein is contained in its 
amino acid sequence (Anfinsen et al., 1961; Haber and Anfinsen, 1961, 1962; Anfinsen, 
1973), which is why the latter is also referred to as the second half of the genetic code 
(Goldberg, 1985): The primary structure forms the link between the one-dimensional 
sequences of DNA and RNA and the three-dimensional protein structure necessary for the 
protein's biological function. The biological activity of a protein further requires structural 
flexibility. Consequently, the native state of proteins is only marginally more stable than the 
unfolded state with a free enthalpy of unfolding between 30 and 70 kJ/mol (Jaenicke, 1996). 
The small stabilization is mainly due to non-covalent interactions such as hydrophobic core 
development, hydrogen bonding, and salt-bridge formation. The latter can counterbalance the 
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decrease in entropy of the protein chain that accompanies the increasing level of order during 
the folding process. 
How does an unfolded protein find its way to its native conformation? In the following, 
this question shall be addressed using the energy landscape model (Figure 2-1). An energy 
landscape describes the internal free energy of each protein conformation as a function of its 
degrees of freedom, such as the dihedral bond angles along the peptide backbone for example 
( E). The possibility that proteins fold by a purely random search of all accessible 
conformations was excluded by Levinthal as the time required for folding would be 
unrealistically long: 1050 years for a protein with 100 amino acids (Levinthal, 1968; Kim and 
Figure 2-1
Figure 2-1: Folding energy landscapes. 
Energy landscapes describe the internal free energy of a polypeptide chain as a function of its conformational 
properties. 
(A) In a landscape with equal energy levels for all denatured states, the protein chain searches for its native state 
N randomly (Dill and Chan, 1996). 
(B) Specific folding pathways narrow down the accessible conformational space, so that an unfolded chain A can 
reach its native state N faster than in panel (A) (Dill and Chan, 1996). 
(C) According to the folding funnel concept, folding of the polypeptide chain leads to a progressive reduction of 
both internal free energy and conformational freedom (Dill and Chan, 1996). 
(D) A slice through (C) is shown. In the lattice model, black beads represent hydrophobic and white beads polar 
amino acids, h stands for the number of hydrophobic contacts. The polypeptide chain can occupy many 
denatured, open conformations (h = 0) and few compact conformations (h = 2 or 3). The native state (h = 5) is 
characterized by a nearly complete lack of conformational entropy (Dill and Chan, 1996). 
(E) The multiple conformations of unfolded protein (top) fall into a folding funnel consisting of an almost 
infinite number of local minima, each of which represents a possible folding state of the polypeptide chain. Most 
of these states are transient folding intermediates. Some of them (e.g. molten globules) are characterized by a 
more stable structure, others act as folding traps that irreversibly capture the protein in a misfolded state 
(Schultz, 2000). 
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Baldwin, 1982). Such a scenario would correspond to an energy landscape, in which all 
denatured states of the protein have the same energy level and only the native state is more 
stable ( A). To solve this so-called "Levinthal paradox", Levinthal postulated the 
existence of specific folding pathways ( B). Beginning from a denatured 
conformation A, the protein reaches the native state N by passing the energy landscape 
through a well-defined sequence of folding events. Intermediates and transition states confine 
the accessible conformational space, thereby allowing folding to proceed in a physiologically 
relevant time frame. Later, the one-dimensional pathway concept of sequential events was 
replaced by the multi-dimensional folding funnel concept of parallel events (
C,D,E). In this model, the folding states of a protein are not defined species, but rather 
ensembles of individual chain conformations, and multiple folding routes are possible to 
reach the native state. Brownian motion leads to individual conformational fluctuations in the 
folding chains bringing into contact even distant amino acid residues. Because native-like 
interactions tend to be more stable than non-native ones, the low-energy native state can be 
found. As a folding chain progresses towards lower internal free energies, the chain's 
conformational entropy narrows down to that of the final native structure (Dill and Chan, 
1996; Schultz, 2000). Two-state folding kinetics can be symbolized by a smooth funnel-
shaped landscape without significant kinetic traps (Figure 2-1C). Especially small proteins 
fold highly cooperatively within microseconds to seconds without significantly populating 
any intermediate state (Jackson, 1998). Their folding pathway can be best described by the 
nucleation-condensation model, in which a non-stable folding nucleus of a small number of 
key residues forms, about which the remainder of the structure can then condense (Kim and 
Baldwin, 1982; Ptitsyn, 1998; Dobson, 2004; Jahn and Radford, 2008). In contrast, multi-
exponential folding is represented by an energy landscape with intermediates (valleys) and 
transition states (hills, Figure 2-1E). Intermediates can emerge from a hydrophobic collapse 
for example, which results within a few milliseconds in so-called molten globules. From these 
marginally stabilized, compact intermediates with native-like secondary structure, the native 
structure then develops (Ptitsyn et al., 1990; Matthews, 1993; Ptitsyn, 1995).  
Figure 2-1
Figure 2-1
Figure 
2-1
 
2.2 Protein aggregation in vivo 
 
Although it is generally accepted that the three-dimensional structure of a protein is 
determined by its primary sequence, a complete reversibility of unfolding is often only 
observed for small proteins. During the refolding of larger proteins, intermediates exposing 
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hydrophobic surfaces accumulate at slow folding steps and promote aggregation. Rate-
limiting steps are for example the formation and reorganization of disulphide bonds or the cis-
trans isomerization of peptidylprolyl bonds.  
In vivo, aggregation poses a serious and universal problem not only because it reduces 
the efficiency of protein folding but also because it may lead to the formation of cytotoxic 
aggregates. Aggregation-prone species may arise both during protein synthesis at the 
ribosome and as a consequence of protein unfolding under stress conditions. During de novo 
synthesis, non-native features are exposed for a time range of seconds to minutes as protein 
domains are thought to complete folding only when their entire sequence has emerged from 
the ribosome (Hartl and Hayer-Hartl, 2002). Compared to in vitro-experiments – which are 
usually performed in polymer-free buffer solutions – aggregation is aggravated in vivo by the 
high intracellular concentrations of macromolecules, namely proteins, nucleic acids, and 
polysaccharides (300-400 g/l). Typically, 20-30 % of the interior of a cell are occupied by 
macromolecules and therefore unavailable for other molecules, a phenomenon referred to as 
macromolecular crowding or the excluded volume effect. How does the excluded volume 
effect stimulate protein aggregation? First, it leads to an increase in the effective 
concentration of the non-native protein chains. Second, if two unfolded protein chains bind to 
each other, the total volume which they occupy will be reduced. As a consequence, the 
remainder of the present macromolecules can disperse better, thus increasing their entropy 
and reducing the total free energy of the whole solution (Ellis, 2001; Hartl and Hayer-Hartl, 
2002; Ellis and Minton, 2006; Zhou et al., 2008).  
Protein aggregation accompanies numerous late-onset diseases in humans, including 
Alzheimer's disease (β-amyloid peptide and tau protein), Parkinson's disease (α-synuclein), 
Huntington's disease (huntingtin with expanded polyglutamine stretch), and spongiform 
encephalopathies (prion protein). Each of these diseases appears to result from a specific 
misfolded protein that can neither be refolded nor effectively degraded by the cell, but instead 
accumulates in intra- or extracellular aggregates in a variety of organs including liver, spleen 
and brain (Figure 2-2B panel E) (Dobson, 1999, 2003; Soto, 2003; Dobson, 2004; Hinault et 
al., 2006; Jahn and Radford, 2008). Although the properties of the involved proteins vary 
significantly when soluble – e.g. α-synuclein is a natively unfolded protein, in contrast to the 
other proteins – they share many characteristics in the aggregated state. Thus, all of them 
aggregate into amyloid fibrils in which β-strands of polypeptide chains are orientated 
perpendicular to the fibril axis (Figure 2-2A). Strikingly, such fibrils can also be formed by 
proteins that are not associated with disease, such as myoglobin for example (Fändrich et al., 
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2001). Thus – although critically depending on the physicochemical properties of the 
individual protein – the amyloid conformation seems to be a generic feature of polypeptide 
chains that, however, is normally not apparent in living cells. Only if the extensive side-chain 
interactions stabilizing the native state of a protein are sufficiently weakened (for example due 
to high temperature, low pH, mutations, faulty proteolytic processing or age-associated 
aberrant functions in the chaperone system), proteins unfold and may form amyloid fibrils. 
The β-sheet core structure of these fibrils is mainly defined by hydrogen bonds involving the 
polypeptide main chain. With the latter being an integral element of all proteins, it becomes 
evident why fibrils arising from different polypeptides are similar in appearance. Not only the 
final aggregate structure but also the aggregation pathways of different polypeptides exhibit 
pronounced similarities (Figure 2-2B). In a thermodynamically unfavorable slow step, 
unfolded or partially folded proteins (panel A) first associate non-specifically to form soluble 
oligomers, so-called aggregation nuclei, from which larger molecule assemblies can grow 
rapidly. The earliest aggregates that are detectable by electron microscopy have bead-like 
Figure 2-2: Amyloid formation. 
(A) A molecular model of an amyloid fibril grown from the SH3 domain of the p85α subunit of bovine 
phosphatidylinositol-3'-kinase has been fitted into its cryo-electron microscopy electron density. The fibril 
consists of four twisted protofilaments that form a hollow tube with a diameter of 60 Å. The depicted model 
presents one possibility how the β-strands of the aggregating protein species could be arranged in the protofibrils 
(Dobson, 1999; Jiménez et al., 1999). 
(B) A schematic overview over the mechanism of amyloid fibril formation is depicted. Partially folded or 
unfolded proteins (A) associate and form soluble aggregates (B) that assemble further to protofibrils (C) and 
mature fibrils (D). The amyloid fibrils often accumulate in plaques or other structures such as the Lewy bodies 
occurring in the course of Parkinson's disease (E). For each aggregated species, an electron microscopy picture is 
shown (adapted from Dobson, 2003). 
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structures (panel B). They are often amorphous or micellar in nature and expose polypeptide 
stretches buried in the native state, others form defined ring-shaped species. In the next step, 
these prefibrillar aggregates assemble to short, thin, sometimes curly protofilaments or 
protofibrils (panel C). By lateral association as well as limited structural reorganization, the 
latter finally transform into stable mature, insoluble fibrils with a diameter of 70 to 120 Å 
(panel D), which are deposited into cellular aggregates (panel E). Interestingly, increasing 
evidence suggests that the major pathogenic protein species in aggregation-associated 
neuronal diseases are not the final amyloid fibrils, but the prefibrillar aggregates exposing 
hydrophobic surfaces that can interfere deleteriously with other proteins or membranes (gain-
of-function hypothesis). Thus, fibril and deposit formation may represent a cellular protection 
mechanism. Besides the gain-of-function hypothesis, two further hypotheses have been 
proposed to explain how protein misfolding and aggregation might be associated with 
neuronal apoptosis (Soto, 2003; Luheshi et al., 2008): From the perspective of the loss-of-
function hypothesis, activity loss of the protein, which is depleted during aggregation, results 
in the failure of crucial cellular processes. In contrast, the brain inflammation hypothesis 
suggests that the protein aggregates lead to a chronic inflammatory reaction in the brain which 
causes neuronal death. It appears probable that a combination of these mechanisms occurs in 
many diseases.  
In vivo, aggregation is minimized by different means. First, polypeptide sequences that 
favor efficient cooperative folding over aggregation have evolutionarily been favored. This 
has been possible as the key residues that nucleate protein folding seem to differ from those 
that nucleate protein aggregation. In general, the aggregation propensity of sequences of 
functional proteins is reduced significantly compared to random polypeptide sequences, for 
example by avoiding long stretches of alternating polar and non-polar amino acids that lead to 
amyloidogenic amphiphilic β-sheets, by introducing stabilizing cis-peptidylprolyl bonds, or 
by protecting the edge-strands of native β-sheets from forming intermolecular hydrogen 
bonds (Dobson, 2004; DePristo et al., 2005; Jahn and Radford, 2008). Second, the cellular 
environment has been evolved to support folding. Thus, pH and in mammals also the 
temperature are carefully controlled. Furthermore, proteolytic systems such as the ubiquitin-
proteasome machinery or autophagy have been developed for the degradation and removal of 
misfolded proteins (Glickman and Ciechanover, 2002; Pickart and Cohen, 2004; Ciechanover, 
2006; Rajawat and Bossis, 2008). Of particular importance are molecular chaperones that are 
not only able to prevent aggregation but can also disentangle already aggregated proteins and 
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support their refolding. In the following sections, these folding mediators will be described in 
detail. 
  
2.3 Molecular chaperones 
 
Molecular chaperones are a large and diverse class of proteins that assist the non-covalent 
assembly and disassembly of other macromolecular structures without being part of the final 
native structures (Ellis and Hemmingsen, 1989; Ellis and Minton, 2006). They bind reversibly 
to exposed hydrophobic sequences and increase the efficiency of the overall folding process 
rather indirectly by reducing the probability of competing reactions such as aggregation. 
Importantly, they do not actively contribute conformational information to the folding process 
or increase the rate of individual folding steps. Acceleration of rate-limiting steps is 
performed by so-called folding catalysts such as peptidylprolyl or protein disulfide isomerases 
(Dobson, 2003, 2004).  
Many chaperones belong to one of the following five protein families of heat shock 
proteins (Hsps): the small Hsps (sHsps), which lack ATPase activity, and the ATPases 
Hsp100, Hsp90, Hsp70, and Hsp60. In eukaryotes, their expression is induced by heat shock 
transcription factors (HSFs) that – under cellular stress conditions such as heat shock or 
oxidative injury – bind to heat shock elements (HSEs) upstream of genes encoding Hsps 
(Shamovsky and Nudler, 2008). Hsps assist in prevention of misfolding and aggregation as 
well as in resolubilization and degradation of partially denatured or aggregated proteins. 
Interestingly, the ability to express Hsps under stress diminishes with increasing age – 
probably one reason why the aggregation-associated neurodegenerative diseases described 
above tend to occur late in life (Hinault et al., 2006). In eukaryotes, Hsps are predominantly 
found in the cytoplasm, nucleus, and mitochondria. The chaperones of the endoplasmic 
reticulum (ER) are named glucose-regulated proteins (Grps) because they are induced by 
glucose starvation rather than by heat shock. Glucose starvation disrupts the glycosylation 
function of the ER and causes misfolded proteins to accumulate in the ER lumen. However, 
Grps are structurally and functionally related to Hsps (Easton et al., 2000). Besides being 
critical in stress-challenged systems, molecular chaperones also perform essential constitutive 
functions under normal physiological conditions. Often dependent on ATP hydrolysis, they 
assist the folding of nascent polypeptide chains both co- and post-translationally, are involved 
in un- and refolding of polypeptides that are transferred across cellular membranes, and guide 
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Figure 2-3: Cytosolic chaperone networks in bacteria and eukaryotes.  
(A) In bacteria, most small proteins fold rapidly without any further chaperone assistance after interaction with TF. Larger proteins are subsequently bound by the DnaK 
machinery (DnaK/DnaJ/GrpE) and optionally transferred to the post-translational chaperonin system GroEL-GroES (adapted from Hartl and Hayer-Hartl, 2002). 
(B) In eukaryotes, NAC is associated to ribosomes similar to TF in bacteria. Most proteins fold upon ribosome release without further assistance or after interaction with the 
Hsp70 system. The proper folding of kinases and transcription factors requires additional binding to Hsp90. Approximately 10 % of the proteins are further transferred to the 
chaperonin TRiC working co- as well as post-translationally. In case of actin and tubulin, this transfer is mediated by PFD (adapted from Hartl and Hayer-Hartl, 2002).  
(C) An increase of temperature leads to the activation of oligomeric sHsps that bind to partially unfolded protein intermediates. Destabilized proteins that co-aggregate with 
sHsps can be efficiently resolubilized and refolded by Hsp100 chaperones cooperating with Hsp70 (adapted from Liberek et al., 2008).  
N: native protein; NAC: nascent chain-associated complex; PFD: prefoldin; sHsp: small heat shock protein; TF: trigger factor; TRiC: TCP1 ring complex. 
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the assembly of oligomeric complexes (Ellis and Minton, 2006). Remarkably, while 
prokaryotes rely on a universal set of chaperones executing both stress response and 
housekeeping duties, eukaryotes have evolved distinct chaperone networks to carry out these 
functions: Stress-inducible Hsps protect the proteome under stress conditions, whereas CLIPS 
(chaperones linked in protein synthesis) are stress-repressed and involved in protein 
biogenesis (Albanese et al., 2006). Figure 2-3 illustrates the sophisticated cellular chaperone 
network, the general principles of which are conserved from prokaryotes to eukaryotes: 
Nascent polypeptides with exposed hydrophobic residues and unstructured backbone regions 
are bound by chaperones during synthesis and transferred between the cooperating folding 
helpers until their native state is reached (Hartl and Hayer-Hartl, 2002; Young et al., 2004; 
Liberek et al., 2008). Generally, the first chaperones that contact the nascent chains are 
ribosome-bound. In bacteria, the emerging polypeptide chain is met by trigger factor, an ATP-
independent chaperone shielding hydrophobic stretches to keep the nascent protein soluble 
(Figure 2-3A). In eukaryotes, the ribosome-associated complex (RAC) and possibly also the 
nascent chain-associated complex (NAC) are supposed to have similar functions (Figure 
2-3B). RAC is a stable heterodimer, which in S. cerevisiae consists of the Hsp70-related 
Ssz1p and the J-domain protein zuotin. Zuotin contains an Hsp70 as well as a ribosome 
binding domain. It has been suggested that RAC recruits Hsp70 proteins to the ribosome 
where the latter are likely to assist the folding of nascent chains. NAC is also a ribosome-
bound heterodimer that contacts emerging polypeptide chains and seems to influence the 
fidelity of the co-translational targeting of nascent chains to the ER. Most small proteins (65-
80 % of all prokaryotic proteins) probably fold rapidly upon synthesis without further 
assistance. The remaining chains bind to the Hsp70 system consisting of an Hsp70 protein, 
such as bacterial DnaK or eukaryotic Hsp70, and a cooperating J-domain (Hsp40) protein as 
well as a nucleotide exchange factor (NEF). Approximately 10 to 20 % of the nascent chains 
are able to fold properly with the help of Hsp70 alone. A subset of slow folding proteins (10-
15 % of the total protein) is subsequently passed on to the cylindrical chaperonins, namely 
GroEL-GroES in bacteria and tailless complex peptide 1 (TCP1) ring complex (TRiC) in 
eukaryotes. GroEL-GroES encapsulates the substrate in a protecting cavity for final folding. 
Eukaryotes have evolved further chaperones with their protein repertoire being more complex 
than the bacterial one: Actin and tubulin nascent chains are for example bound by prefoldin, 
which cooperates with TRiC. Other proteins, especially kinases and transcription factors, 
require Hsp90 to reach their final native structures. Above all under destabilizing, 
aggregation-promoting stress conditions, two further classes of chaperones perform important 
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tasks in pro- as well as in eukaryotes (Figure 2-3C and Figure 2-4E,F): Small Hsps bind to 
aggregates thereby modulating the physicochemical properties of the latter in a way that 
Hsp100 chaperones together with Hsp70 can effectively resolubilize the aggregated proteins 
to pass them back into the chaperone network. Whereas the remaining paragraphs of this 
introduction are dedicated to a detailed description of the Hsp70 chaperone system, the 
chaperonins, the Hsp90 system and the Hsp100 chaperones shall be introduced shortly in the 
next section (Figure 2-4). 
 
2.4 The chaperonin, Hsp90 and Hsp100 systems 
 
The chaperonins are a conserved class of large double-ring complexes of approximately 
800 kDa with a central cavity (Figure 2-4A) (Leroux and Hartl, 2000; Hartl and Hayer-Hartl, 
2002; Spiess et al., 2004; Young et al., 2004; Saibil, 2008). They can be divided into two 
subgroups: The group I chaperonins, also known as Hsp60s, are found in bacteria as well as in 
organelles of endosymbiotic origin, while the group II chaperonins are of archaeal and 
eukaryotic origin. The E. coli group I chaperonin GroEL is composed of seven identical 
subunits per ring and acts in cooperation with the homoheptameric 'capping' cofactor GroES. 
The latter serves as a detachable lid for the cavity and creates a folding chamber that encloses 
polypeptide substrates. In contrast, the group II chaperonin TRiC from the eukaryotic cytosol 
contains eight different subunits per ring and works independently of a GroES-like 
cochaperone. Instead, it is characterized by a built-in lid. While GroEL was only observed to 
promote post-translational folding, TRiC is also able to work co-translationally. Key features 
of the interaction between the chaperonins and their non-native substrates are (i) 
internalization and isolation to prevent aggregation, (ii) confinement, i.e. restriction of 
conformational space and thus smoothening of the energy landscape, to avoid the formation 
of certain trapped intermediates, and (iii) passive or possibly active unfolding of kinetically 
trapped intermediates. GroEL is functionally asymmetric with a positive intra- and a negative 
inter-ring allostery. After capturing the non-native substrate via hydrophobic interactions with 
the so-called trans ring1, simultaneous ATP and GroES binding results in large scale 
conformational rearrangements. First, the cavity of the trans ring is significantly enlarged so 
that the substrate protein can be encapsulated. Second, the trans ring's surface properties shift 
from hydrophobic to hydrophilic during the transition (Figure 2-4B). In addition, GroES 
                                                 
1 The trans ring is defined as the free end of the GroEL-GroES complex, whereas the cis ring is the GroES-
bound ring. 
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Figure 2-4: Important cellular chaperone systems. 
(A) Frontal and top views of the GroEL-GroES-(ADP)7 complex are shown in surface representation. The trans
ring is colored in green, the cis ring in blue, and GroES in dark blue. One monomer of each GroEL ring as well
as one GroES monomer are highlighted in ribbon representation (PDB entry code 1GRL (Braig et al., 1994)).  
(B) The mechanism of GroEL-GroES mediated protein folding is illustrated. GroEL and GroES are colored as
in (A). I: folding intermediate; N: native protein. See text for details (Hartl and Hayer-Hartl, 2002). 
(C) The crystal structure of the nucleotide-free E. coli Hsp90 HptG is shown in ribbon representation on the left.
The N-terminal domain (ND) is colored in orange, the middle domain (MD) in green, and the C-terminal
domain (CD) in blue. The apo HptG dimer is characterized by an open V-shape (PDB entry code 2IOQ (Shiau
et al., 2006)). On the right, the structure of the AMPPNP bound yeast Hsp90, Hsp82, is depicted. Nucleotide
binding leads to conformational changes resulting in a compact and twisted dimer (PDB entry code 2CG9 (Ali
et al., 2006)).  
(D) The ATPase cycle of Hsp90 is shown schematically. Hsp90 domains are colored as in (C). See text for
details (adapted from Wandinger et al., 2008). 
(E) Frontal and top views of the murine protein p97 are shown in ribbon representation. The six monomers are
colored in green, violet, dark blue, yellow, blue, and orange, respectively. p97 is involved in both membrane
fusion and ubiquitin dependent protein degradation. p97 was the first class I AAA+ protein crystallized as an
intact oligomer and its structure serves as a useful model for the structure of Hsp100 chaperones (PDB entry
code 1R7R (Huyton et al., 2003)). 
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binding causes the dissociation of both ADP and GroES from the former cis ring. Folding is 
allowed to proceed for approximately 10 s, then the ATP is hydrolyzed. Subsequent binding 
of ATP/GroES to the trans ring induces the opening of the cage and substrate release. Non-
native substrate can be recaptured until it has reached its native structure. Bioinformatic 
analysis suggests that a large fraction of GroEL substrates have an α/β fold and a molecular 
weight of up to 60 kDa. However, GroEL can also assist the folding of proteins which are too 
large to be encapsulated. 
Hsp90 is an abundant chaperone found in the cytoplasm, ER and mitochondria of 
eukaryotes as well as in eubacteria (Young et al., 2004; Saibil, 2008; Wandinger et al., 2008). 
It stabilizes client proteins such as transcription factors, regulatory kinases, or steroid 
hormone receptors until they are activated by downstream effectors. The known Hsp90 
substrates lack common structural features, but have been suggested to be characterized by 
protein instability. Hsp90 is a flexible dimer with each monomer consisting of an N-terminal 
nucleotide binding domain (ND) followed by a middle domain (MD) and a C-terminal 
dimerization domain (CD; Figure 2-4C). The basal ATPase activity of Hsp90 is rather low: 
Human Hsp90 hydrolyzes one molecule of ATP every 20 minutes. A model for the Hsp90 
ATPase cycle is illustrated in Figure 2-4D. Upon ATP binding (step 1), the ND undergoes a 
conformational change causing the so-called ATP lid to close over the nucleotide binding 
pocket (step 2). Subsequently, a short N-terminal segment is released from its original 
position and aligns with the respective part of the other monomer (step 3) leading to the 
formation of a compact dimer, in which the monomers are twisted around each other and in 
which the ND and MD are tightly associated. This conformation is ATPase active (step 4). 
After ATP hydrolysis, the NDs dissociate, the ATP lids open (step 5) and ADP and Pi are 
released (step 6) so that Hsp90 is ready for another cycle. Strikingly, more than a dozen of 
distinct Hsp90 cofactors have been found to modulate Hsp90 activity. Some of them regulate 
the Hsp90 ATPase activity by binding preferentially to a specific Hsp90 conformation. The 
main class of cofactors are the tetratricopeptide repeat (TPR) domain proteins, which interact 
with the ultimate C-terminal EEVD motif of Hsp90. One TPR domain protein is the Hsp 
organizing protein (HOP), known as Sti1p in S. cerevisiae. It is thought to physically link 
Hsp90 and Hsp70 by binding to the EEVD motifs of both chaperones, thereby possibly 
Figure 2-4 continued: Important cellular chaperone systems. 
(F) The functions of AAA+ proteins in protein degradation (upper panel) and disaggregation (lower panel). 
Whereas specifically tagged proteins (tag) are degraded by an AAA+ protein/ClpP complex, aggregates are 
dissolved by an AAA+ protein/Hsp70 complex. The P-element as well as the mobile loops harboring aromatic 
amino acids necessary for the threading activity for AAA+ proteins are highlighted. See text for details (adapted 
from Mogk et al., 2008). 
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coordinating substrate transfer from Hsp70 to Hsp90. Currently, the mechanism by which 
Hsp90 binds its substrates is not clear. Recent electron microscopy studies suggest that 
substrates might bind asymmetrically to one side of the dimer. 
The Hsp100 chaperones are members of the AAA+ superfamily (ATPases associated 
with various cellular activities). They play crucial roles in both degradation and refolding of 
misfolded proteins, depending on whether they associate with a peptidase or a chaperone 
system, respectively (Figure 2-3C and Figure 2-4F) (Liberek et al., 2008; Mogk et al., 2008; 
Saibil, 2008). Their activity strictly relies on the AAA domain, which not only binds and 
hydrolyzes ATP but also mediates oligomerization to hexameric rings. Depending on the 
composition of a monomer, AAA+ proteins are divided into two subgroups: The monomers of 
class I proteins contain two AAA domains ( E), monomers of class II proteins only 
one. The functional diversity of the AAA+ proteins arises from additional specific domains. 
Thus, the prokaryotic class I protein ClpA for example possesses a conserved P-element, 
through which it interacts with the barrel-shaped heptameric peptidase ClpP (Figure 2-4F, 
upper panel). In the complex, the AAA+ protein unfolds substrate proteins specifically tagged 
for degradation by threading them through its central channel to prepare them for degradation 
in the proteolytic chamber of the peptidase. The mechanical force required for the threading 
activity is mainly generated by conserved aromatic residues that are located on mobile loops 
at the central pore and bind and release the substrate in a nucleotide-controlled manner. In 
contrast to ClpA, the class I proteins ClpB (E. coli) or Hsp104 (S. cerevisiae) do not interact 
with peptidases but with Hsp70 and promote protein disaggregation rather than degradation. 
Other than ClpA, ClpB/Hsp104 does not contain a P-element but is characterized by a so-
called M-domain that is strictly required for the cooperation with Hsp70. The disaggregation 
activity of the Hsp70-ClpB/Hsp104 complex confers thermotolerance to the cells. 
Interestingly, ClpB homologs are only found in lower eukaryotes and plants which both have 
restricted motility and therefore cannot evade environmental stress like higher animals. The 
following model has been suggested for the Hsp70-ClpB/Hsp104 disaggregation process 
(Figure 2-4F, lower panel): Hsp70 is thought to loosen single polypeptides at the surface of 
the aggregate and to mediate their transfer to the central pore of ClpB/Hsp104. ClpB/Hsp104 
then exerts a ClpA-like threading activity. After translocation, the polypeptide is likely to be 
refolded by the Hsp70 chaperone system.  
Figure 2-4
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2.5 The Hsp70 system 
 
Hsp70s are key components of the cellular chaperone network in eukaryotes, bacteria, and 
some archaea. They perform a central role at the interface of protein folding, degradation and 
transport (Figure 2-3). Hsp70s coordinate between upstream chaperones such as the 
ribosome-bound folding helpers and downstream components such as the chaperonins, 
Hsp90, Hsp100, the proteasome, or the mitochondrial import receptor TOM70 (70 kDa 
translocase of the outer mitochondrial membrane), a key component for protein import into 
this organelle (Young et al., 2004). In addition to the cooperation with the listed systems, a 
vast ensemble of specialized cochaperones as well as a diversification into distinct hsp70 
genes allow Hsp70s to execute a broad spectrum of cellular functions (Mayer and Bukau, 
2005). The diversification distinguishes Hsp70s from most other chaperone families, which 
do not usually have multiple representatives in the same organism. E. coli for example 
harbors three Hsp70s. In the budding yeast S. cerevisiae, the Hsp70 superfamily contains 14 
homologs, 10 of which are classic Hsp70s. The latter can be functionally divided into two 
groups, the "generalists" (for example Ssa1-4p in S. cerevisiae with Ss standing for Stress 
seventy) and the "specialists" (for example the ribosome-associated Ssb1p and 2p in S. 
cerevisiae) (Morano, 2007). Another distinctive criterion for Hsp70s is their expression 
pattern: Their expression is either constitutive (e.g. mammalian Hsc70) or inducible by 
various environmental stimuli (e.g. mammalian Hsp70) and may depend on the stage of 
development (e.g. mammalian Hsc70t).  
Considering the central role of Hsp70s in cellular protein biology, it is not surprising 
that these chaperones are involved in human disease. As an anti-apoptotic protein, Hsp70 is 
complicit in cancer progression. Moreover, Hsp70 has a protective effect in 
neurodegenerative diseases. 
 
2.5.1 Structure and reaction cycle of Hsp70 
 
All Hsp70 homologs share a common architecture comprising an N-terminal nucleotide 
binding domain (NBD, 45 kDa) with similarity to actin and a C-terminal peptide binding 
domain (PBD, 25 kDa) (Mayer and Bukau, 2005; Genevaux et al., 2007). The NBD consists 
of two lobes, termed I and II, which are separated by a deep cleft, at the bottom of which the 
nucleotide is bound (Figure 2-5A). Each lobe is further divided into two small subdomains, a 
and b. The PBD is composed of a β-sandwich domain (15 kDa) comprising two four-stranded 
β-sheets with four upwards protruding loops (inner loops L1,2 and L4,5, outer loops L3,4 and 
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L5,6) and a lid-like three helix bundle domain (3HBD; B) (Zhu et al., 1996). The 
peptide binding cleft is formed by β-strands 1 and 2 as well as the loops L1,2 and L3,4, with the 
latter taking part in backbone-backbone hydrogen bonds with the extended substrate peptide. 
NBD and PBD are connected by a conserved linker containing a stretch of four hydrophobic 
Figure 2-5
Figure 2-5: Hsp70 structure and reaction cycle. 
A: The structure of the ADP-bound NBD of Hsp70 is shown. The NBD is depicted in ribbon and ADP in stick
representation. The NBD subdomains are indicated, Ia and IIb are colored in red, Ib and IIa in light pink.  
B: The structure of the PBD of DnaK in complex with a substrate peptide is shown. The PBD is depicted in
ribbon and the bound peptide in stick representation. The β-sandwich subdomain of the PBD is colored in
yellow, the 3HBD in green. The peptide NRLLLTG is shown in cyan. Loops are labeled (PDB entry code
1DKZ (Zhu et al., 1996)). 
C: Amino acid sequence alignment of the linker regions of evolutionarily distant Hsp70s. The numbers indicate
the percentage of pairwise sequence identity of the entire protein sequences relative to E. coli DnaK. Ec, E. coli;
Hs, H. sapiens; Sc, S. cerevisiae; BYV, Beet yellow virus  (Vogel et al., 2006b). 
D: Hsp70-mediated folding relies on two different conformational states of Hsp70. In the ATP state, peptide
binding is dynamic, while in the ADP and apo state, hydrophobic sequences exposed by unfolded proteins
(represented as a blue line) are stably bound. Interconversion between the two states is catalyzed by J-proteins
(Hsp40s) and NEFs. Hsp40s recognize unfolded substrates and recruit them to Hsp70 (step 1). Substrate as well
as transient J-protein binding trigger ATP hydrolysis by Hsp70 (step 2). NEFs catalyze the dissociation of ADP
from Hsp70 by stabilizing an open conformation of its NBD (steps 3 and 4). Upon rebinding of ATP, the inter-
domain linker is sequestered between the NBD and the PBD, the PBD opens and the substrate is released for
folding (step 5). 
 
2 Introduction 
 
18
amino acids flanked by two aspartic acid residues (Figure 2-5C). This linker has been 
suggested to be important for the NBD/PBD inter-domain communication: Whereas it is 
flexible and exposed in the nucleotide-free as well as in the ADP state of the NBD, it is buried 
at the NBD/PBD interface in the ATP state (Figure 2-5D) (Laufen et al., 1999; Rist et al., 
2006; Vogel et al., 2006a; Vogel et al., 2006b; Swain et al., 2007; Chang et al., 2008). 
Hsp70s are likely to perform all their cellular functions by a similar fundamental 
mechanism of substrate binding and release (Mayer et al., 2000; Mayer and Bukau, 2005). 
The substrate binding characteristics of the PBD are governed allosterically by the nucleotide 
status of the NBD (Figure 2-5D). In both the ATP and the ADP states, the PBD is thought to 
exist in equilibria of open and closed conformations. However, the rates for opening (ko) and 
closing (kc) are suggested to vary significantly between the two states – in the ATP state 
(ko > kc), substrate binding is dynamic, whereas in the ADP and apo state (ko < kc), unfolded 
proteins are stably bound. 
 Three structural features of the PBD are of particular importance for substrate binding 
(Mayer et al., 2000; Mayer and Bukau, 2005). The most important element is a hydrophobic 
pocket that accommodates a single hydrophobic side chain of the substrate and is the main 
contributor to the substrate binding energy. The hydrophobic nature of the central cavity and 
the negative surface potential in the surroundings of the cavity explain the substrate 
specificity of Hsp70s for extended peptides exposing hydrophobic as well as positively 
charged amino acid residues. The second important element is the so-called arch which is 
formed by two residues of loop L1,2 and L3,4 and encloses the backbone of the bound peptide. 
Interestingly, the arch-forming residues are the only substrate-contacting residues of the 
hydrophobic cavity that are highly variable in sequence and thus may contribute to the 
substrate specificity and functional specialization of Hsp70s. As third element, the α-helical 
lid (3HBD) ensures tight binding of the substrate protein in the ADP state. Arch and lid form 
a two-gated closing device. Extensive rearrangements in lid, arch and hydrophobic cavity are 
necessary for both substrate binding and release (Figure 2-5D steps 2 and 5). 
The transition from the ATP to the ADP state of Hsp70 is triggered by J-proteins 
(Hsp40s) (see chapter 2.5.2). They recognize unfolded substrate proteins, recruit them to 
Hsp70 (Figure 2-5D step 1) and induce ATP hydrolysis, thus enabling tight substrate binding 
(Figure 2-5D step 2). The reverse transition from the ADP to the ATP state and, consequently, 
substrate release is accelerated by NEFs (discussed in detail in chapters 2.5.3, 2.5.4, 2.5.5, 
2.5.6, and 2.5.7). NEF binding stabilizes an open conformation of the Hsp70 NBD (Figure 
2-5D step 3) and thereby triggers the release of bound ADP (Figure 2-5D step 4). Subsequent 
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rebinding of ATP, which is present in higher concentrations than ADP under physiological 
conditions, induces opening of the lid and the substrate is released for folding (Figure 2-5D 
step 5) (Mayer and Bukau, 2005). 
The mechanism by which Hsp70s facilitate substrate folding is not yet clear (Mayer and 
Bukau, 2005). According to the kinetic partitioning model, repeated cyles of substrate binding 
and release by Hsp70 keep the concentration of the unfolded substrate sufficiently low to 
prevent aggregation and to give free molecules the opportunity to reach their native fold. The 
local unfolding model suggests that binding and release cycles induce local unfolding of 
misfolded parts in the substrate polypeptide thereby allowing kinetically trapped proteins to 
fold properly. However, both models are unable to explain the disaggregation and membrane 
translocation activities of Hsp70 molecules. For these Hsp70 functions, the so-called entropic 
pulling model has been suggested (Sousa and Lafer, 2006; Goloubinoff and De Los Rios, 
2007): Hsp70 may bind to a hydrophobic peptide segment of either the aggregated protein or 
the protein emerging from the translocation pore in the mitochondrial matrix or ER. If only a 
few amino acid residues span the space between the chaperone binding site and the aggregate 
or pore, the thermal movements of Hsp70 will be sterically restricted. To increase its freedom 
of movement, the substrate-locked Hsp70 is thought to tumble away from the aggregate or 
pore. The resulting gain in entropy could balance the enthalpic costs for aggregate 
disentangling in case of protein disaggregation. In case of protein translocation, the entropic 
pulling force might be used to accelerate the unfolding of the cytosolic part of the substrate 
protein as well as substrate import. 
 
2.5.2 Hsp40 cochaperones induce the ATPase activity of Hsp70 
 
In absence of cochaperones, ATP hydrolysis is the rate-limiting step in the reaction cycle of 
most Hsp70s. Since the stimulation of ATP hydrolysis by substrate binding itself reaches only 
two- to ten-fold and thus is too low to drive the functional Hsp70 cycle, inefficient Hsp70 
cycling induced by unspecific peptide interactions is avoided. However, synergistically with 
J-domain cochaperones, protein substrates increase ATP hydrolysis significantly – more than 
1000-fold in the case of E. coli DnaJ (Mayer and Bukau, 2005; Genevaux et al., 2007). It has 
been suggested that repositioning of the Hsp70 linker region by J-protein binding plays a 
crucial role in the transmission of the "J signal" to the Hsp70 active site (Vogel et al., 2006b; 
Jiang et al., 2007; Swain et al., 2007).  
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J-proteins are a heterogeneous group of multi-domain proteins ( C), the 
number of which typically exceeds the number of Hsp70s in an organism (Qiu et al., 2006). 
Six J-protein-encoding genes were identified in the E. coli, 22 in the S. cerevisiae, and at least 
41 in the human genome. Specific J-proteins have been found in the cytosol, the nucleus, 
endosomes, mitochondria, the ER, and at ribosomes. Their expression can be ubiquitous as 
well as tissue-specific. Whereas some J-proteins functionally interact only with distinct 
Hsp70s, others cooperate with several different ones.  
Figure 2-6
Figure 2-6
 All J-proteins are characterized by the presence of a conserved, usually N-terminal J-
domain, which is necessary for Hsp70 binding (Qiu et al., 2006). The J-domain has 
approximately 70 amino acids and consists of four α-helices ( A). Helices II and III 
form a compact antiparallel coiled-coil fold and are connected by an exposed loop that 
Figure 2-6: J-domain proteins. 
(A) An NMR structure of the J-domain of E. coli DnaJ is shown in ribbon representation (PDB entry code 1XBL
(Pellecchia et al., 1996)). The conserved HPD motif is highlighted by ball-and-stick representation, helices II
and III are labeled (adapted from Mayer and Bukau, 2005). 
(B) A model for the C-terminal part of the Ydj1p dimer is shown in ribbon representation. α-helices are colored
blue, β-strands green. The two zinc atoms, which are coordinated by the cysteine-rich region, are shown as blue
spheres. Whereas the second zinc centre (Zn2) might be involved in Hsp70 chaperone cycle activation, the first
zinc centre (Zn1) is likely to contribute to substrate binding by Ydj1p. The C-terminal domain (CTD) is
composed of two homologous β-barrel subdomains, CTDs I and II. CTD I is essential for substrate binding: The
peptide substrate GWLYEIS (red) binds by extending a β-sheet of CTD I. Specifically, the central leucine inserts
into a hydrophobic pocket on the surface of Ydj1p. Homodimerization of Ydj1p occurs via the ultimate C-
terminal tail. The dimer is characterized by a large cleft between the monomers, which might accommodate the
substrate  (PDB entry code for the monomeric Ydj1p peptide binding fragment in complex with the substrate
peptide 1NLT (Li et al., 2003) and for the dimeric Ydj1p C-terminal fragment 1XOA (Wu et al., 2005)).  
(C) The subdomain organization of the three classes of J-proteins is illustrated schematically. J: J-domain,
purple; G/F: glycine and phenylalanine rich region, orange; Zn: Zn2+ binding domain, blue; CTDs: C-terminal
domains, green. 
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comprises the highly conserved HPD (His Pro Asp)-motif critical for the interaction with 
Hsp70. Moreover, strictly conserved positive residues in helix II contribute to the J-
protein/Hsp70 interaction (Genevaux et al., 2002). The Hsp70 NBD is contacted at the cleft 
between subdomain Ia and IIa as well as at the inter-domain linker (Suh et al., 1998; Suh et 
al., 1999; Jiang et al., 2007). Although the Hsp70 NBD is thought to be the major binding site 
for J-proteins, the Hsp70 PBD also seems to contribute vitally to the J-protein interaction 
(Suh et al., 1998; Suh et al., 1999). 
Based on the presence of further conserved domains in addition to the J-domain, three 
groups of J-proteins are distinguished (Figure 2-6C) (Walsh et al., 2004; Qiu et al., 2006; 
Genevaux et al., 2007). Type I proteins such as E. coli DnaJ, yeast Ydj1p, and human Hdj2, 
consist of (i) a J-domain, (ii) a flexible glycine and phenylalanine (G/F)-rich region, (iii) a 
central Zn coordinating cysteine-rich domain and (iv) a less conserved C-terminal region 
involved in substrate binding and homodimerization (Figure 2-6B). The G/F-rich region is 
known to be critical for the specific function of some J-proteins, but its precise role is still not 
understood. It may play a role in the inter-domain coordination between the J-domain and the 
substrate binding regions (Tzankov et al., 2008). Compared to type I proteins, type II proteins 
(e.g. yeast Sis1p and human Hdj1) have a less conserved G/F-rich region and lack the 
cysteine-rich domain. Type I and II J-proteins seem to have similar functions and to work as 
general purpose catalysts of the Hsp70 ATPase activity. Both can interact with non-native 
substrate proteins, which they recruit to their Hsp70 partners. In contrast, type III proteins 
seem to be much more specialized: Apart from the shared J-domain, different type III J-
proteins possess a variety of distinct domains, which allows them to perform specific 
functions. Importantly, several type III proteins are thought to assist the recruitment of a 
select isoform of Hsp70 to discrete cellular sites. The S. cerevisiae type III J-protein zuotin or 
the human homolog MPP11, both components of the cognate RAC complexes, recruit distinct 
Hsp70s to the ribosome for example (see also chapter 2.3). 
 
2.5.3 Hsp70 nucleotide exchange  
 
NMR studies suggest that the NBD of Hsp70s is highly flexible (Zhang and Zuiderweg, 2004; 
Mayer and Bukau, 2005). A shearing and tilting motion of the lobes towards each other leads 
to an opening and closing of the nucleotide binding cleft with the opening frequency 
depending on the bound nucleotide (nucleotide-free > ADP > ADP + Pi > ATP) and the 
Hsp70 isoform. Based on the nucleotide dissociation rates, three classes of Hsp70 molecules 
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can be distinguished with E. coli DnaK, E. coli HscA, and human Hsc70 serving as 
prototypes: Compared to DnaK, the spontaneous nucleotide dissociation rates of bovine 
Hsc70 and HscA are approximately 20- and 700-fold higher, respectively. These differences 
between the Hsp70s are thought to result from subtle structural variations in their NBDs with 
the most important ones being located close to the nucleotide binding site at the interface 
between the two Hsp70 lobes (Brehmer et al., 2001). In DnaK, three conserved elements 
seem to stabilize this interface and therefore ADP binding (Figure 2-7A,B): a hydrophobic 
patch at the top of the inter-lobe cleft (Ile58-Leu228 in Geobacillus kaustophilus DnaK) and 
two salt bridges (Arg55-Asp233, upper; Lys54-Glu236, lower). In agreement with looser 
nucleotide binding, Hsc70 homologs lack the hydrophobic contact as well as the upper salt 
bridge, and HscA homologs do not possess any of the three elements (Figure 2-7B). 
Correlating with their ADP dissociation rates, the three Hsp70 subfamilies vary in their 
dependence on NEFs (Mayer and Bukau, 2005). While bacterial DnaK strictly requires the 
NEF GrpE to perform its chaperone activities, HscA homologs – which are characterized by 
high spontaneous dissociation rates – seem to work independently of a NEF. Eukaryotic 
Hsc70 homologs have intermediate ADP dissociation rates and depend on NEFs only when 
ATP hydrolysis is strongly stimulated. Under these conditions nucleotide dissociation 
Figure 2-7: Structural differences in the NBDs of Hsp70s. 
(A) The NBD of Geobacillus kaustophilus DnaK is shown in ribbon representation and colored in red. ADP and 
Pi are depicted in stick representation. The hydrophobic interaction of Ile58-Leu228 and the salt bridges R55-
D233 and K54-E236 at the interface of the nucleotide binding cleft are visualized in purple, green and blue, 
respectively (PDB entry code 2V7Y (Chang et al., 2008)). 
(B) Amino acid sequences of the lobe I-lobe II interface of Hsp70 homologs are aligned according to the
structures of B. taurus Hsc70 (ADP-bound, PDB entry code 1HSC) and E. coli DnaK (nucleotide-free and GrpE-
bound, PDB entry code 1DKG). The presence or absence of the E. coli DnaK salt bridges Arg56-Glu264 and 
Lys55-Glu267 as well as of the hydrophobic interaction Val59-Met259 (black arrowheads) in various homologs 
is presented. The asterisk indicates sequence identity, the colon sequence similarity within the three Hsp70
subgroups. Eco: E. coli, Bsu: Bacillus subtilis, Mma: Methanosarcina mazei, Psa: Pisum sativum, Sce: S. 
cerevisiae, Ath: Arabidopsis thaliana, Hsa: Homo sapiens, Hin: Haemophilus influenzae, Pae: Pseudomonas 
aeruginosa, Avi: Acetobacter vinelandii, Bap: Buchneria aphidicola (adapted from Brehmer et al., 2001). 
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becomes rate-limiting for substrate release from Hsp70. In the eukaryotic cytosol and ER, 
three classes of NEFs have been identified so far, the BAG (Bcl2-associated athanogene) 
domain proteins, homologs of Fes1p/HspBP1 (Hsp70 binding protein 1) and homologs of 
Hsp110/Grp170. Their significance becomes evident when considering that dysfunction of the 
human ER homolog of HspBP1 leads to the rare inherited neurodegenerative disease 
Marinesco-Sjögren syndrome (Anttonen et al., 2005; Senderek et al., 2005). Furthermore, 
Hsp110/Grp170 homologs were shown to be essential for cell viability: Removal of cytosolic 
Hsp110 from yeast and deletion of grp170 in mice is lethal for both species (Kitao et al., 
2001; Shaner et al., 2004). 
 
2.5.4 GrpE  
 
GrpE (growth P-like gene E) is an essential, 
stress-inducible gene, which codes for the 
NEF of E. coli DnaK, GrpE (Harrison, 2003). 
GrpE forms homodimers. Each monomer 
consists of an unordered segment at the N-
terminus, a helix hairpin composed of a long 
and a short α-helix, and a C-terminal β-sheet 
domain (Figure 2-8) (Harrison et al., 1997). 
Homodimerization is mediated by the α-
helical domain.  
In the cocrystal structure with the NBD 
of DnaK, essentially all DnaK contacts 
involve only one – the so-called proximal – 
GrpE monomer, which is bent towards the 
DnaK NBD and thus leads to asymmetry in 
the GrpE dimer (Figure 2-8). The bulk of the 
GrpE/DnaK interactions are mediated by the 
protruding proximal β-sheet domain. The latter binds mainly through hydrophobic contacts to 
the mouth of the nucleotide binding cleft of DnaK and forces subdomain IIb to rotate outward 
by 14°. This open conformation of the NBD is incompatible with tight nucleotide binding. 
Interestingly, GrpE almost indiscriminately stimulates the dissociation of ADP and ATP from 
DnaK (Brehmer et al., 2001). In addition to the mouth of the DnaK NBD, two loops – the so-
 Figure 2-8: DnaK in complex with its NEF GrpE.
A ribbon representation of the dimeric GrpE in
complex with the NBD of DnaK is shown. The NBD
of DnaK is colored in red tones as in Figure 2-5A.
Subdomains Ib and IIb are indicated. Whereas the
GrpE monomer proximal to DnaK is colored in dark
blue, the distal monomer is represented in light blue.
Important structural features are labeled (PDB entry
code 1DKG (Harrison et al., 1997)).  
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called GrpE signature loop in subdomain IIb and a loop in subdomain Ia – were shown to be 
essential for GrpE binding (Buchberger et al., 1994; Brehmer et al., 2001).  
The long helices of GrpE not only contribute to DnaK binding but are also thought to 
serve as a thermosensor. At elevated temperature, they undergo a reversible helix-to-coil 
transition (TM ≈ 50 °C), which reduces the nucleotide exchange activity of GrpE towards 
DnaK (Grimshaw et al., 2001; Gelinas et al., 2002, 2003; Siegenthaler and Christen, 2005, 
2006). Consequently, the fraction of ADP-bound DnaK/substrate complexes is suggested to 
rise transiently, which is likely to contribute to the prevention of protein aggregation under 
non-permissive conditions.  
Independently of its NEF activity, GrpE is also thought to promote substrate release 
from the DnaK PBD with the help of its unordered N-terminal region, which seems to serve 
as a pseudo-substrate for DnaK (Chesnokova et al., 2003; Harrison, 2003; Brehmer et al., 
2004; Moro et al., 2007). 
 
2.5.5 BAG domain proteins 
 
In eukaryotes, GrpE homologs have only been found in bacteria-derived compartments, 
namely in mitochondria (e.g. MgeI in S. cerevisiae) and chloroplasts. The NEFs that perform 
nucleotide exchange on eukaryotic Hsp70s in the cytosol and ER are evolutionarily 
independent of GrpE. One group of these NEFs are BAG domain proteins (BDPs).  
BDPs form a heterogeneous family of multi-domain proteins (Takayama and Reed, 
2001; Alberti et al., 2003; Mayer and Bukau, 2005; Kabbage and Dickman, 2008). As 
illustrated for the eight human BDPs in Figure 2-9A, their common feature is the so-called 
BAG domain, which is located at the C-termini and mediates the interaction with the Hsp70 
partners. The further domain composition is specific for each BDP, allowing individual BDPs 
to interact with distinct target proteins as well as to assume different localizations in the cell. 
As a consequence, similar to type III J-proteins, BDPs have been suggested to serve as 
molecular adaptors, which are able to recruit Hsp70 chaperones to specific substrates or 
cellular compartments. BDPs have been reported to regulate a variety of cellular processes, 
often in cooperation with Hsp70. For example, human BAG-1 and Hsp70 are involved (i) in 
the regulation of Raf-1 protein kinase (Song et al., 2001), (ii) in the regulation of the 
transcriptional activity of androgen receptors (Froesch et al., 1998), or (iii) in protein 
degradation (Lüders et al., 2000; Alberti et al., 2002). Human BAG-4 – also known as 
silencer of death domains (SODD) – has been suggested to recruit Hsp70 to tumor necrosis 
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Figure 2-9: BAG domain proteins. 
(A) The subdomain organization of the eight human BDPs is illustrated schematically. BAG-1L, BAG-1M, and
BAG-1S are splicing variants of BAG-1. BAG domain, dark blue; ubiquitin-like domain, yellow; TXSEEX
motif, gray; PXXP motif, cyan; WW motif, light blue; DNA-binding motif, light green; nuclear localization
signal, green. The number of amino acids of the individual BDPs is indicated.   
(B) A ribbon representation of the BAG domain of BAG-1 in complex with the NBD of Hsc70 is shown. The
NBD of Hsc70 is colored in red tones as in Figure 2-5A, its subdomains are indicated. The BAG domain is
colored in dark blue and the three helices of the three helix bundle are labeled (PDB entry code 1HX1
(Sondermann et al., 2001)).  
 
factor receptor 1 (TNFR1) to prevent ligand-independent oligomerization of the latter (Jiang 
et al., 1999).  
Homologs of the BAG domain were found in diverse organisms ranging from yeast to 
mammals. The BAG domain is essential and sufficient for the nucleotide exchange function 
of BDPs. It contains 110 to 124 amino acids arranged in three anti-parallel helices of 30 to 40 
amino acids each (Figure 2-9B) (Sondermann et al., 2001). Helices two and three contact 
Hsc70 subdomains Ib and IIb mainly via highly conserved electrostatic interactions. Helix one 
might fix the orientation of the two other α-helices to facilitate efficient Hsc70 binding. 
Hsc70 complex formation with the BAG domain leads to an outward rotation of Hsc70 
subdomain IIb by 14° relative to the structure of ADP-bound Hsc70. Since this open 
conformation of the NBD is characterized by a distorted nucleotide binding site, the BAG 
domain accelerates ADP dissociation and consequently substrate release from Hsp70. 
Remarkably, the conformational states of the Hsc70 and DnaK NBDs stabilized by the BAG 
domain and GrpE, respectively, are very similar. The fact that the two NEFs are structurally 
unrelated, but employ the same molecular switch in Hsp70 suggests a convergent evolution of 
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the two proteins. Interestingly, the human Hsp70 interacting protein (HIP) was reported to 
antagonize the NEF activity of BAG-1 (Höhfeld et al., 1995).  
 
2.5.6 HspBP1 homologs 
 
HspBP1 homologs represent another distinct class of conserved NEFs for eukaryotic Hsp70s 
(Kabani et al., 2002b). In contrast to BDPs, HspBP1 homologs are single domain proteins and 
consequently might act as general, non-specialized NEFs for Hsp70 chaperones. 
HspBP1 is a relatively abundant protein in the human cytosol that has a higher 
expression level than Hsp70-1 in both normal and tumor cells (Tanimura et al., 2007). 
Initially, HspBP1 was identified as an Hsp70-interacting protein that inhibited Hsp70-
mediated protein refolding (Raynes and Guerriero, 1998; Tzankov et al., 2008). Later studies 
revealed its NEF activity on Hsc70 (Kabani et al., 2002b).  
The S. cerevisiae HspBP1 ortholog is named Fes1p and was found to be four times 
more abundant than the membrane-anchored yeast BDP Snl1p in vivo 
(Fes1p: Snl1p: Ssa1/2p = 4: 1: 189) (Kabani et al., 2002a; Ghaemmaghami et al., 2003). 
Deletion of FES1 causes a temperature-sensitive phenotype. Fes1p exchanges nucleotide on 
the yeast Hsp70 homologs Ssa1p and Ssb1p and supports efficient de novo protein folding in 
vivo (Kabani et al., 2002a; Shomura et al., 2005; Dragovic et al., 2006a). Interestingly, Fes1p 
seems to act during protein translation (Kabani et al., 2002a; Dragovic et al., 2006b). It 
competes with RAC for Ssb1p binding. As the two proteins have opposed functions – 
whereas RAC promotes ATP hydrolysis on Ssb1p and thus tight substrate binding, Fes1p 
accelerates ADP-ATP exchange – this finding could be of importance for the regulation of 
Ssb1p in co-translational protein folding.  
Sls1p/Sil1p (also termed BAP (BiP-associated protein) in mammalian cells) was 
identified as ER-lumenal HspBP1 homolog in mammals and yeast. It exchanges nucleotide on 
BiP, the Hsp70 homolog of the ER. In yeast, Sls1p/Sil1p is involved in the translocation of 
proteins into the ER as well as in ER-associated degradation (ERAD), probably by increasing 
the efficiency of the ER-resident Hsp70 Kar2p, the yeast homolog of BiP (Boisramé et al., 
1996; Boisramé et al., 1998; Kabani et al., 2000; Babour et al., 2008). As mentioned in 
chapter 2.5.3 already, mutations in SIL1 cause the Marinesco-Sjögren syndrome, a rare 
autosomal recessive cerebellar ataxia complicated by cataracts, developmental delay and 
myopathy (Anttonen et al., 2005; Senderek et al., 2005). In mice, loss of Sil1 function causes 
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an abnormal accumulation of ubiquitinated proteins in the ER and nucleus of cerebellar 
Purkinje cells leading to the neurodegeneration of the latter.   
Figure 2-10A shows the crystal structure of the core domain of human HspBP1 (BP1c) 
bound to lobe II of Hsp70 (Shomura et al., 2005). BP1c is an all α-helical protein containing 
four central Armadillo repeats (ARM1-4) flanked by capping helices at the chain termini. In 
the complex, BP1c wraps around subdomain IIb of the NBD of Hsp70. A high degree of 
surface and charge complementarity leads to an extended and tight interface between the two 
proteins. As most residues involved in the intermolecular contacts are highly conserved, it is 
likely that all HspBP1 homologs bind to their Hsp70 partners in a similar manner (Shomura et 
al., 2005; Dragovic et al., 2006b).  
The suggested mechanism for HspBP1-driven nucleotide exchange on Hsp70 differs 
from the one proposed for GrpE and the BAG domain (Figure 2-10B) (Shomura et al., 2005). 
Whereas the BAG domain binds to the central nucleotide binding cleft from the top by 
making contacts with both subdomains Ib and IIb, HspBP1 contacts subdomain IIb from the 
side. A NBD conformation as found in the BAG/GrpE complex would lead to sterical 
interference between NBD subdomain Ib and the N-terminus of HspBP1. Consequently, 
HspBP1 is thought to distort lobe I and to separate it from lobe II in addition to stabilizing an 
outward rotation of subdomain IIb. This notion is in agreement with experimental data 
Figure 2-10: HspBP1. 
(A) The complex of BP1c and Hsp70 lobe II is shown in ribbon representation. BP1c is colored in dark blue and
the four Armadillo repeats as well as N- and C-termini are labeled. Lobe II of DnaK is colored in red tones as in
Figure 2-5A, its subdomains are indicated (PDB entry code 1XQS (Shomura et al., 2005)). 
(B) Schematic models for the nucleotide exchange mechanisms of HspBP1 and BAG-1/GrpE. HspBP1 binding
is suggested to result in a distortion of Hsp70 lobe I as well as in an opening of lobe II (upper panel). BAG-1 and
GrpE lock subdomain IIb in an open conformation (lower panel). In both cases, the twisted Hsp70 NBD
conformations are incompatible with ADP binding. ATP rebinding leads to the dissociation of the NEF/Hsp70
complexes (adapted from Shomura et al., 2005).  
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showing that NBD lobe I is protease-sensitive in the HspBP1, but protease-resistant in the 
BAG domain complex. The separation of the two lobes in the HspBP1/NBDHsc70 complex is 
likely to trigger ADP release.  
It has been suggested that the different conformations imposed on the Hsp70 NBD by 
HspBP1 and the BAG domain might regulate the crosstalk between the PBD and downstream 
effectors such as the cochaperone CHIP (C-terminus of heat shock cognate 70 stress protein-
interacting protein) (Demand et al., 2001; Alberti et al., 2004). CHIP was reported to form 
ternary complexes with both HspBP1/Hsc70 and BAG-1/Hsc70. It negatively regulates 
Hsp70 ATPase and chaperone activities and – as an E3 ubiquitin ligase – supports the 
ubiquitination of unfolded Hsp70 substrates. Whereas the degradation function of CHIP is 
inhibited by HspBP1, it is stimulated by BAG-1.  
 
2.5.7 Hsp110 homologs 
 
Hsp110/Grp170 homologs form the third and probably principal class of eukaryotic NEFs. 
While Hsp110s are predominantly located in the cytosol, Grp170s are ER-lumenal proteins. 
In humans and mice, three Hsp110 family members have been identified: Hsp110 – more 
precisely the constitutively expressed Hsp105α and its heat-inducible splicing variant 
Hsp105β −, Apg-1, and Apg-2 (A: ATP binding domain, p: peptide binding domain, g: germ 
cell derived) (Easton et al., 2000). After Hsp70 and Hsp90, Hsp110 is the third most abundant 
Hsp in most mammalian cell lines and tissues studied so far. In heat-shocked chinese hamster 
ovary (CHO) cells, Hsp110 accounts for 0.7 % of total cell protein compared to 3.2 % for 
Hsc70 and Hsp70 combined and 1.2 % for Hsp90 (Subjeck et al., 1982). Hsp110 is broadly 
expressed in diverse mammalian tissues. However, expression levels are tissue-specific: 
While the constitutive expression of Hsp110 is low in heart and skeletal muscle for example, 
it is highly expressed in liver and brain (Lee-Yoon et al., 1995; Yasuda et al., 1995; Oh et al., 
1997). Apg-1 and Apg-2 are primarily expressed in the gonads; their expression levels in all 
other mouse tissues are low (Kaneko et al., 1997a; Kaneko et al., 1997b).  
S. cerevisiae possesses two Hsp110 homologs, Sse1p and Sse2p, which are both 
upregulated upon stress. Under normal growth conditions, only SSE1 is abundantly expressed 
(Mukai et al., 1993). For log-phase cells, a ratio of Sse1/2p to Ssa1/2p of 1 to 8 was 
determined (Ghaemmaghami et al., 2003).  
Interestingly, Hsp110/Grp170 homologs are distant relatives of canonical Hsp70s and as 
such belong to the Hsp70 superfamily (Morano, 2007). Like regular Hsp70s, they are 
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composed of an N-terminal NBD followed by a linker, a β-sandwich domain and a C-terminal 
3HBD (Figure 2-11A). However, most Hsp110s and Grp170s differ from Hsp70s by an 
additional C-terminal extension and a large acidic insertion into the β-sandwich domain. The 
latter is considerably longer in Grp170s. Furthermore, the Hsp110/Grp170 domains are much 
more divergent than the highly conserved domains of canonical Hsp70s (Shaner and Morano, 
2007). While yeast Ssa1p and human Hsp70 share 74 % overall sequence identity, yeast 
Sse1p and human Hsp110 are only 32 % identical. The sequence identity between the yeast 
and human Grp170 homologs, Lhs1p and Orp150 (oxygen-regulated protein), drops to 21 %.  
Strikingly, Grp170s are essentially as diverged from Hsp110s as from regular Hsp70s 
regarding the overall sequence similarity (Figure 2-11B) (Easton et al., 2000). 
Deletion of hsp110 or grp170 genes can have severe consequences for the cell, 
highlighting their importance. Whereas yeast cells lacking the SSE1 gene are characterized by 
Figure 2-11: Hsp110 homologs.  
(A) Hsp110s/Grp170s share the general domain composition with Hsp70s. Hsp70 domains are colored as
introduced in Figure 2-5. Compared to Hsp70s, Hsp110s/Grp170s are characterized by an insertion (ins.) into the
β-sandwich domain and a C-terminal extension (ext.). 
(B) The unrooted phylogenetic tree for canonical Hsp70 and Hsp110/Grp170 homologs illustrates the degree of
relationship between regular Hsp70s (green), Hsp110s (red), and Grp170s (blue) based on a sequence alignment.
While regular bacterial and eukaryotic Hsp70s share high sequence identity, Hsp110/Grp170 homologs are much
more variable. Grp170s are almost as diverged from Hsp110s as from Hsp70s. The Hsp110s from yeast and
Neurospora crassa are slightly more similar to the Hsp70/DnaK family than the Hsp110s and Grp170s from
higher eukaryotes. ATHS: Arabidopsis thaliana; BOV: bovine; C.E.: Caenorhabditis elegans; CHO: Chinese
Hamster Ovary; D.M.: Drosophila melanogaster; ECOLI: Escherichia coli; HUM: human; MOUS: mouse;
N.C.: Neurospora crassa; POM.: Saccharomyces pombe; S.C.: Saccharomyces cerevisiae; S.F.:
Strongylocentrotus franciscanus; S.P.: Saccharomyces pombe (adapted from Easton et al., 2000). 
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a growth defect, deletion of SSE2 alone does not lead to any phenotype. Deletion of both 
SSE1 and SSE2, however, is lethal for yeast (Mukai et al., 1993; Shaner et al., 2004; Raviol et 
al., 2006b). Surprisingly, mammalian Hsp110 does not complement the deletion of SSE1 
suggesting a significant functional divergence between the Hsp110 homologs in different 
organisms (Shaner et al., 2004). Strikingly, the deletion of Grp170 leads to embryonic 
lethality in mice (Kitao et al., 2001). The yeast Grp170 gene LHS1 is not essential for cell 
viability, however (Baxter et al., 1996; Craven et al., 1996; Hamilton and Flynn, 1996). 
Initially, Hsp110 homologs were shown to confer thermotolerance to cells in vivo and, 
comparable to canonical Hsp70s, to prevent aggregation of denatured proteins in vitro as well 
as to sustain them in a folding-competent state (Oh et al., 1997; Brodsky et al., 1999; Oh et 
al., 1999). However, Hsp110s were found unable to fold proteins independently of regular 
Hsp70s (Oh et al., 1997; Raviol et al., 2006a). In contrast to canonical Hsp70s, the ATPase 
activity appears not essential for Hsp110s: Although Sse1p shows a basal ATPase activity 
that is comparable to the ATPase rates of canonical Hsp70s, its biological function only 
depends on ATP binding but not on ATP hydrolysis (Shaner et al., 2004; Raviol et al., 
2006a). In contrast to a mutation abolishing Sse1p ATPase activity (K69M), a point mutation 
impairing ATP binding (G205D) cannot completely complement the deletion mutant 
ΔSSE1ΔSSE2. It was shown that nucleotide binding, and especially ATP binding, stabilizes 
Sse1p, indicating nucleotide-dependent conformational changes (Raviol et al., 2006a; Shaner 
et al., 2006).  
In addition to its function in aggregation prevention, early studies revealed a 
cooperation between Sse1p and Hsp90 (Liu et al., 1999; Goeckeler et al., 2002). For example, 
Sse1p is required for the effective in vitro expression of functional glucocorticoid receptor, a 
model substrate of the Hsp90 chaperone machinery. Furthermore, the Hsp90-dependent 
degradation of the mammalian von Hippel-Lindau tumor suppressor is abrogated in yeast 
lacking SSE1, indicating that Sse1p contributes to the turnover of this protein (McClellan et 
al., 2005). 
Subsequent studies then suggested that Hsp110 functionally cooperates with the Hsp70 
system. Coimmunoprecipitation studies showed that mammalian Hsp110 forms high 
molecular weight complexes with Hsp70 and the sHsp Hsp25 in vivo as well as in vitro 
(Hatayama et al., 1998; Wang et al., 2000). Similarly, Sse1p was found to stably 
heterodimerize with Ssa1/2p and Ssb1/2p, while Sse2p only seems to bind to Ssa1p (Shaner et 
al., 2005; Yam et al., 2005; Shaner et al., 2006). Taking into account the relative 
concentrations of Sse1p, Ssa1-4p, and Ssb1/2p in the cell, virtually the entire pool of cellular 
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Sse1p would conceivably be captured in these chaperone complexes. Whereas the 
Ssb1/2p·Sse1p complex was proposed to play a role in co-translational nascent chain 
stabilization, Ssa1-4p·Sse1p seems to act mostly at a post-translational stage to facilitate the 
folding of a more restricted protein subset. Since loss of Sse1p enhances polypeptide binding 
to both Ssa1p and Ssb2p, Sse1p has been suggested to work as an important regulator of the 
Hsp70/substrate interaction (Yam et al., 2005). Consistent with this notion were the 
observations that (i) Lhs1p, the yeast Grp170 homolog, acts as a NEF on Kar2p, the yeast ER-
resident Hsp70 (Steel et al., 2004) and that (ii) Sse1p stimulates the steady state ATPase 
activity of Ssa1p synergistically with the type I J-protein Ydj1p (Shaner et al., 2005). 
Assumptions that Hsp110s might work as NEF for Hsp70s were affirmed by the Hartl 
and Bukau laboratories (Dragovic et al., 2006a; Raviol et al., 2006b). In vitro, yeast Sse1p 
exchanges nucleotide on Ssa1p as well as on Ssb1p, Sse2p catalyzes nucleotide exchange on 
Ssa1p and human Hsp110 on human Hsp70. This suggests a conserved interaction between 
Hsp110 and Hsp70 chaperones in all eukaryotes. In further support of this hypothesis, Sse1p 
is even able to exchange nucleotide on mammalian Hsc70. Protein truncation studies revealed 
the Hsp70 and Hsp110 regions that are necessary to form a functional heterodimeric complex: 
Whereas almost the entire Sse1p molecule is required for nucleotide exchange activity, the 
NBD of Hsc70 was shown to be sufficient for functional complex formation with Sse1p 
(Dragovic et al., 2006a; Shaner et al., 2006).  
Along with nucleotide exchange, mammalian Hsp110 accelerates substrate release from 
the Hsp70 chaperone in vitro. Moreover, in concert with the respective Hsp70 and Hsp40 
chaperones, Sse1p and Hsp110 promote the in vitro as well as the in vivo refolding of firefly 
luciferase with regard to both rate and yield (Dragovic et al., 2006a; Raviol et al., 2006b). 
Reports on an inhibitory effect of Hsp110 homologs on in vitro substrate refolding can be 
explained by differences in the experimental conditions (Yamagishi et al., 2000; Shaner et al., 
2006). For example, the stoichiometry of Hsp110s and Hsp70s seems to be important for 
proper function because deletion as well as overexpression of SSE1 is toxic for yeast (Shaner 
et al., 2004; Dragovic et al., 2006a). Two further observations support an in vivo role of 
Sse1p in a functional chaperoning complex with Ssa1p and Ydj1p: First, the budding yeast 
mating pheromone alpha factor precursor (ppαF), whose translocation into the ER is Ssa1p-
dependent, accumulates in a ΔSSE1 strain and second, a ΔSSE1ΔYDJ1 strain is inviable 
(Shaner et al., 2004; Shaner et al., 2006).  
Interestingly, the NEF function of Sse1p was recently also found to be required for 
efficient de novo formation as well as stable propagation of [PSI+], the prion form of the S. 
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cerevisiae translation release factor Sup35 (Fan et al., 2007; Kryndushkin and Wickner, 2007; 
Sadlish et al., 2008). Possibly, Sse1p exerts its function by increasing the cytosolic level of 
substrate-free Ssa1p, whose overexpression was shown to stimulate prion formation. In 
addition, Sse1p might promote the transition to the prion form in a NEF-independent manner 
by directly stabilizing early intermediates in the Sup35 prion conversion and thereby 
facilitating seed formation. Alternatively, Sse1p may also bind to existing prion fibers and 
thus inhibit the disaggregating curing function of Hsp104 (Sadlish et al., 2008). Interestingly, 
in contrast to [PSI+] propagation, [URE3] (the prion form of S. cerevisiae Ure2p) propagation 
is disrupted not only by depletion but also by overproduction of Sse1p. This indicates a highly 
prion-specific effect of Sse1p (Kryndushkin and Wickner, 2007). 
Notably, the cytosolic NEFs Sse1p and Fes1p catalyze nucleotide exchange on the same 
Hsp70 partners. However, their functions seem to be only partially redundant. Overexpression 
of FES1 rescues a ΔSSE1ΔSSE2 strain, but not as effectively as expression of SSE1. Possibly, 
complexes of Hsp70 with Sse1p and Fes1p, respectively, are adapted to different substrate 
spectra. For example, being an Hsp70 family member, Sse1p might specifically recognize 
substrates (Dragovic et al., 2006a; Dragovic et al., 2006b).  
 
2.6 Aim of the study 
 
Recent studies have revealed that Hsp110 homologs trigger nucleotide exchange on canonical 
Hsp70s and support efficient folding of Hsp70 substrates in vitro as well as in vivo (Dragovic 
et al., 2006a; Raviol et al., 2006b). However, the mechanism by which Hsp70 and Hsp110 
cooperate in protein folding is largely unclear. Specifically, it remains to be clarified how 
Hsp110s exchange nucleotide on their Hsp70 partners. Strikingly, almost the entire length of 
Sse1p (77 kDa) is required for functional interaction with Hsp70 (Dragovic et al., 2006a). 
This is particularly surprising when considering that the much smaller BAG domain (13 kDa) 
is also sufficient for nucleotide exchange on Hsp70. Furthermore, the role of direct 
Hsp110/substrate interactions in Hsp70-mediated protein folding is still elusive. Possibly, 
additional Hsp110 functions beyond nucleotide exchange could explain why the NEF Fes1p 
cannot completely complement the loss of Hsp110 in yeast (Raviol et al., 2006b). Finally, it is 
not clear yet whether Hsp70-like allosteric coupling between the Hsp110 NBD and PDB is 
required for Hsp110 function. 
The goal of the present study was to solve the crystal structure of a complex between an 
Hsp110 and an Hsp70 protein, preferably using one of the best-studied systems, i.e. human 
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Hsp110 and Hsp70/Hsc70 or yeast Sse1p and Ssa1p/Ssb1p. The structure would open a 
rational strategy to investigate the cooperation between the two chaperones by mutational 
analysis. Specific amino acid exchanges at the interface between the two complex partners 
should reveal the structural requirements for nucleotide exchange by Hsp110 homologs. 
Mutations at the putative peptide binding site in the β-sandwich domain of the Hsp110 protein 
should clarify the role of direct Hsp110/substrate interactions. Amino acid exchanges at 
Hsp110 domain-domain interfaces should reveal whether inter-domain signaling is similarly 
important for Hsp110 as for Hsp70 chaperones. The combination of both structural and 
functional data should lead to a model for the cooperation of Hsp110 and Hsp70 in protein 
folding.  
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3 MATERIALS AND METHODS 
 
3.1 Chemicals and biochemicals 
 
Unless otherwise stated, chemicals were of pro analysi quality and purchased from Sigma-
Aldrich (Steinheim, Germany) or Merck (Darmstadt, Germany). 
 
BioMol (Hamburg, Germany): HEPES 
Bio-Rad (München, Germany): 
• Bradford protein assay reagent 
• Ethidium bromide 
Biozym Scientific GmbH (Hessisch Oldendorf, Germany): Agarose 
Clontech (Heidelberg, Germany): Herring testis carrier DNA 
Difco (Heidelberg, Germany): 
• Bacto Agar 
• Bacto Tryptone 
• Bacto peptone 
• Bacto Yeast Extract 
• Bacto Yeast Nitrogen Base 
Dr. D.J. Thiele, Ph.D., Duke University Medical Center (Durham, USA): pYEP-SSA3-lacZ 
Fermentas (St. Leon-Rot, Germany):  
• GeneRuler 1 kb DNA Ladder 
• PageRuler Prestained Protein Ladder 
• PageRuler Protein Ladder 
• Restriction enzyme EheI 
Fluka (Deisenhofen, Germany): 
• ADA 
• Bis-Tris 
• H2O2 
• Luminol 
• polyethylene glycols of different molecular weights 
• Sodium cacodylate 
GE Healthcare (München, Germany): 
• Chelating Sepharose 
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• Chloramphenicol 
• DEAE-Sepharose 
• MES 
Hampton Research (Aliso Viejo, USA):  
• Crystal Screen 
• Crystal Screen 2 
• Crystal Screen Lite 
• Index Screen 
Invitrogen (Karlsruhe, Germany): pPROEX HTb 
Dr. J.L. Brodsky (University of Pittsburgh, Pittsburgh, USA):  
• 6-carboxyfluorescein labeled peptide LICGFRVVLMYRF 
• Unlabeled LICGFRVVLMYRF 
J.M. Gabler Saliter GmbH & Co. KG (Obergünzburg, Germany): Skim milk powder  
JPT Peptide Technologies GmbH (Berlin, Germany): Luciferase peptide membrane 
Metabion (Martinsried, Germany): 
• dNTPs 
• mi-Plasmid Miniprep Kit 
• oligonucleotides (primers) 
• oligopeptide dansyl-NRLLLTGC 
Mo Bi Tec (Göttingen, Germany): MABA-ATP 
MPI for Biochemistry, Department of Cellular Biochemistry (Martinsried, Germany): 
Protein complex screen (Radaev and Sun, 2002; Radaev et al., 2006) 
MPI for Biochemistry, Core Facility (Martinsried, Germany): Oligopeptides 
New England Biolabs (Frankfurt am Main, Germany): 
• BSA 
• Restriction endonucleases 
• T4 DNA ligase 
• Vent DNA polymerase 
Promega (Mannheim, Germany): 
• Luciferase Assay System (#E1501) 
• Pfu polymerase 
• PureYield Plasmid Midiprep System 
• Taq polymerase 
• Wizard Plus SV Minipreps DNA Purification System 
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• Wizard SV Gel and PCR Clean-Up System 
Qiagen (Hilden, Germany): 
• Crystallization Screen NeXtal ProComplex Suite 
• Qiagen Plasmid Midi Kit 
• QIAprep Spin Miniprep Kit 
Roche (Basel, Switzerland): 
• AMP-PNP 
• Benzonase 
• DTT 
• EDTA-free Complete protease inhibitor cocktail 
• Expand Long Template PCR System  
• Hexokinase 
• Proteinase K 
• Shrimp alkaline phosphatase 
Roth (Karlsruhe, Germany): 
• Ampicilin 
• IPTG 
Serva (Heidelberg, Germany): 
• Acrylamide-Bis 
• BSA (fraction V) 
• Coomassie Blue R250 
• PMSF 
• SDS  
Stratagene (Heidelberg, Germany): Herculase Enhanced DNA Polymerase 
 
3.2 Antibodies 
 
Rabbit polyclonal Hsp12 antibody:  generous gift from Dr. M. Haslbeck (TU 
München, Germany), dilution 1:2000 
Rabbit polyclonal Hsp42 antibody:  generous gift from Dr. M. Haslbeck (TU 
München, Germany), dilution 1:2000 
Mouse monoclonal Hsp70 (MA3-007) antibody:  Thermo Fisher Scientific (Waltham, 
USA), dilution 1:1000 
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Rabbit polyclonal Hsp104 (PA3-016) antibody:  Thermo Fisher Scientific (Waltham, 
USA), dilution 1:2430 
Rabbit polyclonal Ssa1 antibody:  Dr. K. Siegers, MPI for Biochemistry 
(Martinsried, Germany), dilution 1:5000 
Rabbit polyclonal Ssa3/Ssa4 antibody:  generous gift from Dr. E. Craig 
(University of Wisconsin, Madison, 
USA), dilution 1:2000 
Rabbit polyclonal Sse1 antibody:  Dr. Z. Dragovic, MPI for Biochemistry 
(Martinsried, Germany), dilution 1:5000 
Goat polyclonal Ydj1 (yN-18) antibody:  Santa Cruz Biotechnology, inc. 
(Heidelberg, Germany), dilution 1:133 
Rabbit polyclonal luciferase antibody:  Department of Cellular Biochemistry, 
MPI for Biochemistry (Martinsried, 
Germany), dilution 1:500 
Mouse polyclonal PGK antibody:  Invitrogen (Karlsruhe, Germany), 
dilution 1:3333  
HRP-conjugated secondary antibodies:  Sigma-Aldrich (Steinheim, Germany), 
dilution 1:3333 
 
 
3.3 Strains 
 
Strain Genotype Origin 
E. coli   
DH5α 
 
supE44ΔlacU169 (φ80lacZΔM15) hsdR17 
recA1 endA1 gyrA96 thi-1 relA1 
Invitrogen 
(Karlsruhe, Germany) 
BL21  
(DE3) 
B F– ompT hsdS(rB– mB–) dcm+ gal λ(DE3)  
 
Stratagene 
(Heidelberg, Germany) 
 
BL21  
(DE3) 
codon plus 
RIL 
B F– ompT hsdS(rB– mB–) dcm+ Tetr  
gal λ(DE3) endA Hte [argU ileY leuW Camr] 
Stratagene 
(Heidelberg, Germany) 
 
Yeast   
YPH499 
 
MATα ade2-101ochre his3Δ200 leu2Δ1 
lys2-801amber trp1Δ63 ura3-52 
Sikorski and Hieter, 
1989 
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Strain Genotype Origin 
SB472 
 
 
MATα ade2-101ochre his3Δ200 leu2Δ1 
lys2-801amber trp1Δ63 ura3-52 sse1::His3 
sse2::KanMX4 pCM189-SSE1-URA3 
Dr. S. A. Schäuffelhut, 
MPI for Biochemistry 
(Martinsried, Germany) 
SB537 
 
 
MATα ade2-101ochre his3Δ200 leu2Δ1 
lys2-801amber trp1Δ63 ura3-52 sse1::His3 
Dr. S. A. Schäuffelhut, 
MPI for Biochemistry 
(Martinsried, Germany) 
MW141 MATα his3-11,15 leu2-3,112 trp1 ura3-52 
ssa1::HIS3 ssa2::LEU2 ssa4::URA3 pGal1-
SSA1 
Deshaies et al., 1988 
 
 
3.4 Media and buffers 
 
3.4.1 Media 
 
Unless otherwise stated, media were prepared with deionized water and autoclaved after 
preparation. 
 
LB medium:   10 g/l Bacto Tryptone 
5 g/l Bacto Yeast Extract  
10 g/l NaCl 
(15 g/l agar for solid medium) 
adjust pH 7.0 with 5 M NaOH 
 
M9 minimal medium:  775 ml H2O (autoclaved) 
20 ml 20 % (w/v) glucose (sterile-filtered) 
2 ml 1 M MgSO4 (autoclaved) 
0,1 ml 1 M CaCl2 (autoclaved) 
200 ml 5x M9 salts (autoclaved) 
 
5x M9 salts:    64 g/l Na2HPO4·7H2O 
15 g/l KH2PO4 
2,5 g/l NaCl 
5 g/l NH4Cl 
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Psi broth:    5 g/l Bacto Yeast Extract 
20 g/l Bacto Tryptone 
5 g/l MgSO4 
adjust pH 7.6 with 5 M KOH 
 
SC medium (1 l):  6,7 g/l Bacto Yeast Nitrogen Base 
2 g/l drop-out mix (see below) 
adjust pH 5.6, autoclave 
50 ml 40 % (w/v) glucose (sterile-filtered) 
if required:  
55.3 mg/l adenine (autoclaved) 
22.4 mg/l uracil (autoclaved) 
219.0 mg/l L-leucine (autoclaved) 
62.9 mg/l L-histidine (autoclaved) 
182.6 mg/l L-lysine (autoclaved)  
81.7 mg/l L-tryptophane (sterile-filtered) 
 
SC plates: as SC medium, but add 20 g/l agar 
Agar solution and Bacto Yeast Nitrogen Base/drop-out mix 
solution need to be autoclaved separately to prevent acidic 
hydrolysis of  the agar, which would occur due to the low pH of 
the Bacto Yeast Nitrogen Base/drop-out mix solution.  
 
5-FOA medium/plates: as SC medium/plates, but add 1 g/l 5-FOA after autoclaving 
 
Drop-out mix: 5 g of each to the following L-amino acids: alanine, arginine, 
asparagine, aspartic acid, cysteine, glutamine, glutamic acid, 
glycine, isoleucine, methionine, phenylalanine, proline, serine, 
threonine, tryptophane, tyrosine 
5 g myo-inositol 
0.5 g p-aminobenzoic acid 
triturate to homogeneity, store as powder 
The following compounds are prepared separately: 
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compound 
final conc. 
in SC medium 
(mg/l) 
stock 
solution 
(g/l) 
volume 
to pipette 
in SC 
medium 
(ml/l) 
comment 
adenine 55.3 5.53 10.0 heat up for 
dissolving 
uracil 22.4 2.24 10.0 heat up in 
NaHCO3 
for 
dissolving 
L-Leu 219.0 13.20 16.6 heat up for 
dissolving 
L-His 62.9 12.57 5.0 - 
L-Lys 182.6 18.26 10.0 - 
L-Trp 81.7 8.17 10.0 sterile filter
 
YPD medium (1 l):   10 g/l Bacto Yeast Extract 
20 g/l Bacto Peptone 
50 ml 40 % (w/v) glucose (sterile-filtered) 
(10 g/l agar for solid medium) 
 
YP-gal medium (1 l):   10 g/l Bacto Yeast Extract 
20 g/l Bacto Peptone 
50 ml 40 % (w/v) galactose (sterile-filtered) 
(10 g/l agar for solid medium) 
 
3.4.2 Buffers and standard solutions 
 
Buffers were prepared with deionized water (electrical resistance 18.2 MΩ·cm). 
 
Alkaline lysis buffer:   1.85 M NaOH 
1 M β-mercaptoethanol 
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Antibiotic solutions (1000x): 100 mg/ml ampicillin 
      28 mg/ml chloramphenicol 
      25 mg/ml kanamycin  
 
ATP buffer:    50 mM HEPES-NaOH pH 7.4 
20 mM NaCl 
2 mM MgCl2 
2 mM DTT 
3 mM ATP  
 
Buffer A:     10 mM HEPES-KOH pH 7.5 
10 mM KCl 
1 mM MgCl2 
 
Buffer A1:     25 mM HEPES-NaOH pH 7.5 
10 mM NaCl 
4 mM MgCl2 
 
Buffer C:      10 mM K-phosphate pH 7.5 
0.5 mM MgCl2 
0.5 mM ATP 
 
Buffer D:     10 mM HEPES-NaOH pH 7.5 
150 mM NaCl 
5 mM EDTA 
5 mM β-mercaptoethanol  
 
Buffer E:     10 mM HEPES-NaOH pH 7.5 
150 mM NaCl 
4 mM MgCl2  
 
Buffer L:     25 mM HEPES-KOH pH 7.5 
300 mM KCl 
4 mM MgCl2 
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Buffer L1:     25 mM HEPES-NaOH pH 7.5 
300 mM NaCl 
4 mM MgCl2 
 
Buffer R:     25 mM HEPES-KOH pH 7.8 
50 mM KCl 
5 mM MgOAc  
1 mM DTT 
 
Buffer S:     50 mM HEPES-NaOH pH 7.4 
500 mM NaCl 
2 mM MgCl2 
2 mM DTT 
 
Buffer Z:     100 mM Na-phosphate pH 7.0 
      10 mM KCl 
      1 mM MgSO4 
      50 mM β-mercaptoethanol 
 
Coomassie destainig solution:  10 % (v/v) ethanol 
10 % (v/v) acetic acid 
 
Coomassie stainig solution:  0.1 % (w/v) Serva Coomassie Blue R250 
40 % (v/v) ethanol 
10 % (v/v) acetic acid 
 
DEAE buffer:     25 mM HEPES-KOH pH 7.4 
20 mM KCl 
4 mM MgCl2 
2 mM DTT 
1 mM ATP 
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DNA-loading buffer (6x):  0.25 % (w/v) bromophenol blue 
      0.25 % (w/v) xylene cyanol FF 
      40 % (w/v) sucrose in H2O 
 
ECL solution I:    100 mM Tris-HCl pH 8.8 
2.5 mM luminol (3-aminophthalhydrazid; stock: 250 mM 
in DMSO, dark, 4 °C) 
0.4 mM p-coumaric acid (stock: 90 mM in DMSO, dark, 
4 °C)   
 
ECL solution II:   100 mM Tris-HCl pH 8.5 
      5.4 mM H2O2  
 
Glycerol buffer:    50 % (v/v) glycerol in buffer R 
      
GTP buffer:     50 mM HEPES-NaOH pH 7.4 
20 mM NaCl 
2 mM MgCl2 
2 mM DTT 
1 mM GTP  
 
HKM2 buffer:    10 mM HEPES-KOH pH 7.4 
      150 mM KCl 
      1 mM MgCl2 
 
HKM3 buffer:    10 mM HEPES-KOH pH 7.4 
      150 mM KCl 
      4 mM MgCl2 
 
PBS (10x):     92 mM Na2HPO4·2H2O 
      16 mM NaH2PO4·H2O  
      1.5 M NaCl 
      adjust pH 7.2 with NaOH  
 
3 Materials and Methods 
 
44
PBST:      1x PBS  
      0.1 % (v/v) Tween 20 
 
Ponceau S stain:   0.2 % (w/v) Ponceau S 
      3 % (v/v) trichloro acetic acid 
 
Protoplast buffer:   100 mM Tris-HCl pH 7.5 
      10 mM EDTA 
      143 mM β-mercaptoethanol 
      0.2 mg/ml Zymolyase 20T 
      0.1 mg/ml RNaseA 
 
Regeneration buffer A:  8 M urea 
      1 % (w/v) SDS 
      0.1 % (v/v) β-mercaptoethanol 
 
Regeneration buffer B:   400 ml H2O 
      500 ml ethanol 
      100 ml acetic acid 
  
SDS-loading buffer (2x):   100 mM Tris-HCl pH 6.8 
4 % (w/v) SDS 
200 mM DTT 
20 % (v/v) glycerol 
0.2 % (w/v) bromphenolblue 
 
SDS-running buffer (10x):  250 mM Tris 
2.5 M glycine 
1 % (w/v) SDS 
 
Stripping buffer:     62.5 mM Tris-HCl pH 6.7 
100 mM β-mercaptoethanol 
      2 % (w/v) SDS 
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TAE buffer (50x):   2 M Tris-acetate 
      50 mM EDTA pH 8.0 
 
TBS (10x):     500 mM Tris-HCl pH 8.0 
      1.37 M NaCl 
      27 mM KCl 
 
TBST (10x):    200 mM Tris-HCl pH 7.5 
      1.37 M NaCl 
      1 % (v/v) Tween 20 
 
TfbI buffer (200 ml):   30 mM K-acetate 
100 mM RbCl 
10 mM CaCl2 
15 % (v/v) glycerol 
      adjust pH 5.8 with 0.1 M acetic acid 
adjust final volume of 180 ml with deionized H2O 
      autoclave 
      add 20 ml of sterile-filtered 500 mM MnCl2·2H2O 
 
TfbII buffer:    10 mM MOPS 
75 mM CaCl2 
10 mM RbCl2 
15 % glycerol 
   adjust pH 6.5 with 0.1 M NaOH 
   sterile filter 
 
Urea-SDS-loading buffer:   200 mM Tris-HCl pH 6.8 
8 M urea 
5 % (w/v) SDS 
0.1 mM EDTA 
143 mM β-mercaptoethanol 
0.03 % (w/v) bromphenolblue 
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Western Blot buffer:    50 mM Tris  
20 % (v/v) methanol 
192 mM glycine 
 
Yeast lysis solution:   0.2 M NaOH 
      1 % (w/v) SDS 
 
3.5 Materials and Instruments 
 
Agilent Technologies (Santa Clara, USA): variable wavelength detector Agilent 1100 series 
Applied Photophysics (Surrey, UK): SX.18V stopped-flow instrument 
Bachofer (Reutlingen, Germany): Hybridization oven 
B. Braun Melsungen AG (Melsungen, Germany): Orbital shaker Certomat R 
Beckman Coulter GmbH (Krefeld, Germany): 
• Centrifuges (GS-6R, Allegra-6R, Avanti J-25 with rotors JLA 10.500 and JA 25.50, 
J6-MI with rotor JS 4.2) 
• DU 640 UV/VIS Spectrophotometer 
• DU 800 UV/VIS Spectrophotometer 
• Optima LE 80K ultracentrifuge with rotor 45 Ti 
Berthold (Huntsville, USA): Luminometer LB9507 
Biometra (Göttingen, Germany): PCR thermocycler 
Bio-Rad (München, Germany): 
• Gene Pulser Xcell electroporation system with electroporation cuvettes (0.1 cm) 
• Horizontal agarose gel electrophoresis system (Wide) Mini-SUB CELL GT 
• Mini Protean II electrophoresis cell 
• Power Pac 300 
BioScience, Inc. (Salt Lake City, USA): Pre-lubricated Sorenson safe seal microcentrifuge 
tubes, RNase/DNase-free 
Biospec (Bartlesville, USA): Bead Beater 
Eppendorf (Hamburg, Germany): 
• Centrifuges (5415D and 5417R) 
• Pipettes (2.5, 10, 20, 100, 200, 1000 µl)  
• Thermomixer comfort 
Fisher Scientific (Schwerte, Germany): Accumet Basic pH meter 
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Fuji/Raytest (Straubenhardt, Germany):  
• Fuji-LAS3000 luminescence and densitometry system with Image Reader LAS-3000  
• Gel imaging software: AIDA v.3.5.0 
GE Healthcare (München, Germany): 
• Äkta FPLC 
• Äkta Purifier 
• Electrophoresis Power Supply – EPS 600 
• Ettan LC 
• Prepacked chromatography columns (HiLoad 16/60 Superdex 200 prep grade, HiLoad 
26/60 Superdex 200 prep grade, HiPrep 26/10 Desalting, HiTrap Chelating HP, 
MonoQ HR 10/10, MonoQ HR 10/16, NAP-5 Sephadex G25 desalting column, NAP-
10 Sephadex G25 desalting column, NAP-25 Sephadex G25 desalting column, 
Superose 12 PC 3.2/30, Superose 12 HR 10/30)  
Hampton Research (Aliso Viejo, USA): 
• Cryo tong 
• Magnetic wand 
• Mounted cryo loops 
• Siliconized glass square cover slides (22 mm) 
• VDX Plate with sealant 
Heidolph (Schwabach, Germany): Heatable magnetic stirrer 
Hellma (Mühlheim, Germany): Quartz cells 
Heraeus (Hanau, Germany): Function line incubator 
Horiba Jobin Yvon GmbH (München, Germany): Spex Fluorolog 3 (with software 
FluorEssence) 
Jasco (Groß-Umstadt, Germany): 
• J-715 spectrometer with peltier-thermostat 
• UV/VIS spectrophotometer V-560 
Mettler Toledo (Gießen, Germany): Balances (AG285 and PB602) 
Millipore (Schwalbach, Germany): 
• Centriprep concentrators (10.000 and 30.000 Da MWCO) 
• Steritop Filtration System (pore size 0.22 μm) 
Misonix (Farmingdale, USA): Sonicator 3000 
Molecular Dimensions Limited (Cambridgeshire, Great Britain):  
• Magnetic cryo vials and cryo caps with data matrix 
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• ESRF sample changer kit 
MPI for Biochemistry (Martinsried, Germany): Western Blot system (semi-dry) 
MWG AG Biotech (Ebersberg, Germany): Gel documentation system 
New Brunswick Scientific (Nürtingen, Germany): Innova 44 incubator shaker 
Olympus Corporation (Tokyo, Japan): Stereo-zoom microscopes SZXZ-ILLK and SZH-
ILLK200 
Sartorius (Göttingen, Germany):  
• Laboratory water purification system Arium 
• Sterile filters Minisart (pore size 0.22 and 0.45 µm) 
• Vivaspin 500 concentrators (10.000 and 30.000 Da MWCO) 
• Vivaspin 20 concentrators (10.000 and 30.000 Da MWCO) 
Scientific Industries, Inc. (Bohemia, USA): Vortex-Genie 2 
Taylor-Wharton (Theodore, USA): Dry shippers 
Whatman GmbH (Dassel, Germany): Whatman Protran nitrocellulose transfer membrane  
Wyatt Technology (Santa Barbara, USA):  
• FFF-MALS with DAWN EOS MALS detector and Optilab DSP refractive index 
detector  
• software ASTRA 
 
3.6 Molecular biological methods 
3.6.1 DNA analytical methods 
3.6.1.1 DNA quantification 
DNA concentrations were determined by UV spectroscopy. DNA solutions were 
appropriately diluted with water, and DNA-free water served as a reference. At a wavelength 
of 260 nm, one absorption unit corresponds to 50 ng/µl double stranded DNA in water. The 
absorbance ratio 260/280 nm for pure DNA should be approximately 1.85. Deviations from 
this value indicate quality deficiencies caused by impurities such as RNA or protein 
(Sambrook et al., 1989). 
 
3.6.1.2 Agarose gel electrophoresis 
Agarose gels contained 0.8 % (w/v) agarose in 1x TAE buffer. Agarose was melted by 
heating. For the visualization of double stranded DNA, 1 µg/ml ethidium bromide was added. 
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Prior to being loaded on the gel, DNA samples were mixed with 6x DNA-loading buffer. 
Agarose gel electrophoresis was performed in 1x TAE buffer at a constant voltage of 80 V. 
 
3.6.1.3 DNA sequencing 
The integrity of all plasmid inserts was verified by DNA sequencing performed by the 
sequencing service of the Core Facility of the MPI for Biochemistry in Martinsried. For one 
sequencing reaction, approximately 5 µl of 100 ng/µl plasmid are needed. Sequencing 
chromatograms were checked with the help of the program Chromas (C. McCarthy, Griffith 
University, Australia), and comparative sequence analysis was performed using the MultAlin 
analysis program (Corpet, 1988; http://bioinfo.genopole-toulouse.prd.fr/multalin/ 
multalin.html). 
 
3.6.2 Purification of DNA fragments and plasmid DNA 
 
For purification of DNA fragments after agarose gel electrophoresis (e.g. after PCR, see 
chapter 3.6.4) or after enzymatic reactions (e.g. after restriction digest, see chapters 3.6.5 and 
3.6.6), anion exchange chromatography was conducted using the Wizard SV Gel and PCR 
Clean-Up System. Differing from the producer's recommendations, only one washing step 
with 500 µl of Membrane Wash Solution was performed. 
For isolation and purification of plasmid DNA from overnight E. coli DH5α cultures, 
the QIAprep Spin Miniprep Kit, the Wizard Plus SV Miniprep DNA Purification System, the 
mi-Plasmid Miniprep Kit, or the Qiagen Plasmid Midi Kit was used according to the 
manufacturer's instructions. 
 
3.6.3 Cloning strategies 
 
To construct sse1-Δloop, in which SSE1 codons 503-524 are replaced by four codons 
(GCCGGATCCGAG, GGATCC: BamHI restricition site) coding for AGSD, pProEX-SSE1 
(Dragovic et al., 2006a) was used as a template. The C-terminal SSE1 fragment (residues 525-
693) was cloned into the expression plasmid pPROEX HTb (Invitrogen) using the restriction 
sites for BamHI and XhoI. This construct was digested with BamHI, and the N-terminal SSE1 
fragment (residues 1-502), which was amplified with primers providing restriction sites for 
EheI and BamHI, was ligated to its C-terminal counterpart. Then, the whole sse1-Δloop 
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construct was amplified via PCR and cloned into pPROEX HTb using the EheI and XhoI 
restriction sites. A list of the utilized primers can be found in chapter 7.1. 
Ssa1N (codons 1-378 from SSA1) was amplified from pPROEX-SSA1 (Shomura et al., 
2005) and cloned into pPROEX HTb between the restriction sites for BamHI and XhoI. 
SSE2 was amplified from yeast genomic DNA (YPH499) and cloned into 
pPROEX HTb between the restriction sites for EheI and XhoI.  
Point mutants of SSE1, SSA1, and ssa1N were produced via a polymerase chain 
reaction (PCR)-based mutagenesis strategy, which relies on the amplification of the respective 
full-length plasmid (pPROEX-SSE1, pPROEX-SSA1, pPROEX-ssa1N) using blunt end primers 
containing the required nucleotide alterations (Weiner et al., 1994). Nucleotides that diverge 
from the wt DNA sequences were always introduced in the forward primer.    
Yeast expression plasmids for the Sse1p variants were constructed as follows: The 
coding regions for wildtype (wt) and mutant variants of Sse1p were excised from the pPROEX 
expression plasmids by digestion with EheI and XhoI and inserted into the yeast expression 
plasmid pRS415ADH (Sikorski and Hieter, 1989; Mumberg et al., 1995) complementarily 
cleaved with SmaI and XhoI. Amplification of the constructed yeast expression plasmids was 
performed in E. coli DH5α cells.  
The pPROEX expression plasmids for His6-Sse1p, His6-Sse1C, His6-Hsp110 (Dragovic 
et al., 2006a), His6-Ssa1p, His6-Fes1p (Shomura et al., 2005), and His6-Hsp70N (Becker et 
al., 2002) have been described previously. The yeast expression plasmids pGal1-SSA1 
(Deshaies et al., 1988) and pCM189-SSE1 (Dragovic et al., 2006a) have been described as 
well. The pPROEX-expression plasmids for His6-Ssb1N and His6-Ydj1p were cloned by Dr. A. 
Bracher and N. Tzvetkov, respectively (both MPI for Biochemistry, Martinsried, München). 
The sequences of all plasmids generated in this study were confirmed by DNA 
sequencing.  
 
3.6.4 Polymerase chain reaction  
 
Amplification of DNA fragments was achieved by PCR. To amplify sse1-Δloop (Sse1Δ(503-
524)) and ssa1N (NBD of Ssa1p) from plasmid DNA, the Pfu polymerase was utilized. In 
contrast, the Expand Long Template PCR System (Roche) was used for the amplification of 
SSE2 from genomic DNA as well as for the PCR-based site-directed mutagenesis on SSE1 
and SSA1. The Expand Long Template PCR System is a mix of Taq DNA polymerase and the 
proofreading Tgo DNA polymerase, which is optimized to efficiently amplify large and 
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genomic DNA fragments. The compositions of the different PCR solutions and the conditions 
for the thermal cycling are summarized in Table 3-1 and Table 3-2, respectively. Primers are 
listed in chapter 7.1. PCR products were analyzed by agarose gel electrophoresis, excised 
from the gel, and purified. 
 
Table 3-1: PCR mixtures. 
Solution 
components 
Amplification of 
sse1-Δloop and ssa1N 
Amplification of SSE2 and 
site-directed mutagenesis 
template DNA 100 ng plasmid DNA 
100 ng genomic (SSE2) or  
plasmid DNA (mutagenesis) 
primers 0.5 µM each 0.8 µM each 
dNTPs 200 µM each 250 µM each 
polymerase 3 U Pfu DNA polymerase 4.38 U Expand Long Template polymerase 
polymerase 
buffer 1x Pfu buffer 1x Expand Long Template buffer 1 
total volume 50 µl 50 µl 
 
Table 3-2: Thermal cycling conditions for PCR amplification. 
 
Step Purpose 
Amplification of  
sse1-Δloop and ssa1N 
Amplification of SSE2 and 
site-directed mutagenesis 
temperature duration temperature duration 
1 initial denaturation 95 °C 2 min 95 °C 5 min 
30 cycles 
2 cycle  denaturation 95 °C 1 min 95 °C 30 s 
3 primer  annealing 50 °C 30 s 52 °C 45 s 
4 primer  extension 72 °C ~1 min/kb 72 °C ~1.5 min/kb
 
5 final  extension 72 °C 4 min 72 °C 10 min 
6 cooling 4 °C ∞ 4 °C ∞ 
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3.6.5 Restriction digest and DNA ligation 
 
For the cloning of sse1-Δloop, ssa1N, and SSE2, purified PCR products (45 µl, see chapter 
3.6.4) or plasmid DNA (1-1.5 µg) were digested with 1 µl of the respective restriction 
enzyme/s (see chapter 7.1) in a total volume of 60 µl. Digests were performed in the 
recommended reaction buffers and in presence of 6 µg BSA at 37 °C for 1 h. While digested 
PCR products were directly purified by anion exchange chromatography, linearized plasmids 
were separated from the excised segment by agarose gel electrophoresis prior to purification.  
Purified insert and plasmid DNA – both dissolved in water – were used for ligation. 
Approximately 100 ng of digested plasmid DNA (pPROEX HTb) and an approximately five-
fold excess of complementarily digested DNA insert were incubated with 200 U of T4 DNA 
ligase in a total volume of 10 µl. The reaction was performed in T4 DNA ligase reaction 
buffer for 2-5 h at room temperature (RT). Afterwards the reaction mix was transformed in E. 
coli DH5α cells (see chapters 3.6.7.1 and 3.6.7.2). The integrity of the inserts was checked by 
restriction analysis and subsequent DNA sequencing. In the restriction analysis, 5 µl of the 
constructed plasmids were incubated with 0.25 µl of the respective restriction enzymes and 
5 µg BSA in a total volume of 20 µl at 37 °C for 1 h. 
 
3.6.6 Site-directed mutagenesis 
 
For the generation of pPROEX expression plasmids of Sse1p and Ssa1p mutants, the purified 
PCR products generated by whole plasmid PCR (see Table 3-1 and Table 3-2 in chapter 
3.6.4) were incubated with DpnI. DpnI digests methylated DNA and thus degrades the 
template DNA. In contrast, the non-methylated linear PCR products bearing the intended 
point mutations were left intact. For digestion, 44 µl of purified PCR product were incubated 
with 20 U of DpnI in NEB buffer 4 for 1 h at 37 °C. The total reaction volume was 50 µl. 
After enzyme inactivation for 20 min at 80 °C and DNA purification, the mutated linear 
sequences were circularized by ligation: In 10 µl reactions, 8 µl of DNA were incubated with 
400 U of T4 DNA ligase in T4 DNA ligase reaction buffer. Ligation was performed for at 
least 3 h at RT. For amplification, the ligation product was transformed into electrocompetent 
E. coli DH5α cells (see chapter 3.6.7.2). The integrity of the insert was checked by restriction 
analysis (see chapter 3.6.5) and subsequent DNA sequencing. 
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3.6.7 Preparation and transformation of competent E. coli cells 
3.6.7.1 Chemocompetent E. coli cells and chemical transformation 
Chemically competent E. coli cells were prepared by the RbCl-method (Hanahan, 1983). 
100 ml of Psi broth were inoculated with 1 ml of an overnight culture of the respective strain 
and incubated at 37 °C to an OD550 of 0.48. While being chilled on ice for 15 min, the culture 
was mixed frequently to speed up the cooling process. Then, the culture was transferred into 
two 50 ml-Falcon tubes and spun in a Beckman GS-6R centrifuge for 20 min at 3400 rpm and 
0 °C. The supernatant was discarded, and the pellet was resuspended in 40 ml of sterile, pre-
chilled TfbI buffer. After incubation on ice for 15 min, cells were centrifuged again (10 min, 
3400 rpm, 0 °C), gently resuspended in 4 ml of sterile, pre-chilled TfbII buffer, and incubated 
on ice for 15 min. 50 µl aliquots were pipetted into Eppendorf tubes pre-chilled at -20 °C, 
immediately frozen in liquid nitrogen and stored at -80 °C. 
For transformation, 50 µl of chemically competent E. coli cells were thawed on ice and 
mixed with 50-100 ng plasmid DNA or 5 µl ligation reaction. After incubation on ice for 
30 min, cells were heat-shocked at 42 °C for 45 s or at 37 °C for 5 min and subsequently 
cooled on ice for 2 min. Next, cells were diluted with 950 µl of LB medium and incubated in 
a shaker for 1 h at 37 °C. For plasmid amplification in DH5α, cells were centrifuged in a table 
centrifuge (Eppendorf 5415D) at 5000 rpm for 2 min, resuspended in approximately 100 µl of 
medium, plated on selective LB agar plates, and incubated overnight at 37 °C. Plasmid 
isolation from liquid overnight cultures was performed as described in chapter 3.6.2. For 
protein overexpression in a BL21 strain (see chapter 3.7.1), 1 l of LB medium supplemented 
with the required antibiotics was directly inoculated with 300-1000 µl of the transformation 
mixture followed by overnight incubation at 30, 34, or 37 °C to an OD600 of 0.6.  
 
3.6.7.2 Electrocompetent E. coli cells and electroporation 
For the preparation of electrocompetent E. coli DH5α cells, 500 ml of LB medium were 
inoculated with 5 ml of an overnight culture of the strain and grown at 37 °C to an OD600 of 
0.7. Cells were chilled on ice for 15 min and pelleted by centrifugation for 20 min at 
4200 rpm and 4 °C (Beckmann centrifuge Avanti J-25 with rotor JS 4.2). Cells were washed 
with (i) 500 ml of ice-cold autoclaved water and with (ii) 250 ml of 10 % (v/v) ice-cold sterile 
glycerol. Then, cells were resuspended in 10 ml of 10 % (v/v) ice-cold sterile glycerol and 
centrifuged for 20 min at 6400 rpm and 4 °C (Beckmann centrifuge Avanti J-25 with rotor JA 
25.50). Finally, cells were resuspended in 1.5 ml of 10 % (v/v) ice-cold sterile glycerol. 40 µl 
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aliquots were pipetted into Eppendorf tubes pre-chilled at -20 °C, immediately frozen in 
liquid nitrogen and stored at -80 °C. 
To transform electrocompetent E. coli DH5α cells, 40 µl cells were thawed on ice, 
mixed with ≤ 5 µl of ligation reaction, and transferred to an electroporation cuvette (0.1 cm) 
pre-chilled on ice. Electroporation was performed by applying a pulse of 1250 V (25 µF, 
200 Ω; Gene Pulser Xcell). Immediately after the pulse, cells were taken up in 800 µl of LB 
medium, incubated in a shaker at 37 °C for 1 h, centrifuged at 5000 rpm for 2 min in a table 
centrifuge (Eppendorf 5415D), resuspended in approximately 100 µl of medium, spread on 
selective LB plates, and incubated overnight at 37 °C. Plasmid isolation from liquid overnight 
cultures was performed as described in chapter 3.6.2. 
 
3.6.8 Lithiumacetate transformation of S. cerevisiae cells 
 
In the present study, all yeast transformations were performed according to the lithiumacetate 
(LiAc) method (see chapter 3.7.5) (Schiestl and Gietz, 1989; Gietz et al., 1995). An YPD 
overnight culture of the respective yeast strain grown at 30 °C was diluted with YPD medium 
to an OD600 of ~0.15 in a total volume of 50 ml. When the culture had reached an OD600 of 
~0.5 (30 °C, 200 rpm), cells were harvested by centrifugation at 3000 g for 5 min. The pellet 
was resuspended in 25 ml of autoclaved water and centrifuged again. Next, cells were washed 
with 1 ml of 100 mM LiAc and transferred into an Eppendorf tube. After 15 s of 
centrifugation at top speed, the pellet was resuspended in 100 mM LiAc to a final volume of 
500 µl. For each transformation, cells from 50 µl were pelleted by centrifugation at 3000 g for 
5 min. The following components were added sequentially: 240 µl of sterile-filtered 50 % 
(v/v) PEG-3350, 36 µl of 1 M LiAc, 5 µl of 10 mg/ml herring testes carrier DNA, 60 µl of 
autoclaved H2O, and 5 µl of plasmid DNA (100 ng to 10 µg). After vigorous mixing for 
1 min, the mixture was incubated in a shaker at 30 °C for 30 min. Then, cells were heat-
shocked at 42 °C for 20 min and harvested by a 15 s centrifugation at 7000 rpm (Eppendorf 
5415D). Cells were resuspended in 1 ml of YPD medium, incubated in a shaker at 30 °C for 
3 h, pelleted by centrifugation, and resuspended in 100 µl of appropriate selective medium. 
Cells were grown on selective plates at 30 °C for 2 d.  
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3.6.9 Construction of sse1 mutant S. cerevisiae strains 
 
To test the functionality of the Sse1p variants in vivo, the ability of the mutants to 
complement the lethal phenotype of the combined deletion of SSE1 and SSE2 in yeast cells 
was tested. For the construction of ΔSSE1ΔSSE2 yeast strains, which express the different 
Sse1p variants, a method called plasmid shuffling was applied. In this approach, a rescue 
plasmid coding for wt SSE1 in the double deletion strain is replaced by the various sse1-
mutant encoding plasmids.  
Specifically, the S. cerevisiae strain SB472 (genotype, MATα ade2-101ochre his3Δ200 
leu2Δl lys2-801amber trp1Δ63 ura3-52 sse1::His3 sse2::KanMX4 pCM189-SSE1-URA3) was 
utilized, in which the lethal phenotype of ΔSSE1ΔSSE2 is rescued by the SSE1 expression 
plasmid pCM189-SSE1-URA3. SB472 was transformed with the different pRS415ADH yeast 
expression plasmids, which code for the sse1 variants (see chapter 3.6.3) as well as for a 
leucine selection marker, and cells were grown on SC-His-Ura-Leu plates at 30 °C for 2 d. In 
the next step, 10-50 colonies were picked, resuspended in 200 µl of autoclaved water, and 
streaked on SC-His-Ura-Leu plates to get single colonies. After 2 d at 30 °C single colonies 
were picked and incubated at 30 °C for 2 d on non-selective YPD plates, a medium, on which  
the rescue plasmid pCM189-SSE1-URA3 is not stringently required. In order to actively select 
against pCM189-SSE1-URA3, single colonies of each strain were picked and streaked on SC-
Leu medium containing 5-FOA and uracil (30 °C, 2 d). The non-toxic 5-FOA compound is 
converted to toxic 5-fluorouracil in yeast strains expressing the functional URA3 gene 
(orotine-5'-monophosphate decarboxylase). Consequently, only yeast cells that have lost 
pCM189-SSE1-URA3 and express a functional sse1 mutant can multiply. Loss of pCM189-
SSE1-URA3 was confirmed by the fact that cells grew on SC-Leu but not on SC-Leu-Ura 
plates (30 °C, 2 d). For generation of cryo stocks, the Sse1p variant-expressing strains were 
finally grown on YPD medium (30 °C, 2 d).  
 Since mutants sse1-(2+3) and sse1-(2+4) could not complement the ΔSSE1ΔSSE2 
double deletion, these two mutants were transformed into the ΔSSE1 S. cerevisiae strain 
SB537 (genotype, MATα ade2-101ochre his3Δ200 leu2Δ1 lys2-801amber trp1Δ63 ura3-52 
sse1::His3). Furthermore, SB537 was transformed with pRS415ADH-SSE1 and the original 
plasmid pRS415ADH. Cells were plated on SC-Leu and grown at 30 °C for 2 d.   
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3.6.10 Isolation of chromosomal DNA from S. cerevisiae  
 
Genomic yeast DNA served as template for the amplification of yeast genes (see chapter 
3.6.4). It was isolated from 2 ml of an YPH499 overnight culture grown to early stationary 
phase at 30 °C. After harvesting by centrifugation at 3000 g for 3 min and washing with 1 ml 
of autoclaved water, cells were resuspended in 200 µl of protoplast buffer and incubated at 
37 °C for 1 h. To prevent sedimentation, cells were gently mixed from time to time. After 
addition of 200 µl of yeast lysis solution and gentle mixing, the cell suspension was incubated 
at 65 °C for 20 min and rapidly chilled on ice. Addition of 200 µl of 5 M KAc and gentle 
mixing of the cell suspension were followed by 15 min of incubation on ice. Precipitated 
potassium dodecylsulfate and denatured proteins were removed by centrifugation for 3 min at 
20000 g and RT, and the supernatant was transferred to a new tube. For precipitating the 
DNA, 600 µl of isopropanol were added. After gentle mixing, the solution was incubated at 
RT for 5 min. Centrifugation for 30 s at 20000 g and RT lead to the sedimentation of the 
chromosomal DNA. The pellet was washed with 70 % ethanol for 10 min at RT. After 
renewed centrifugation, the DNA was dried for 1-2 min in vacuum and subsequently 
dissolved in 35 µl of autoclaved water.  
 
3.7 Protein biochemical and biophysical methods 
3.7.1 Protein expression and purification 
 
All protein purification steps were performed at 4 °C unless otherwise stated.  
 
3.7.1.1 Hsp110 homologs 
Sse1-Δloop was expressed as an N-terminally His-tagged fusion protein using E. coli 
BL21(DE3) cod+ RIL as host and LB supplemented with ampicillin (Amp) and 
chloramphenicol (Cm) as culture medium. At an OD600 of 0.6, protein expression was induced 
with 0.2 mM IPTG, and cells were subsequently grown at 18 °C for 16 h. Cells were 
harvested by centrifugation at 5000 g and 4 °C for 45 min. The cell mass from a 6 l culture 
was resuspended in 180 ml of buffer L1 supplemented with 10 mM imidazole, 5 mM β-
mercaptoethanol, 1 mM PMSF, and 1x Complete protease inhibitor cocktail. Cell lysis via 
ultrasonication was performed on ice by applying ten 25 s pulses of maximum output level 
interrupted by breaks of 1 min 35 s. After removal of cell debris by centrifugation at 50000 g 
and 4 °C for 30 min, the supernatant was sterile-filtered and loaded on a 5 ml Ni2+-HiTrap 
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Chelating Sepharose column equilibrated in buffer L1 containing 10 mM imidazole. The 
column was washed with 10 CV of the same buffer, and His6-Sse1-Δloop was eluted by 
applying a linear gradient of 10 to 1000 mM imidazole in buffer L1 over 50 ml. The protein 
content of the 5 ml fractions was analyzed by SDS-PAGE (see chapter 3.7.2.2). For cleavage 
of the His6-tag, the protein-containing fractions were incubated with His6-TEV protease at a 
molar ratio of 20:1 in the presence of 1 mM DTT and 4.25 mM EDTA at 4 °C overnight. To 
remove bound nucleotide, the protein solution was dialyzed three times for 24 h against buffer 
D. After exchanging buffer D against buffer E, the dialysate was passed through 5 ml Ni2+-
HiTrap Chelating Sepharose equilibrated in the same buffer to remove residual His6-Sse1-
Δloop and His6-TEV protease. Aliquots of the concentrated flow-through fraction 
(11.8 mg/ml) were frozen in liquid nitrogen and stored at -80 °C. 
Wt Sse1p and Sse2p as well as the Sse1p mutants were expressed and purified similarly 
to Sse1-Δloop. The modifications are described in the following. Protein expression was 
induced with 0.25 mM IPTG at 18 °C for at least 16 h. Instead of NaCl, KCl was used in all 
buffers employed during the purification process. After Ni-affinity chromatography in buffer 
L (10-1000 mM imidazole) and TEV protease cleavage, the protein solutions were (i) diluted 
to a final concentration of 40-60 mM imidazole with buffer L or (ii) buffer-exchanged against 
HKM2 and subsequently supplemented with 20 mM imidazole. Next, the protein solutions 
were passed over a second 5 ml Ni2+-HiTrap Chelating column equilibrated (i) in buffer L 
with 20 mM imidazole or (ii) in HKM2 buffer with 20 mM imidazole, respectively. The flow-
through fractions were concentrated (≥ 4 mg/ml) and dialysed against HKM2 overnight. 
Alternatively, the concentrated flow-through fractions were directly flash-frozen in liquid 
nitrogen. Immediately prior to use, soluble aggregates were removed by Superose 12 size 
exclusion chromatography using HKM2 buffer as running buffer. 
To obtain nucleotide-free Sse1p, purified His6-Sse1p (in buffer E) was incubated with 
shrimp alkaline phophatase (3.3 U/mg protein, 1 h, 25 °C). For the phosphatase incubation, 
the buffer was augmented with 50 mM Tris pH 8.5 and 5 mM MgCl2. To remove the 
phosphatase, the protein sample was supplemented with 10 mM imidazole, and Ni-affinity 
chromatography in buffer L (10-1000 mM imidazole) was performed. TEV protease cleavage, 
sample dilution to a final concentration of ~40 mM imidazole, renewed Ni-affinity 
chromatography in buffer L supplemented with 20 mM imidazole, and dialysis against HKM2 
were conducted as described above.  
Hsp110 was also purified similarly to Sse1-Δloop. Protein expression was induced with 
0.8 mM IPTG at 18 °C for 16 h. Ni-affinity chromatography in buffer L1 (10-1000 mM 
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imidazole) and TEV protease cleavage were followed by anion exchange chromatography. 
Specifically, after dilution with buffer A1 to a final concentration of ~180 mM NaCl, the 
protein solution was loaded on MonoQ, which had been equilibrated in buffer A1. The 
column was washed with 5 CV of the same buffer and developed with a NaCl gradient from 
10 to 1000 mM over 10 CV. Hsp110-containing fractions were supplemented with 20 mM 
imidazole and passed over a second Ni-affinity chromatography column equilibrated in buffer 
E containing 20 mM imidazole. The flow-through fractions were pooled and buffer-
exchanged against buffer E. After concentration to 11.3 mg/ml, Hsp110 aliquots were snap-
frozen in liquid nitrogen and stored at -80 °C.  
 
3.7.1.2 Hsp70 homologs 
Ssa1p, Ssa1N and the corresponding mutants were expressed as N-terminally His-tagged 
fusion proteins using E. coli BL21(DE3) cod+ RIL as host and LB supplemented with Amp 
and Cm as culture medium. At an OD600 of 0.6, protein expression was induced with 0.25 mM 
IPTG, and cells were subsequently grown at 18 °C overnight. Cell harvesting, cell lysis via 
ultrasonication (in buffer L supplemented with 10 mM imidazole, 5 mM β-mercaptoethanol, 
1 mM PMSF, and 1x Complete protease inhibitor cocktail), Ni-affinity chromatography (in 
buffer L with an imidazole gradient from 10 to 1000 mM), and TEV protease cleavage were 
performed as described for Sse1-Δloop in chapter 3.7.1.1. After dilution with buffer A to a 
final concentration of ~100 mM KCl, the protein solutions were loaded on MonoQ. The 
column was washed with 12.5 CV buffer A and developed with a KCl gradient from 10 to 
1000 mM in 25 CV buffer A. The Ssa1 variant-containing fractions were augmented with 
20 mM imidazole and passed through 5 ml Ni2+-HiTrap Chelating Sepharose equilibrated in 
HKM2 supplemented with 20 mM imidazole. The flow-through fractions were dialyzed 
against HKM2 at 4 °C overnight, concentrated to ≥ 1.25 mg/ml, snap-frozen in liquid nitrogen 
and stored at -80 °C. Prior to use, soluble aggregates were removed by Superose 12 size 
exclusion chromatography using HKM2 buffer as running buffer. If necessary, nucleotide 
bound to Ssa1p was either removed by incubation of the protein solution with 50 mM EDTA 
(1 h, 4 °C) and subsequent Superose 12 size exclusion chromatography with 150 mM KCl, 
10 mM HEPES-KOH pH 7.5 serving as running buffer or by incubation with shrimp alkaline 
phosphatase after the initial Ni-affinity chromatography (3.3 U/mg protein, 1 h, 25 °C). For 
the phosphatase incubation, the buffer was augmented with 50 mM Tris pH 8.5 and 5 mM 
MgCl2. Next, the buffer of the protein sample was exchanged against buffer L supplemented 
with 10 mM imidazole, and the phosphatase was removed by Ni-affinity chromatography (in 
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buffer L with an imidazole gradient from 10 to 1000 mM). TEV protease cleavage and the 
further purification were conducted as described above.  
Alternatively, Ssa1p was purified from the S. cerevisiae strain MW141 (genotype, 
MATα his3-11,15 leu2-3,112 trp1 ura3-52 ssa1::HIS3 ssa2::LEU2 ssa4::URA3 pGal1-SSA1) 
(Deshaies et al., 1988). MW141 was streaked on YP-Gal plates and incubated at 30 °C for 
2 d. Next, a 50 ml YP-Gal culture, which was inoculated with 4 colonies and grown at 30 °C 
overnight, was used to inoculate 6 l of YP-Gal medium. Cells were grown to an OD600 of ~8 
at 30 °C and harvested by centrifugation at 5000 g and 4 °C for 45 min yielding ~80 g of 
yeast cell mass. The pellet was resuspended in 10 % sterile glycerol and dripped into liquid 
nitrogen. The resulting granulate was stored at -80 °C. For lysis, cells were thawed at RT for 
~1 h and resuspended in 150 ml of buffer S containing 0.5 mM EDTA, 1 mM PMSF, and 1x 
Complete protease inhibitor cocktail. Lysis was performed in an iced bead beater with 400 g 
of glass beads (Ø 425-600 µm) by applying 20 cycles of 30s pulses interrupted by breaks of 
90 s. Then the glass beads were separated by vacuum filtration and thoroughly washed with 
100 ml of buffer S containing 0.5 mM EDTA, 1 mM PMSF, and 1x Complete protease 
inhibitor cocktail. The combined filtrates were subjected to centrifugation using a Beckmann 
centrifuge with JLA 10.500 rotor at 4000 rpm and 4 °C for 10 min. After centrifugation of the 
resulting supernatant in a JLA 10.500 rotor at 10000 rpm and 4 °C for 30 min, the new 
supernatant was centrifuged in a Beckmann ultracentrifuge with a 45 Ti rotor at 36000 rpm 
and 4 °C for 1 h. The lipid drops on the surface of the supernatant were removed, and the 
clarified lysate was passed over ~20 ml ATP-agarose resin, which had been prepared by 
swelling 1.5 g of lyophilized powder in H2O and which had subsequently been equilibrated in 
buffer S. After washing the resin with (i) 5 CV of buffer S and (ii) 5 CV of GTP buffer, the 
sample was eluted with 5 CV of ATP buffer. The Ssa1p-containing fractions were identified 
by SDS-PAGE as well as by Western blotting (see chapters 3.7.2.2 and 3.7.2.3) and applied to 
a 10 ml DEAE-Sepharose column. After washing with 10 CV of DEAE buffer, the column 
was developed by applying a linear gradient of 20-1000 mM KCl in 20 CV of DEAE buffer. 
The protein-containing fractions were identified with the Bio-Rad protein assay and were 
analyzed by SDS-PAGE as well as by Western blotting. A slight contamination with 
Sse1p/Sse2p was apparent. 15 µl aliquots containing 10-15 mg/ml Ssa1p were frozen in liquid 
nitrogen and stored at -80 °C. 
His6-Ssb1N (amino acids 1-384) was expressed in E. coli BL21(DE3) cod+ RIL at 
18 °C overnight after induction with 0.25 mM IPTG. Cell harvesting, cell lysis via 
ultrasonication, and Ni-affinity chromatography were performed as described for Sse1-Δloop 
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in chapter 3.7.1.1. TEV protease cleavage was executed at RT, but otherwise as for Sse1-
Δloop. After dilution with buffer A1 to a final concentration of ~100 mM NaCl, the protein 
sample was loaded on MonoQ, which was subsequently developed with a linear gradient of 
10-1000 mM NaCl in 20 CV buffer A1. Augmented with 20 mM imidazole, the Ssb1N- 
containing fractions were passed through Ni2+-HiTrap Chelating Sepharose equilibrated in 
buffer L1 supplemented with 20 mM imidazole. The flow-through fraction was dialyzed 
against HKM3 buffer at 4 °C overnight, concentrated to ~7 mg/ml, snap-frozen in liquid 
nitrogen and stored at -80 °C. 
His6-Hsp70N (amino acids 1-382) was expressed in E. coli BL21(DE3) cod+ RIL at 
18 °C overnight after induction with 0.8 mM IPTG. Cell harvesting, cell lysis via 
ultrasonication (in buffer L supplemented with 10 mM imidazole, 5 mM β-mercaptoethanol, 
1 mM PMSF, and 1x Complete protease inhibitor cocktail), Ni-affinity chromatography (in 
buffer L with a linear gradient from 10 to 1000 mM imidazole), and TEV protease cleavage 
were performed as described for Sse1-Δloop in chapter 3.7.1.1. After buffer exchange against 
HKM2, the protein solution was passed through Ni2+-HiTrap Chelating Sepharose 
equilibrated in the same buffer. Next, the buffer of the concentrated flow-through fraction was 
exchanged against buffer A, and the protein sample was loaded on MonoQ, which was 
developed by applying a linear gradient of 10 to 1000 mM KCl in 5 CV of buffer A. The 
Hsp70N-containing fraction (6.7 mg/ml) was snap-frozen in liquid nitrogen and stored at  
-80 °C.  
 
3.7.1.3 Ydj1p 
After induction with 1 mM IPTG, His6-Ydj1p was expressed in E. coli BL21(DE3) cod+ RIL 
at 18 °C overnight. Cell harvesting, ultrasonication (in buffer L supplemented with 10 mM 
imidazole, 5 mM β-mercaptoethanol, 1 mM PMSF, and 1x Complete protease inhibitor 
cocktail), Ni-affinity chromatography (in buffer L with a linear gradient from 10 to 1000 mM 
imidazole) and TEV protease cleavage were performed as described for Sse1-Δloop in chapter 
3.7.1.1. After dilution with buffer A to a final concentration of ~70 mM KCl, the protein 
solution was loaded on MonoQ, which was equilibrated in buffer A and developed with a 
KCl-gradient from 10 to 1000 mM over 25 CV. The Ydj1p-containing fraction was diluted 
with buffer L, supplemented with 20 mM imidazole and passed through 5 ml Ni2+-HiTrap 
Chelating Sepharose equilibrated in buffer L augmented with 20 mM imidazole. The 
concentrated flow-through fraction was dialyzed against HKM2 at 4 °C overnight. 50 and 
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100 µl aliquots containing 16.8 mg/ml Ydj1p were snap-frozen in liquid nitrogen and stored 
at -80 °C. 
 
3.7.1.4 Selenomethionine-derivatized proteins 
For the preparation of selenomethionine (SeMet)-labeled Sse1-Δloop and Hsp70N, E. coli 
BL21(DE3) cod+ RIL cells were transformed with pProEX-sse1-Δloop or pProEX-hsp70N, 
respectively, and grown on LB plates containing Amp and Cm at 37 °C overnight. For both 
pProEX-hsp70N-transformed as well as pProEX-sse1-Δloop-transformed cultures, four 4 ml 
LB-Amp-Cm cultures were then inoculated with one single colony each and incubated at 
37 °C for 1 h. In the next step, 20 µl of each culture were used to inoculate four 4 ml LB-
Amp-Cm cultures. After overnight incubation at 37 °C, the cultures were harvested by 
centrifugation at 3000 g and 4 °C for 10 min. The sedimented cells were resuspended in 4 ml 
of M9 medium, centrifuged again, and resuspended as before in 4 ml of M9 medium. For both 
pProEX-hsp70N-transformed and pProEX-sse1-Δloop-transformed cells, the four respective 
pre-cultures were used to inoculate three 1 l M9-Amp-Cm cultures, which were pre-warmed 
to 37 °C and subsequently grown at 37 °C. At an OD600 of 0.6, the following amino acids 
were added under vigorous shaking: 125 mg/l L-lysine (in H2O), 100 mg/l L-phenylalanine 
(in 0.5 M HCl), 100 mg/l L-threonine (in 0.1 M HCl), 50 mg/l L-isoleucine (in 0.1 M HCl), 
50 mg/l L-leucine (in 0.5 M HCl), 50 mg/l L-valine (in 0.5 M HCl), and 60 mg/l L-
selenomethionine (in 0.1 M HCl) (modified from Van Duyne et al., 1993). An equivalent 
amount of 2 M NaOH was added to neutralize the added HCl. After 15 min of further growth 
at 37 °C, Sse1-Δloop and Hsp70N protein expression was induced with 0.2 and 0.8 mM 
IPTG, respectively. The cultures were grown at 18 °C for ~16 h. Cell harvesting, 
ultrasonication (in buffer L supplemented with 10 mM imidazole, 10 mM β-mercaptoethanol, 
1 mM PMSF, and 1x Complete protease inhibitor cocktail), and Ni-affinity chromatography 
(in buffer L with a linear gradient from 10 to 1000 mM imidazole) were performed as 
described for Sse1-Δloop in chapter 3.7.1.1. After TEV protease cleavage – which was 
conducted in additional presence of 10 mM β-mercaptoethanol, but otherwise as for Sse1-
Δloop – the sample buffers were exchanged against HKM2 buffer, and the protein solutions 
were passed through Ni2+-HiTrap Chelating Sepharose equilibrated in the same buffer. The 
SeMet-Sse1-Δloop- and SeMet-Hsp70N-containing flow-through fractions were concentrated 
to 5 and 6.7 mg/ml, augmented with 10 mM β-mercaptoethanol, flash-frozen in liquid 
nitrogen, and stored at -80 °C. 
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3.7.2 Protein analytical methods 
3.7.2.1 Protein quantification 
Protein concentrations were determined spectrophotometrically by measuring the absorption 
of the protein solution at 280 nm. Protein solutions were appropriately diluted with buffer, 
and protein-free buffer solution served as a reference. The theoretical molar extinction 
coefficients ε280nm, which were calculated from the respective protein sequences using the 
ProtParam tool at the ExPASy proteomics server (http://us.expasy.org/tools/protparam.html, 
(Pace et al., 1995)), were used to convert the measured absorption into concentration 
according to the Lambert-Beer-law. 
For nucleotide-containing protein solutions as well as for solutions containing a mixture 
of proteins, protein concentrations were measured colorimetrically at a wavelength of 595 nm, 
using the Bio-Rad protein assay reagent according to the manufacturer's recommendations 
(Bradford, 1976). Unless otherwise stated, a calibration curve with BSA was prepared as a 
reference. Irrespectively of the applied method, the readings of three independent 
measurements were averaged for each protein concentration determination. 
 
3.7.2.2 SDS-PAGE 
 
Table 3-3: Composition of resolving and stacking gels for SDS-PAGE. 
solution component 
(for 10 ml) 
resolving gel stacking gel
8 % AA 10 % AA 12 % AA 15 % AA 5 % AA 
H2O 4.6 ml 4.0 ml 3.3 ml 2.3 ml 6.8 ml 
30 % acrylamide (AA) / 
0.8 % bis-AA 2.7 ml 3.3 ml 4.0 ml 5.0 ml 1.7 ml 
1.5 M Tris (pH 8.8) 2.5 ml 2.5 ml 2.5 ml 2.5 ml - 
1.0 M Tris (pH 6.8) - - -  1.25 ml 
10 % SDS 100 µl 100 µl 100 µl 100 µl 100 µl 
10 % ammonium persulfate 100 µl 100 µl 100 µl 100 µl 100 µl 
TEMED 6 µl 4 µl 4 µl 4 µl 10 µl 
 
The content of protein solutions was analyzed by discontinuous Tris-glycine sodium 
dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE). This method allows the 
separation of proteins primarily according to their molecular weight (Laemmli, 1970). Gels 
were prepared according to Table 3-3 (Maniatis et al., 1989). To improve gel quality, the 
resolving gels were covered with a layer of isopropanol immediately after casting. Before 
being loaded onto the gels, protein samples were mixed with 2x SDS-loading dye, boiled at 
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94 °C for 5 min, and spun briefly at maximum speed in a table centrifuge (Eppendorf 5415D). 
Electrophoresis was performed in SDS-electrophoresis buffer at a constant voltage of 200 V. 
After electrophoresis, gels were stained with Coomassie staining and destained with 
Coomassie destaining solution. Unless otherwise stated, photos of the gels were taken with 
the gel documentation system of  MWG AG Biotech (Ebersberg, Germany). 
 
3.7.2.3 Western blotting 
For immunoblotting, a slightly modified published protocol was applied (Towbin et al., 
1979). After separation by SDS-PAGE, proteins were transferred from the gel to a 
nitrocellulose membrane with the help of a semi-dry Western blotting unit. The transfer was 
performed in Western blot buffer at a constant current of 80 mA/gel for 60-90 min and 
checked by Ponceau staining. Blots were subsequently blocked for 1 h with 3-5 % (w/v) milk 
powder in TBST or PBST. After incubation with the primary antibody (dilution see chapter 
3.2) in TBST/PBST + 3 % (w/v) milkpowder for 1-3 h at RT or overnight at 4 °C, the blots 
were washed twice with TBST/PBST + 3 % (w/v) milkpowder for 5 min. Incubation with a 
horseradish peroxidase (HRP)-conjugated secondary antibody (dilution 1:3333) in 
TBST/PBST + 3 % (w/v) milkpowder for 1-3 h at RT followed. Finally, the blots were 
washed three times with TBST/PBST for 5 min. For immunodetection, ECL (enhanced 
chemiluminescence) solution was freshly prepared by mixing equal amounts of ECL solutions 
I and II. ECL solution II was always supplemented with 0.05 % (v/v) of 8.8 M H2O2 prior to 
use. Membranes were covered with the detection mixture, and protein bands were detected 
and documented with the Fuji-LAS3000 luminescence and densitometry system. If necessary, 
blots were stripped by incubation with stripping buffer at 70 °C for 45 min.  
 
3.7.2.4 TCA precipitation 
For TCA (trichloro acetic acid) precipitation of purified proteins, a two-fold volume of 
20 % (w/v) TCA was added to the protein sample, resulting in a final TCA concentration of 
13 % (w/v). After incubation on ice for 15 min and centrifugation at 20000 g and 4 °C for 
15 min, the protein pellet was washed with 1 ml of ice-cold acetone and pelleted again by 
centrifugation at 20000 g and 4 °C for 10 min. The washing step was repeated three times. 
Next, the pelleted sample was incubated at RT until all residual acetone was evaporated and 
dissolved in 15 µl of 1x SDS-loading buffer. In case of incomplete removal of TCA, the color 
of the bromphenolblue of the SDS-loading buffer became yellow, and 1 M Tris-HCl pH 8.5 
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was added until the color turned back to blue. The sample was boiled at 94 °C for 5 min and 
subjected to SDS-PAGE analysis. 
 
3.7.2.5 Edman degradation 
To find out, whether Sse1-Δloop (and also Sse1p) was degraded by Proteinase K at the N-
terminus (see chapter 3.7.4.3), N-terminal sequencing was conducted. 20 µM of Sse1Δloop 
were incubated with 10 mM ATP in HKM2 buffer at RT for 30 min. Then 0.5 µg/ml 
Proteinase K were added and the reaction solution was incubated at RT for 30 min. After 
stopping the degradation reaction with 2 mM PMSF, the sample was chilled on ice for 2 min 
and centrifuged at RT for 2 min. The supernatant was concentrated to 7.1 mg/ml, and N-
terminal sequencing of the degradation product was performed by the Core Facility of the 
MPI for Biochemistry in Martinsried. 
 
3.7.2.6 Mass spectrometry 
The molecular weight of Sse1-Δloop-ΔC was determined by mass spectrometry. 20 µM Sse1-
Δloop were incubated with 10 mM ATP in HKM3 buffer at RT for 30 min. Then 0.5 µg/ml 
Proteinase K were added and the reaction solution was incubated at RT for 50 min. After 
stopping the degradation reaction with 10 mM PMSF, the sample was chilled on ice for 2 min 
and centrifuged at RT for 2 min. The molecular weight of the degradation product in the 
supernatant was determined by electrospray ionization (ESI) mass spectrometry by Dr. Sonya 
Schermann (MPI for Biochemistry, Martinsried, Germany).     
 
3.7.2.7 FFF-MALS 
The stoichiometries of the Sse1-Δloop/Ssa1N, the Sse1-Δloop/Ssb1N, and the Sse1-
Δloop/Hsp70N complexes were analyzed by field flow fractionation (FFF) followed by 
multiangle light scattering (MALS). Complexes were prepared as described in chapter 3.7.3.1 
for the Sse1-Δloop/Hsp70N complex. For FFF, 80 µg of the distinct protein complexes where 
injected. HKM2 was used as running buffer with the injection flow set to 0.2 ml/min and the 
elution, detector and cross flows to 1 ml/min. The spacer foil separating the two plates that 
form the sample channel was 490 nm thick. The ultrafiltration membrane covering the 
permeable bottom plate had a MWCO of 10 kDa. The fractionation device was connected to 
three successive detectors: a DAWN EOS MALS detector (690 nm laser), a variable 
wavelength detector (absorbance at 280 nm, Agilent 1100 series), and an Optilab DSP 
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refractive index detector (690 nm). Masses were calculated using the ASTRA software with 
the dn/dc value set to 0.185 ml/g. The FFF-MALS experiments were performed by Dr. 
Manajit Hayer-Hartl (MPI for Biochemistry, Martinsried, Germany). 
 
3.7.2.8 Circular dichroism spectroscopy 
The secondary structure and melting behavior of the Sse1p variants and Sse2p were analyzed 
by circular dichroism (CD) spectroscopy. Far-UV CD spectra as well as thermal and GdnHCl-
induced transitions were measured with a Jasco J-715 spectrometer equipped with a Peltier-
thermostat using 0.1 cm cuvettes. The proteins were analyzed at a concentration of 2.5 µM 
(Sse1C 5.7 µM) in buffer C.  
Wavelength scans were recorded at 4 °C (before and after heating of the protein sample) 
and 42 °C in a wavelength range of 195 to 250 nm. The band width was set to 1 nm, the 
response to 2 s, the data pitch to 0.1 nm, and the scanning speed to 50 nm/min. For each 
protein spectrum, two scans were averaged and corrected by the corresponding buffer 
spectrum. The measured mean ellipticity θ (in mdeg) was converted into the mean molar 
ellipticity per amino acid residue [θ]MRW (in deg cm2 dmol-1) using the equation 
[θ]MRW = θ/(c·d·NAS·10). Therein, c stands for the protein concentration in M, d for the cell 
path length in cm, and NAS for the number of amino acid residues of the investigated protein. 
Sse1p, Sse1-Δloop, the Sse1p point mutation variants, Sse1C, and Sse2p have 695, 677, 695, 
302, and 695 amino acid residues, respectively. Finally, the CD spectra were smoothened by 
applying a fast fourier transformation (FFT) filter. For Sse1p, additionally a CD spectrum in 
HKM2 buffer supplemented with 6 M GdnHCl was measured. 
Temperature scans were measured at 222 nm in a temperature range of 4 to 70 °C. The 
band width was set to 1 nm, the response to 16 s, the data pitch to 0.1 °C, and the scanning 
speed to 60 °C h-1. The measured mean ellipticity θ was converted into the mean molar 
ellipticity per amino acid residue [θ]MRW as described above. The thermal transitions were 
smoothened by applying a FFT filter. To determine the melting temperature of the Sse1p 
variants, the thermal transitions were fitted to a two state model with fixed baselines for the 
native and denatured protein using the program Grafit 3.0 (Erithacus Software, Staines, Great 
Britain). To check the reversibility of partial unfolding of the Sse1p variants, thermal 
unfolding and subsequent refolding transitions were measured in a temperature range from 4 
to 42 °C.   
For Sse1p, a GdnHCl-induced equilibrium transition was measured in HKM2 buffer at 
20 °C. The protein concentration was 2.5 µM and the GdnHCl concentrations reached from 0 
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to 6 M. To ensure establishment of the equilibrium, the protein samples were incubated at 
20 °C for 2 h prior to measurement. For each sample, the molar ellipticity at 222 nm was 
recorded for 30 s in intervals of 0.5 s. The final molar ellipticities represent the average values 
of these data points corrected by a buffer baseline. The band width was set to 1 nm and the 
response to 8 s. 
 
3.7.3 Protein crystallization and structure determination 
3.7.3.1 Complex formation 
The native as well as the SeMet-substituted complexes of Sse1-Δloop and Hsp70N were 
formed by mixing equimolar amounts of the purified proteins in the presence of a four-fold 
excess ATP. Free ATP and unbound Hsp70N were removed by gel filtration on Superose 12 
using HKM2 buffer. Fractions containing the complex were pooled and concentrated to 
6.3 mg/ml and 8.5 mg/ml, respectively, and Complete protease inhibitor cocktail was added.  
 
3.7.3.2 Complex crystallization 
Native as well as the SeMet-substituted complexes of Sse1-Δloop and Hsp70N were 
crystallized by the hanging drop vapor diffusion method. Mixtures of 1 µl of the protein 
solution and 1 µl of the precipitant solution were equilibrated against 500 µl of the precipitant 
solution. Siliconized cover slides and 24-well plates with silicon grease as sealant were used. 
Initial screening of crystallization conditions was carried out at both 20 and 4 °C using the 
precipitant solution kits Crystal Screen, Crystal Screen 2, Crystal Screen Lite, Index Screen, 
NeXtal ProComplex Suite, and Protein complex screen (Radaev and Sun, 2002; Radaev et al., 
2006). In selected conditions of the two latter screens, crystals of the Sse1-Δloop/Hsp70N 
complex were observed after days to weeks at 4 °C. The protein content of the crystals was 
checked by 10 % SDS-PAGE. For sample preparation, the crystals were washed in 1 µl of 
cryo solution (35 % of PEG plus glycerol) and subsequently dissolved in 8 µl of HKM2 
buffer. After addition of 8 µl of 2x SDS-loading buffer and heat denaturation, the complete 
protein sample was analyzed as described in chapter 3.7.2.2. 
For the native complex, the final optimized precipitant solution contained 17 % (w/v) 
polyethylene glycol (PEG)-6000, 50 mM KCl, 100 mM HEPES-KOH pH 7.5. For the SeMet-
substituted complex, the optimized precipitant solution was 15 % (w/v) PEG-6000, 100 mM 
Tris-HCl pH 8.0, 10 mM DTT. For cryo-protection, the crystals were transferred stepwise 
into cryo solution: First, the crystals were incubated in a 1:1 mixture of precipitant and cryo 
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solution for ~10 min, then they were transferred to 100 % cryo solution for ~10 min. The cryo 
solutions were 20 % (w/v) PEG-6000, 15 % (v/v) glycerol, 200 mM KCl, 100 mM HEPES-
KOH pH 7.5 for the native complex and 22 % (w/v) PEG-6000, 13 % (v/v) glycerol, 100 mM 
Tris-HCl pH 8.0 for the SeMet-substituted complex. Finally, the crystals were fished with 
nylon loops fitted onto magnetic bases and immediately flash-frozen in liquid nitrogen. 
 
3.7.3.3 Structure determination 
Diffraction data were collected by the oscillation method at beamline X10SA of the Swiss 
Synchrotron Light Source (SLS; Villigen, Switzerland) at a temperature of 100 K. Prior to the 
MAD experiment, SeMet incorporation into the crystallized protein complex was verified by 
collecting an X-ray fluorescence excitation spectrum in the energy range of the KI absorption 
edge of selenium (12614-12693 eV). From the excitation spectrum, the anomalous scattering 
factors f' and f'' were calculated using the program Chooch (Evans and Pettifer, 2001). As 
collection wavelengths for the MAD datasets, the maximum of f'' (12.662 keV, peak), the 
minimum of f' (12.657 keV, inflection point), and a remote wavelength clearly above the 
absorption edge (12.757 keV) were chosen. After initial autoindexing of the reflections from 
diffraction images, which were collected at perpendicular orientations of the crystal, and 
automated estimation of the mosaicity, a data collection strategy was devised with the 
STRATEGY option of the program IPMosflm using the ANOMALOUS flag and data 
collection simulation with TESTGEN (Leslie, 1992). To acquire almost complete and 
sufficiently redundant datasets, 150 images were recorded in a range of 90 ° with an 
increment of 0.6 ° and an exposure of 1 s per image. The distance between the mounted 
crystal and the CCD detector was set to 290 mm corresponding to a resolution of 2.6 Å for the 
given wavelength at the detector edge. In order to minimize radiation damage during data 
collection, the primary X-ray beam was attenuated to 17 % intensity with metal filters. For 
obtaining maximum resolution in the reference dataset, a second remote dataset was measured 
at higher intensity (30 %) after shifting the crystal laterally to an unexposed region and setting 
the crystal- detector distance to 250 mm (2.3 Å).  
The images were integrated with IPMosflm, and Scala (Evans, 1997) was used for 
internal scaling of the individual datasets. Then the different datasets were compared and 
normalized with XPrep (Bruker, Madison, USA). In the XPrep-processed data, 25 selenium 
sites were determined from the anomalous differences by direct methods using ShelX-D 
(Uson and Sheldrick, 1999). Sharp was used to refine the heavy atom sites and to calculate the 
phases (de la Fortelle and Bricogne, 1997). Density modification was carried out with 
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Resolve (Terwilliger, 2000) using the default options and assuming a 58 % solvent content. 
Identifying and applying the correct non-crystallographic symmetry by Resolve was essential 
for calculation of phases sufficiently good for interpretable electron density maps. Building of 
a partial model and sequence docking were carried out with ArpWarp6.1 (Perrakis et al., 
1999). Thereby, a backbone coverage of 71 % was achieved, and 51 % of the side chains were 
automatically built. Subsequent iterative manual model building and refinement were 
performed with Coot (Emsley and Cowtan, 2004) and Refmac5 (Murshudov et al., 1997). 
Residues without detectable side chain density were modeled as alanines. The TLS 
(translation libration screw) refinement option of Refmac5 improved the refinement statistics 
significantly towards the end of the refinement: Upon TLS refinement, the R-factors were 
reduced by ~6 %. Using the TLS option, the anisotropic thermal motions of sections in the 
model ("TLS groups") that behave like rigid bodies can be modeled expending only few 
parameters. For modeling anisotropic motions of individual atoms, large amounts of data, i.e. 
high resolution data (typically ~1.3 Å), would be required. TLS groups were assigned 
according to the domain structure of the proteins: (i) NBD of Sse1-Δloop (residues 2-396) 
including ATP, Mg2+, and K+, (ii) β-sandwich domain of Sse1-Δloop (residues 397-540), (iii) 
3HBD of Sse1-Δloop (residues 541-655), (iv) subdomains Ia, Ib, IIa of Hsp70N (residues 4-
229, 308-382), and (v) subdomain IIb of Hsp70N (residues 230-307). Solvent molecules were 
assigned to the respective TLS groups.  
A 2.3 Å native dataset isomorphous to the MAD data was solved using the SeMet 
structure as an initial model. In order to reduce model bias, ArpWarp6.1 was used to 
autobuild a partial model (83 % backbone and 75 % side chain coverage), which was 
complemented by manual model building. The refined native model exhibited superior quality 
compared to the SeMet model and hence was used for further structural analysis. 
 
3.7.3.4 Structure analysis  
The stereochemistry of the model was evaluated by the program Procheck (Laskowski et al., 
1993). Coordinates were aligned with Lsqman (Kleywegt and Jones, 1994) and Lsqkab 
(Kabsch, 1976). The sequence alignment was prepared with MultAlin (Corpet, 1988) and 
ESPript (Gouet et al., 1999). The interaction surface in the Sse1p/Hsp70 complex was 
analyzed with Areaimol (Lee and Richards, 1971), Contact (Skarzynski, 1988), and Naccess 
(Hubbard and Thornton, 1993). Surface shape complementarity between the complex partners 
was estimated using SC (Lawrence and Colman, 1993). Rotation axes were determined with 
3 Materials and Methods 
 
69
the DynDom server (Hayward and Berendsen, 1998). Figures were generated with the 
program Pymol (DeLano, 2002). 
 
3.7.4 Functional in vitro assays 
3.7.4.1 Sse1p/Ssa1N complex formation assay 
To investigate the nucleotide dependence of Sse1p/Ssa1N complex formation, the proteins 
(17.2 µM each) were mixed in absence of nucleotide or in presence of 40 µM ADP or ATP. 
HKM2 buffer was added to a final volume of 30 µl. The mixture was applied to an analytical 
Superose 12 column operated at RT in HKM2 buffer. 50 µl fractions were collected, 5 µl of 
which were analyzed by SDS-PAGE (see chapter 3.7.2.2). In addition, 0.5 µl of the mixture 
applied to size exclusion chromatography were loaded on the 10 % gel. Photos of the gels 
were taken with the Fuji-LAS3000 luminescence and densitometry system. The protein bands 
in the complex-containing fractions were analyzed by densitometry (AIDA). For 
quantification, the quotient of (Ssa1Ncomplex/Sse1pcomplex)/(Ssa1Nload/Sse1pload) was calculated. 
The quotients determined from three independent experiments were averaged. For 
comparison, the quotient from the experiment performed in presence of ATP was set to 1.  
To estimate the relative binding affinities of the Sse1p variants for Ssa1N, the same 
experimental setup was used. The proteins were always mixed in presence of 40 µM ATP. 
 
3.7.4.2 Determination of the dissociation constant for the Sse1p/Ssa1N interaction 
A stoichiometric complex of His6-Sse1p and ATP was prepared by incubation of the protein 
with 0.5 mM ATP at 25 ºC for 10 min in HKM2 buffer. After removal of unbound ATP via a 
NAP 25 desalting column, the complex was kept on ice. The concentration was determined by 
a Bio-Rad protein assay calibrated with nucleotide-free His6-Sse1p as reference protein. 
Aliquots were snap-frozen in liquid nitrogen and stored at -80 °C. In a total volume of 1 ml, 
His6-Sse1p·ATP (0.2 µM) was incubated for 30 min at 25 °C under vigorous shaking with 
increasing concentrations of Ssa1N (0.1-2.0 µM) and 150 µl of Ni2+-charged chelating 
Sepharose. The reaction buffer was HKM2 supplemented with 20 mM imidazole. The gel 
beads were sedimented by centrifugation, and 800 µl of the supernatant were removed. 800 µl 
of HKM2 buffer containing 347 mM imidazole were added to the slurry, and the mixture was 
incubated as above for 5 min, followed by centrifugation. Samples of the supernatants at low 
and high imidazole concentrations were subjected to SDS-PAGE. Photos of the gels were 
taken with the Fuji-LAS3000 luminescence and densitometry system. The Ssa1N content was 
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analyzed by densitometry (AIDA) using an Ssa1N concentration series as standard. As a 
control for background binding to the beads, another set of experiments without His6-Sse1p 
was performed. The amount of His6-Sse1p-bound Ssa1N was calculated with the following 
formula: [bound Ssa1N] = [Ssa1Nhigh imidazole] - [Ssa1Nlow imidazole]/5 and plotted against 
[Ssa1Nlow imidazole]. The resulting points were fitted with the program Grafit 3.0 (Erithacus 
Software, Staines, Great Britain) using the following equation: [bound Ssa1N] = [His6-
Sse1p] · [Ssa1Nlow imidazole]/(KD + [Ssa1Nlow imidazole]) assuming a 1:1 complex and no 
background binding. The dissociation constant determination was conducted by Dr. Andreas 
Bracher.  
 
3.7.4.3 Proteinase K resistance assay  
To test the protease resistance of Sse1p, Sse1-Δloop, and Hsp110, 3 µM of the respective 
Hsp110 homolog were incubated with 0, 0.5, 1, 2, 4, 8, 16, 32, 64, and 128 µg/ml Proteinase 
K in HKM3 buffer for 30 min at RT (Vtotal = 50 µl). After terminating the degradation 
reaction by adding 100 mM PMSF to a final concentration of 9 mM, the samples were chilled 
on ice for 5 min and centrifuged at RT for 2 min. 10 µl of the supernatants were mixed with 
10 µl 2x SDS-loading buffer and denatured at 94 °C for 5 min. 10 µl of each sample were 
loaded onto an 8 % SDS gel and subjected to SDS-PAGE (see chapter 3.7.2.2). In a second 
series of experiments the influence of ATP on protein stability was tested: Prior to Proteinase 
K exposure, the Hsp110 homologs were incubated with 1 mM ATP for 30 min at RT. 
The Proteinase K resistance of the NBDs of Ssb1p and Hsp70 were analogously 
investigated. However, 7 µM instead of 3 µM protein were used. 
Furthermore, the Proteinase K resistance of the following complexes was analyzed: 
Sse1p/Ssb1N (51.8 µM), Sse1-Δloop/Ssa1N (31.3 µM), Sse1Δ-loop/Ssb1N (53.2 µM), Sse1-
Δloop/Hsp70N (53.0 µM), and Hsp110/Hsp70N (41.0 µM). The individual purified proteins 
were mixed at the indicated concentrations and in presence of 100 µM ATP (1 mM for Sse1-
Δloop/Ssa1N). Free ATP and unbound Hsp70N were removed by gel filtration on Superose 
12 using HKM3 or HKM2 (for Sse1-Δloop/Ssa1N and Sse1-Δloop/Hsp70N) as running 
buffer. The complexes were principally eluted in two 500 µl fractions, which were pooled. In 
a total volume of 60 µl, 50 µl of the complex fractions were incubated with Proteinase K 
(concentrations see above) at RT for 30 min. The protease reaction was stopped with 3.3 mM 
PMSF. The further procedure was the same as described for the Proteinase K degradation of 
the Hsp110 homologs. Instead of 10 µl, 15 µl of the SDS samples were loaded onto 8 % SDS 
gels.  
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3.7.4.4 Nucleotide release assay 
To determine whether (i) the NBD of Hsp70 homologs is sufficient for a functional 
interaction with Sse1p and whether (ii) the different Sse1p variants can still trigger nucleotide 
release from Hsp70, nucleotide release assays were performed. Nucleotide release kinetics of 
the fluorescent nucleotide analog MABA-ADP (N8-(4N′-methylanthraniloylaminobutyl)-8 
aminoadenosine 5′-diphosphate) from the Hsp70 NBD were followed in a stopped-flow setup 
as previously described (Gässler et al., 2001). All components were in HKM2 buffer 
containing 1 mM DTT. Hsp70·MABA-ADP complexes were formed by incubating 2.5 µM 
Hsp70N, Ssa1N or Ssa1p with an equimolar amount of MABA-ADP at 30 °C for 30 min. The 
nucleotide exchange factor solutions contained 250 µM ATP (2.5 mM ATP) and either 
2.5 µM NEF (25 µM NEF) or no protein (values in parentheses are for experiments with 
25 µM Sse1p variant). For the determination of the nucleotide release rates, equal volumes of 
the solutions were rapidly mixed at 30 °C in the stopped-flow apparatus. Release of labeled 
nucleotide was monitored by the decrease in fluorescence of the unbound MABA-ADP. The 
excitation wavelength was adjusted to 360 nm, and a cut-off filter at 420 nm was used for 
detection. The two slits of the monochromator were set to 5 nm and 2.5 nm, respectively. 
During the first second, 200 datapoints were collected; during the following 20 s further 200 
datapoints were recorded. Each experiment was repeated four times. Rates were determined 
from the average of the individual fluorescence traces using the program Grafit 3.0 (Erithacus 
Software, Staines, Great Britain). 
 
3.7.4.5 Peptide release assay 
To test whether amino acid substitutions in Sse1p influence substrate release from the Hsp70 
partner, a peptide release assay was conducted. Peptide release rates were determined with a 
stopped-flow instrument using dansyl-labeled NR peptide (dansyl-NRLLLTGC, D-NR) 
(Gässler et al., 2001). All components were in HKM2 buffer containing 1 mM DTT. For 
preparation of an Ssa1p·ADP·D-NR complex, 2.5 µM ADP-bound Ssa1p were pre-incubated 
with an equimolar amount of D-NR for 30 min at 30 °C. For preparation of a nucleotide-free 
Ssa1p·D-NR complex, an Ssa1p·ADP·D-NR mixture was treated with 2 U of shrimp alkaline 
phosphatase in 50 mM Tris-HCl pH 8.5 for 3 h at 25 ºC. Next, the solution was diluted with 
HKM2 and DTT to a final Ssa1p/D-NR concentration of 2.5 µM. The Ssa1p·D-NR or 
Ssa1p·ADP·D-NR complexes were then mixed (volume ratio 1:1) at 30 ºC with 250 µM 
unlabeled NR and 250 µM ATP in the presence or absence of 2.5 µM of the distinct Sse1p 
variant. For control, the substrate-chaperone complex was mixed with unlabeled NR or with 
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unlabeled NR and Sse1p in absence of ATP. Release of D-NR was monitored by the decrease 
in fluorescence of the unbound D-NR. The excitation wavelength was adjusted to 334 nm, 
and a cut-off filter at 385 nm was used for detection. The two slits of the monochromator 
were set to 5 nm and 2.5 nm, respectively. During the first second, 500 datapoints were 
collected; during the following 20 s further 500 datapoints were recorded. Each experiment 
was repeated four times. Rates were determined from the average of the individual 
fluorescence traces using the program Grafit 3.0 (Erithacus Software, Staines, Great Britain). 
 
3.7.4.6 Luciferase refolding assay 
To test the influence of amino acid substitutions in Sse1p on luciferase refolding, firefly 
luciferase (100 nM) was incubated in buffer R at 42 °C in the presence of 3 µM Ssa1p for 
10 min. Refolding was initiated by addition of 3 µM Ydj1p, 0.5 µM Sse1p variant, and 3 mM 
ATP and allowed to proceed at 30 °C. The utilized Ssa1p was purified from yeast (see chapter 
3.7.1.2, stock concentration 148.9 µM). The Ydj1p and Sse1p variant stocks were diluted with 
glycerol buffer to 37.6 and 8.9 µM, respectively, prior to use. For control, luciferase was (i) 
denatured and refolded in absence of any chaperone, (ii) denatured and refolded in presence 
of Ssa1p, and (iii) denatured in presence of Ssa1p and refolded in presence of Ydj1p, but 
absence of Sse1p. At the indicated time points, 1 µl aliquots were mixed with 20 µl of buffer 
R supplemented with 3 mM ATP and 1 mg/ml BSA. After addition of 50 µl of luciferase 
assay reagent (diluted 1:5 with buffer R supplemented with 3 mM ATP and 1 mg/ml BSA), 
activity was determined in a luminometer (1 s delay, 1 s measurement) with the 100 % value 
corresponding to the enzyme activity of native luciferase in buffer R containing 3 mM ATP 
prior to heating. Each experiment was repeated independently for at least three times. 
 
3.7.4.7 Sse1p/peptide interaction 
3.7.4.7.1 Peptide scan 
The Sse1p peptide binding specificity was assessed in a peptide scan. 13 amino acid long 
peptides, which covered the sequence of firefly luciferase and partially overlapped by ten 
amino acids, were covalently linked to a cellulose-PEG-membrane by their C-termini (JPT 
Peptide Technologies GmbH). An additional β-alanine was added between the peptide and the 
membrane, and all cysteines were replaced by serines. Acetylation of the N-termini of the 
peptides ensured higher stability against degradation. Furthermore, the uncharged N-acetyl 
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group mimicked the luciferase region as found in the native protein better than the charged 
NH3+-group. Each of the 180 peptide spots carried approximately 5 nmol of peptide.  
After rinsing the dry peptide membrane for 5 min in methanol, it was washed three 
times for 10 min in TBS and blocked in TBS + 1 % (w/v) milkpowder for 3 h at RT. 
Subsequently, it was incubated with 10 µg/ml Sse1p in TBS + 1 % (w/v) milkpowder at RT 
overnight. Afterwards, the membrane was washed three times for 5 min in TBST buffer. For 
detection of peptide-bound Sse1p, the membrane was incubated with Sse1p antiserum in 
TBST + 1 % (w/v) milkpowder (dilution 1:5000) at RT for 45 min and washed twice with 
TBST buffer for 5 min. Then, the membrane was incubated with a HRP-conjugated secondary 
antibody in TBST + 1 % (w/v) milkpowder for 45 min. After three-fold washing in TBST, 
peptide binding was visualized using ECL solutions I and II as described in chapter 3.7.2.3. In 
order to detect direct hybridization of the antibodies with the peptide spots, a control 
experiment was performed, in which the incubation step with Sse1p was omitted. 
For regeneration, the membrane was washed three times for 10 min in water, followed 
by four 30 min incubation steps at 50 °C in stripping buffer. Afterwards, the membrane was 
sequentially incubated in 10x PBS and in TBST. Both steps were performed at RT for 20 min 
and repeated three times. If re-used within a few days, the membrane was stored in TBST at 
4 °C. For long-term storage, the membrane was dried and kept at -20 °C. Specifically, it was 
washed three times with TBS for 10 min. After two-fold washing with methanol for 1 min, 
the membrane was air dried. If this regeneration procedure was not successful in reducing 
residual staining, the membrane was regenerated as follows: The membrane was sequentially 
washed twice with water, three times with regeneration buffer A, three times with 
regeneration buffer B, once with water, and three times with TBST. Each washing step was 
conducted at RT for 10 min. If this regeneration protocol failed as well, the membrane was 
incubated with 0.1 M HCl for 1 h, followed by three 10 min washing steps in TBS.   
 
3.7.4.7.2 Anisotropy measurements 
To test Sse1p peptide binding in solution, anisotropy measurements with a fluorescently 
labeled substrate peptide were performed. Specifically, 6-carboxyfluorescein conjugated 
LICGFRVVLMYRF (LIC-peptide) was used. The peptide was dissolved in DMF (609 µM), 
and the stock solution was stored at -80 °C. For the experiment, a 1 µM aqueous stock 
solution of the peptide was freshly prepared in siliconized tubes. 11 different Sse1p dilutions 
(0, 0.5, 1, 2, 5, 10, 20, 50, 100, 200, 500 nM) in HKM2 buffer containing 10 nM of the 
labeled LIC-peptide were incubated at RT for 20 min (total volume 350 µl) in siliconized 
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tubes. Anisotropy measurements were performed at 20 °C using a Fluorolog 3 
spectrofluorimeter and a cylindric fluorescence cuvette. Excitation and emission wavelengths 
were set to 494 and 521 nm, respectively. Both excitation and emission slit widths were 
adjusted to 5 nm, the integration time was set to 0.3 s.  
 
3.7.4.8 Luciferase aggregation prevention and refolding assays 
3.7.4.8.1 Light scattering assay 
The aggregation prevention activity of Sse1p was tested in light scattering experiments using 
a Fluorolog 3 spectrofluorimeter. The light scattering by 100 nM firefly luciferase was 
monitored in a cylindric fluorescence cuvette during incubation at 42 °C in presence or 
absence of 0.5 µM Sse1p (total volume 300 µl). Sterile-filtered and degassed buffer R 
supplemented with 3 mM ATP served as reaction buffer. Excitation as well as emission 
wavelengths were set to 350 nm. The excitation slit width was adjusted to 2 nm, the emission 
slit width to 1 nm. One datapoint per second was collected. To correct for fluctuations in the 
excitation light source, the reference signal (R) was recorded in addition to the actual signal 
(S). For evaluation, the ratio of S/R was used.  
 
3.7.4.8.2 Luciferase refolding assay 
The capacity of the Sse1p variants to keep firefly luciferase in a folding competent state at 
elevated temperatures was tested as follows: 100 nM firefly luciferase were thermally 
denatured at 42 °C for 25 min in buffer R containing 3 mM ATP and 0.5 µM Sse1p variant. 
Refolding was initiated by addition of 3 µM Ssa1p and 3 µM Ydj1p and allowed to proceed at 
30 °C (for further details see chapter 3.7.4.6). For control, luciferase was (i) denatured and 
refolded in absence of any chaperone, (ii) denatured in absence of any chaperone and refolded 
in presence of Ssa1p and Ydj1, (iii) denatured in presence of BSA and refolded in presence of 
Ssa1p and Ydj1, (iv) denatured in absence of any chaperone and refolded in presence of 
Ssa1p, Ydj1, and Sse1p, and (v) denatured in presence of BSA and refolded in presence of 
Ssa1p, Ydj1, and Sse1p. At the indicated time points, 1 µl aliquots were mixed with 20 µl of 
buffer R supplemented with 3 mM ATP and 1 mg/ml BSA. After addition of 50 µl of 
luciferase assay reagent (diluted 1:5 with buffer R supplemented with 3 mM ATP and 
1 mg/ml BSA), activity was determined in a luminometer (1 s delay, 1 s measurement) with 
the 100 % value corresponding to the enzyme activity of native luciferase in buffer R 
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containing 3 mM ATP prior to heating. Each experiment was repeated independently for at 
least three times. 
3.7.5 Functional in vivo assays 
3.7.5.1 Yeast growth assay 
It was tested whether the ectopically expressed Sse1p mutants can support the growth of the 
ΔSSE1ΔSSE2 S. cerevisiae strain SB472 to the same extent as ectopically expressed wt Sse1p. 
Therefore, glycerol stocks of modified SB472 cells expressing the various variants (see 
chapter 3.6.9) were streaked on YPD plates and incubated at 30 °C for 2 d. Next, cells from 3-
6 colonies were inoculated onto 20 ml of YPD medium and grown at 30 °C overnight. After 
dilution to an OD600 of 0.15 in a total volume of 20 ml, cultures were grown for 5 h at 30 °C 
until they reached mid-log phase (OD600 ≈ 0.5). For each strain, an OD600 corresponding to 
0.5 in 1 ml was harvested by centrifugation at 5000 rpm for 5 min (Eppendorf 5415D), and 
the cell pellets were resuspended in 1 ml of autoclaved water. From each suspension, four ten-
fold serial dilutions in water were prepared. 4 µl of each dilution were spotted onto YPD agar 
plates, which were subsequently incubated at 30 or 37 ºC for 2 d. The viability of ΔSSE1 
SB537 strains transformed with either pRS415ADH, pRS415ADH-SSE1, pRS415ADH-sse1-
(2+3) or pRS415ADH-sse1-(2+4) was tested in an analogous experimental setup. 
  
3.7.5.2 Protein expression analysis by Western blotting 
Western blotting of whole cell lysates was performed to analyze the expressions levels of the 
Sse1p variants as well as of various chaperones (Hsp12p, Hsp42p, Hsp104p, Ssa1p, Ydj1p) in 
modified ΔSSE1ΔSSE2 SB472 strains harboring sse1 mutant expression plasmids (see chapter 
3.6.9). As a control, the expression levels of Sse1p and the listed chaperones in YPH499 cells 
was determined. Cell lysates were prepared from cultures that were grown in YPD medium to 
mid-log phase at 30 ºC and again 4 h after shifting the growth temperature to 37 ºC. Cell lysis 
was performed as follows: The equivalent to an OD600 of 10 in 1 ml was harvested 
(Beckmann GS-6R, 3400 rpm, 5 min, 4 °C), and the pellet was resuspended in 2 ml fresh 
medium. 450 µl of the cell suspension were then supplemented with 450 µl of ice-cold 
30 mM NaN3, the mixture was centrifuged at 14000 rpm and 4 °C for 2 min (Eppendorf 
5417R), and the cell pellet was immediately frozen in liquid nitrogen. The sedimented cells 
were resuspended in 1 ml of ice-cold, autoclaved H2O and 150 µl of alkaline lysis buffer were 
added. During the incubation time of 10 min, the cell suspension was vigorously mixed for 
five times at least. To precipitate the proteins, 150 µl of 50 % (w/v) TCA were added. After 
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incubation on ice for 20 min, the mixture was centrifuged at 14000 rpm and 4 °C for 10 min 
(Eppendorf 5417R), and the pellet was resuspended in 500 µl of chilled acetone. Short 
centrifugation of the suspension at 14000 rpm and 4 °C was followed by dissolving the pellet 
in 100 µl of urea-SDS-loading buffer. The sample was incubated at 65 °C for 15 min and 
briefly centrifuged. 15 µl of the sample were loaded on a 10 % SDS gels (15 % for Hsp12 
detection). Western blotting was performed as described in chapter 3.7.2.3, the utilized 
dilutions for the different primary antibodies are indicated in chapter 3.2. The protein band of 
endogenous phosphoglycerate kinase (PGK) was used as a loading control. 
The expression level of Ssa3p in modified SB472 and SB537 strains, which harbor an 
expression plasmid for a distinct sse1 variant as well as a β-galactosidase reporter plasmid 
(see chapter 3.7.5.3), was estimated using a slightly modified protocol compared to the one 
described above. For each strain, an OD600 corresponding to 2.5 in 1 ml was harvested from a 
mid-log phase culture grown in SC-Leu-Ura medium at 30 °C. The cell pellets were washed 
with 1 ml of ice-cold, autoclaved H2O and immediately snap-frozen in liquid nitrogen. After 
further incubation of the cultures at 37 °C for 3.5 h, another sample was drawn. Alkaline lysis 
of the cells was conducted as described above. 10 µl of the final samples were separated by 
10 % SDS-PAGE and further analyzed by Western blotting. 
The expression levels of Sse1p, Sse1-(2+9) and Sse1-(2+10) in modified SB537 were 
analyzed as described above, but 10 µl of the final samples were loaded on a 10 % SDS gel. 
SB537 cells transformed with the original plasmid pRS415ADH served as a control. 
 
3.7.5.3 β-galactosidase reporter assay for stress response 
To investigate whether modified SB472 and SB537 strains, which ectopically express sse1 
variants, are more stressed than wt YPH499 cells, the mutant strains as well as YPH499 were 
transformed with pYEP-SSA3-lacZ, a yeast plasmid coding for β-galactosidase under control 
of the stress-inducible SSA3 promotor (see chapter 3.6.8). Since pYEP-SSA3-lacZ also codes 
for an uracil selection marker, mutant strains were incubated on SC-Leu-Ura plates after 
transformation at 30 °C for 2 d. Transformed YPH499 was grown on SC-Ura plates. For the 
β-galactosidase assay, a suspension culture of each strain was grown in SC-Leu-Ura (SC-Ura 
for YPH499) at 30 °C to mid-log phase. Three times an OD600 corresponding to 2.5 in 1 ml 
was harvested from each culture. The pellets were washed with 1 ml of ice-cold, autoclaved 
H2O and were immediately snap-frozen in liquid nitrogen. After the remainder of the cultures 
was incubated at 37 °C for 3.5 h, three further samples were drawn for each strain. Next, the 
sedimented cells were resuspended in 700 µl of buffer Z. For membrane permeabilization, 
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50 µl of chloroform and 50 µl of 0.1 % (w/v) SDS were added to the cell suspensions. 
Furthermore, chloroform and 0.1 % (w/v) SDS were added to three aliquots of 700 µl buffer 
Z, which served as a control. The samples were vigorously mixed for 10 s and incubated at 
30 °C for 5 min. Then 200 µl of ONPG-solution (4 mg/ml in buffer Z) were added to each 
sample, and the mixtures were incubated at 30 °C for 5-6 min. Following termination of the β-
galactosidase reactions by addition of 350 µl of 1 M Na2CO3, the samples were clarified by 
centrifugation. The absorbance of the supernatants of the cell suspensions was measured at 
420 nm against the supernatant of one of the control samples. If necessary, appropriate 
dilutions were prepared. The specific β-galactosidase activity was expressed in Miller units 
and calculated as follows: (dilution factor · A420 · 1000)/(OD600 · time of incubation with 
ONPG in min). A420 was the average value from triplicate samples. For cells grown at 30 °C, 
three independent experiments were conducted; for cells additionally grown at 37 °C, the β-
galactosidase reporter assay was repeated twice (four times for the YPH499 strain). In 
addition to the reporter gene expression, the endogenous SSA3 expression levels of the 
cultures were checked by Western blotting as described in chapter 3.7.5.2.  
 
3.7.5.4 Protein stability analysis 
In order to assess the stability of the mutant forms of sse1 expressed by modified SB472 at 
30 ºC, cycloheximide chase experiments were performed (Hiller et al., 1996; Park et al., 
2007). For each strain, the equivalent to an OD600 of 10 in 1 ml was harvested from a mid-log 
phase YPD culture (Beckmann GS-6R, 3400 rpm, 5 min, 4 °C). After washing with 2 ml of 
fresh medium, the pellets were resuspended in 2 ml of fresh medium, and protein biosynthesis 
was terminated by addition of the translation elongation inhibitor cycloheximide to a final 
concentration of 0.48 mg/ml. 450 µl of the cell suspensions were then supplemented with 
450 µl of ice-cold 30 mM NaN3, the mixtures were centrifuged at 14000 rpm and 4 °C for 
2 min (Eppendorf 5417R), and the cell pellets were immediately snap-frozen in liquid 
nitrogen (time point 0 h). The remainder of the cell cultures was further incubated at 30 °C, 
and samples were taken as described above after 1, 2, and 3 h. Alkaline lysis was performed 
as described in chapter 3.7.5.2, and 15 µl of the final samples were analyzed by 10 % SDS-
PAGE and Western blotting (chapters 3.2 and 3.7.2.3). 
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4 RESULTS 
 
4.1 Complex formation between Hsp110s and Hsp70 NBDs 
 
To investigate how Hsp70s and Hsp110s cooperate in protein folding as well as to elucidate 
the mechanistic basis for nucleotide exchange by Hsp110s on Hsp70s, we set out to solve the 
crystal structure of an Hsp110/Hsp70 complex. The first objective was to find protein 
constructs of Hsp70 and Hsp110 suitable for crystallization. In addition, we characterized 
these Hsp70/Hsp110 complexes by biochemical and biophysical methods: We investigated 
the nucleotide dependence of complex formation and determined the stoichiometry, the 
dissociation constant as well as the stability of the complex.  
First, we optimized the Hsp70 partner for crystallization purposes. Earlier studies had 
revealed that the Hsp70 NBD is sufficient to form functional complexes with the NEFs GrpE, 
BAG-1, and HspBP1 (Harrison et al., 1997; Sondermann et al., 2001; Shomura et al., 2005). 
We found that this is also the case for complex formation with Hsp110 family members. In 
size exclusion chromatography experiments, the NBDs of the yeast Hsp70 homologs Ssa1p 
(Ssa1N) and Ssb1p (Ssb1N) as well as of human Hsp70 (Hsp70N) coeluted with the ATP-
bound yeast Hsp110 homolog Sse1p (Figure 4-1A and data not shown; for nucleotide 
dependence of complex formation see below). In absence of Sse1p, the NBDs eluted later, at 
the expected molecular weight. Complex formation was also observed for Hsp70N and its 
cognate NEF Hsp110 (data not shown). Furthermore, we could show that Sse1p is able to 
exchange nucleotide on Hsp70 NBDs. Sse1p·ATP accelerated the dissociation of the 
fluorescent probe MABA-ADP from Ssa1N and full-length Ssa1p as well as from 
heterologous Hsp70N to a similar degree when compared to the spontaneous dissociation  
(63-, 93-, and 103-fold, respectively; Figure 4-1B). For DnaK, the dissociation constant of 
MABA-ADP is comparable to that of unlabeled ADP, confirming that the presence of the 
fluorophore does not affect the binding mode of the nucleotide (Theyssen et al., 1996). Two 
main conclusions can be drawn from these results: First, the interaction of cytosolic Hsp110s 
with the NBDs of Hsp70 homologs is sufficient for binding and nucleotide exchange. Second, 
the interaction between Hsp70s and Hsp110s seems to be highly conserved, since it not only 
occurs between endogenous pairs (Sse1p/Ssa1N, Sse1p/Ssb1N; Hsp110/Hsp70N) but also 
between heterologous partner proteins (Sse1p/Hsp70N). The latter finding might be a 
consequence of the remarkably high degree of sequence identity between the NBDs of 
canonical Hsp70 homologs (approximately 75 % sequence identity between yeast and human 
cytosolic orthologs). 
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Not only the Hsp70 but also the Hsp110 partner protein was optimized for 
crystallization purposes. Compared to Hsp70 chaperones, the sequences of Hsp110/Grp170 
homologs contain a poorly conserved and presumably flexible insertion in the β-sandwich 
domain and an extension at the ultimate C-terminus. Since these additional segments are 
comparatively short in yeast Sse1p and since Sse1p was found to be more stable than human 
Hsp110 (see below), Sse1p was chosen as Hsp110 partner in the complex. Several examples 
exist for dramatic improvements in crystallizability by removal of presumably disordered, 
charged loop insertions, for example in the cases of the Hsp90/Sba1 (Ali et al., 2006) and the 
cap binding complex (Mazza et al., 2001) structures. Therefore, we replaced the acidic 
insertion within the β-sandwich domain of Sse1p (amino acid residues 503-524) by the 
Figure 4-1: Biochemical characterization of the Sse1p/Hsp70 interaction. 
(A) Sse1p/Ssa1N complex formation is most efficient in presence of ATP. A mixture of Sse1p, Ssa1N
(17.2 µM each) and either no nucleotide, ADP or ATP (40 µM) was applied to a Superose 12 size exclusion
chromatography column. Fractions were analyzed by SDS-PAGE (left panel), and the intensities of the Ssa1N
bands in complex-containing fractions (lanes 1-3) were quantified by densitometry (right panel). Each gel
filtration run was repeated three times, standard deviations (SDs) are indicated.  
(B) Sse1p exchanges nucleotide on all tested Hsp70 proteins. The fluorescent probe MABA-ADP was bound to
2.5 μM of an Hsp70 protein (Ssa1p, Ssa1N or Hsp70N, as indicated) and mixed in a stopped-flow apparatus
with a solution containing 250 μM ATP or ADP and either 2.5 μM NEF or no protein. The fluorescence traces
of four mixing experiments were averaged (left panel), and the decline in fluorescence was fitted with a mono-
or bi-exponential model. The bars in the right panel indicate the rate constants for the dominant dissociation
process in a representative experiment. 
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peptide linker sequence AGSD. This substitution did neither affect protein stability nor 
nucleotide exchange activity compared to full-length Sse1p (Figure 4-1B, Figure 4-2C, and 
data not shown). The modified Sse1p variant was termed Sse1-Δloop. Furthermore, the C-
terminus (amino acid residues 658-693) of Sse1-Δloop could be removed without perturbing 
the nucleotide exchange factor activity (Sse1-Δloop-ΔC, Figure 4-1B). Thus, both variable 
segments in the Sse1p sequence are expendable for Hsp70N binding and nucleotide exchange 
activity.  
Morano and coworkers reported that heterologous complex formation between Sse1p 
and C-terminally truncated bovine Hsp70 occurred most efficiently in presence of ATP 
(Shaner et al., 2006). This is contrary to expectations since a NEF should compete with the 
nucleotide for Hsp70. In order to test whether nucleotide addition was indeed required for 
complex formation, we investigated the nucleotide dependence of complex formation for the 
Sse1p/Ssa1N complex (Figure 4-1A). While almost no complex formation was detectable by 
size exclusion chromatography in the absence of nucleotide, Ssa1N coeluted with Sse1p upon 
incubation with ATP or, to a lesser extent, after incubation with ADP. Analysis by size 
exclusion chromatography ensured that excessive nucleotide was removed. When ATP was 
included in the running buffer – as expected – no complex formation was observed (data not 
shown). Consistent with weaker complex formation in presence of ADP, Sse1p·ADP 
triggered nucleotide dissociation on Ssa1p less efficiently than Sse1p·ATP (Figure 4-1B).  
Size distribution analysis of the complex-containing gel filtration fractions by field flow 
fractionation (FFF) followed by multiangle light scattering (MALS) analysis indicated 1:1 
stoichiometry for all examined Sse1-Δloop/NBDHsp70 complexes (Figure 4-2A). For the 
Sse1p/Ssa1N complex, we determined a KD value of ~0.4 µM (Figure 4-2B), which is close to 
the KD of ~0.1 µM reported for the interaction of the full-length proteins (Raviol et al., 
2006b), suggesting that the Hsp70 PBD does not contribute much to Hsp110 binding.  
Limited proteolysis experiments with Proteinase K revealed that Sse1p and Sse1-Δloop 
were significantly stabilized in presence of ATP and by complex formation with an Hsp70 
NBD; Figure 4-2C shows the experiment for the Sse1p/Ssa1N complex (see also Shaner et 
al., 2006). As demonstrated by mass spectrometry and Edman degradation, only the 36 C-
terminal residues of the ATP-bound Sse1-Δloop were removed, indicating that this region is 
accessible and presumably unstructured (data not shown). As mentioned above, these amino 
acid residues (658-693) are dispensable for function (Figure 4-1B and see also Shaner et al., 
2004). By contrast, human Hsp110 was found to be highly sensitive to Proteinase K also in 
presence of ATP and Hsp70N (data not shown). These data are consistent with the 
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Figure 4-2: Biochemical characterization of the Sse1p/Hsp70 interaction. 
(A) Sse1-Δloop forms binary complexes with Hsp70 NBDs. The molar masses of the Sse1-Δloop complexes as
well as for uncomplexed Sse1-Δloop were analyzed by FFF followed by MALS. The molecular masses of Sse1-
Δloop (black), Sse1-Δloop/Ssa1N (blue), Sse1-Δloop/Ssb1N (yellow), and Sse1-Δloop/Hsp70N (red) were
determined to 75.6 kDa (75.3 kDa), 101.1 kDa (117.0 kDa), 91.5 kDa (117.2 kDa), and 97.5 kDa (118.1 kDa),
respectively. The numbers in brackets indicate the theoretical molecular masses calculated with the ExPASy
ProtParam tool. In the graph, the horizontal lines across the peaks indicate the molar masses and homogeneities
of the respective protein bands. 
(B) The Sse1p/Ssa1N interaction is characterized by a similar KD value as the Sse1p/Ssa1p interaction. The KD
value for complex formation between Sse1p and Ssa1N was estimated from the distribution of Ssa1N between
supernatant and Ni2+ resin-bound His-tagged Sse1p at different Ssa1N concentrations. His-tagged Sse1p was
pretreated with ATP and used at a concentration of 0.2 μM. 
(C) Sse1-Δloop·ATP and Ssa1N form a protease-resistant complex. The indicated purified proteins were
incubated with a series of increasing concentrations of Proteinase K (0, 0.5, 1, 2, 4, 8, 16, 32, 64, and 128 µg/ml)
for 30 min at RT. The samples were analyzed by 8 % SDS-PAGE. While nucleotide-free Sse1-Δloop was
degraded already at a Proteinase K concentration of 0.5 µg/ml, Sse1-Δloop was significantly stabilized in the
presence of ATP. Further stabilization was observed in the additional presence of Ssa1N. 
 
observation that Hsp110 was fragmented – likely by residual E. coli proteases – after 
incubation of an Hsp110/Hsp70N complex at 20 °C for 24 h, whereas the Sse1-Δloop/Ssb1N 
complex remained unchanged under the same conditions. The Sse1-Δloop/Ssa1N complex 
was shown to be stable for at least six days, when stored at 4 °C and in presence of protease 
inhibitor (data not shown).  
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4.2 Complex crystallization 
 Figure 4-3: Initial crystals for the
Hsp110/Hsp70 complex. 
(A)-(E) The Sse1-Δloop-ΔC/Hsp70N
complex crystallized as hexagonal rods
in many conditions (200-500 µm). In all
pictures, sideviews of the rods are
shown; the crosssections had hexagonal
shape. All precipitant solutions
contained PEG and low salt
concentrations or no salt at all. The
protein concentration was 6.3 mg/ml,
the sample buffer was HKM2.
Crystallization was performed by the
hanging drop vapor diffusion method in
presence of Complete protease inhibitor
at 4 °C. 
(F) Sse1-Δloop/Hsp70N initially
crystallized as splayed rods in the
indicated precipitant solution
(~300 µm). The protein concentration
was 7.2 mg/ml. Apart from that, the
experimental setup was identical to (A)-
(E). 
(G) Both crystal forms contained the
two complex partners. To check the
protein content, crystals washed with
cryo buffer were dissolved in HKM2
buffer and applied to 10 % SDS-PAGE
analysis. Since the dissolved
orthorhombic Sse1-Δloop/Hsp70N
crystal was small, the corresponding
protein bands were very pale after
Coomassie staining. For comparison,
purified Hsp70N, Sse1-Δloop, and
Sse1-Δloop-ΔC were loaded on the gel
as well.  
 
The complexes were formed by mixing the respective Sse1p construct (Sse1-Δloop or Sse1-
Δloop-ΔC) with an equimolar amount of one of the Hsp70 NBDs in presence of an excess of 
ATP. Unbound ATP and NBD were removed by size exclusion chromatography. Since the 
Sse1-Δloop/Ssa1N complex was stable at 4 °C and in presence of protease inhibitor for at 
least six days (see chapter 4.1), all crystallization trials were performed under these 
conditions. Protein crystals were obtained from screens, which are specifically designed for 
the crystallization of protein-protein complexes and are characterized by mild pH conditions 
(Radaev and Sun, 2002; Radaev et al., 2006). While we were unable to obtain regular crystals 
from complexes containing Ssa1N or Ssb1N, large (up to ~500 µm) crystals of Hsp70N-
containing complexes were found. From Sse1-Δloop-ΔC/Hsp70N, hexagonal columns grew 
in many conditions that all contained PEGs of different molecular weights as a precipitant 
(Figure 4-3A-E). Crystallographic analysis showed that all these crystals had virtually the 
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same unit cell dimensions. Remarkably, these crystals were only obtained when Sse1-Δloop-
ΔC was produced via limited proteolysis of Sse1-Δloop·ATP. Complexes formed with cloned 
and purified Sse1-Δloop-ΔC did not crystallize. Sse1-Δloop/Hsp70N initially crystallized as 
splayed rods in 15 % PEG-8000, 0.1 M HEPES pH 7.5 (Figure 4-3F). Diffraction experiments 
at a microfocus beamline indicated that these rods were clusters of small crystals, whose 
diffraction power was however superior to the one of the hexagonal crystals. Optimization 
resulted in large, monocrystalline rods.  
Figure 4-4: Optimized crystals for the Hsp110/Hsp70 complex. 
(A) A hexagonal crystal (150 µm) of Sse1-Δloop-ΔC/Hsp70N mounted in a cryo loop is shown. The six-fold
axis runs diagonally from the upper left to the lower right. During mounting, we aimed at orienting the long six-
fold axis of the crystals along the rotation spindle of the goniometer to avoid spot overlap in the diffraction
pattern. The blue box indicates the size and position of the X-ray beam during data collection.  
(B) An orthorhombic crystal (300 µm) of Sse1-Δloop/Hsp70N mounted in a cryo loop is shown. 
(C) A diffraction image of a hexagonal crystal is depicted. As a consequence of the long c axis of the crystal
(779 Å), the reflections along the c direction (from upper left to lower right) were very close to each other in the
reciprocal space. Furthermore, the anisotropy of the diffraction pattern becomes apparent: In c direction, the
resolution was much better than in the other directions. The white vertical bar is the shadow of the beam stop,
which prevents the primary beam to hit the detector in the center of the image. The diffuse halo at around 3.5 Å
resolution is caused by X-ray scattering of unordered water molecules in the sample. 
(D) A diffraction image of an orthorhombic crystal is depicted. The shadow of the beam stop and the diffuse
halo resulting from X-ray scattering of water molecules are explained in (C). 
(E) Magnification of a region of the diffraction image depicted in (C), highlighting the closeness of the
reflections in c direction. Please note, that the rows of reflections have alternating intensities. 
(F) Magnification of a region of the diffraction image depicted in (D). Since the unit cell of the orthorhombic
crystals is much smaller than the one of the hexagonal crystals, the reflections are well separated in all three
directions.  
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SDS-PAGE analysis confirmed that both crystal forms contained the two complex 
partners at apparent 1:1 stoichiometry (Figure 4-3G). The band patterns of the dissolved 
crystals were comparable to the one of the initial protein samples, indicating that further 
proteolysis did not occur. 
Analysis of the diffraction datasets collected from the hexagonal crystals showed that 
the latter belonged to spacegroup P65 or P61 with unit cell dimensions of 
a·b·c = 155.4 Å·155.4 Å·779 Å (Figure 4-4A). The large c axis corresponded to a very small 
reciprocal lattice length and thus caused problems of spot overlap and misindexing (
E). Interestingly, every second diffraction order in a and b directions was very weak, 
indicating a superlattice structure in these directions ( E). The diffraction patterns 
were remarkably anisotropic, with resolution limits of 3.2 Å along c and below 4 Å in the 
other directions for the largest crystals (data obtained at ESRF beamline ID23-1, Figure 
4-4C). With a Matthews coefficient of 2.15 Å3/Da (Matthews, 1968), the asymmetric unit was 
expected to contain 11 copies of the complex. The second crystal form was likely to harbor 
only two complexes per asymmetric unit and belonged to spacegroup P212121 with lattice 
parameters of a·b·c = 129.5 Å·141.9 Å·151.7 Å (Figure 4-4B,D,F and Table 4-1). Large 
crystals diffracted to 2.3 Å resolution at SLS beamline X10SA. This crystal form was hence 
clearly superior for structure solution compared to the hexagonal lattice, and structure solution 
with the latter crystals was not followed up. 
Figure 
4-4
Figure 4-4
Figure 4-4
 
4.3 Structure determination 
 
Structure solution by X-ray crystallography is achieved by summation of so-called structure 
factors, complex numbers which are characterized by an amplitude and a phase. While the 
amplitudes of the structure factors can be derived from the intensities of the reflections in the 
diffraction pattern ( C-F), the phase information is lost during the data collection 
process and can only be obtained indirectly. To solve the phase problem, a technique called 
multiple wavelength anomalous diffraction (MAD) can be applied. In MAD, the anomalous 
diffraction of heavy atoms is utilized for phase calculation. Anomalous diffraction occurs in 
the region of the absorption edge of heavy atoms and results in small differences in the 
intensities of symmetry-related reflections, which have the same intensity in normal elastic 
Thomson scattering. From the differences, the heavy atom substructure can be calculated, and 
the phases of the structure factors for the complete protein can be derived in a second step.  
4 Results 
 
85
In the present study, selenium was used as anomalous scatterer. Selenium was 
introduced by incorporation of the unnatural amino acid SeMet at methionine positions. Since 
selenium and sulphur have comparable covalence radii, SeMet is almost isosteric to 
methionine and virtually does not disrupt the protein structure. For incorporation, SeMet was 
added to the growth medium of the E. coli Sse1-Δloop and Hsp70N expression strains, whose 
methionine biosynthesis was suppressed using catabolite repression. Crystals of the SeMet-
labeled complex grew under similar conditions as crystals of the native complex and also 
belonged to space group P212121 with lattice parameters of a·b·c = 129.9 Å·141.5 Å·150.4 Å 
and a resolution limit of 2.35 Å (Table 4-1). The X-ray fluorescence excitation scan of the 
crystal shown in Figure 4-5A confirmed the incorporation of selenium into the complex 
proteins. In addition, the energy-dependent values of the anomalous scattering factors f ' and 
f '' of selenium were calculated from the fluorescence spectrum. For the MAD data collection, 
the two X-ray energies were selected, at which the contribution of f ' and f '' to the overall 
scattering factor of selenium fanom was maximal (fanom = f  + Δf  + if '' = f ' + if ''). For the third 
reference dataset, an energy above the absortion edge was chosen (see chapter 3.7.3.3). From 
the anomalous differences within and between the datasets, the positions of 25 out of 34 
selenium atoms in the asymmetric unit were determined by direct methods using ShelX-D 
Figure 4-5: Complex structure determination using MAD with selenium as anomalous scatterer.  
(A) An X-ray fluorescence excitation scan of a crystal containing the SeMet-derivatized complex is shown. The
fluorescence excitation spectrum (black) was measured in the energy range of the KI absorption edge of
selenium. From the excitation spectrum, the anomalous scattering factors f ' (red) and f '' (blue) were calculated
using the program Chooch (Evans and Pettifer, 2001). As collection wavelengths for the MAD datasets, the
maximum of f '' (12.662 keV, peak), the minimum of f ' (12.657 keV, inflection point), and a remote wavelength
clearly above the absorption edge (12.757 keV) were chosen. 
(B) The experimental electron density map of a section of the β-sandwich domain of Sse1-Δloop (chain A) is
depicted. The electron density map (cyan) was calculated with 2.35 Å resolution data and was contoured at a σ-
level of 1.2. The anomalous difference map is colored in violet (σ-level: 15), indicating the two selenium atoms
in this section. The final model for the structure is shown in stick representation with carbon atoms colored in
brown, nitrogen atoms in blue, oxygen atoms in red, and selenium atoms in orange.         
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(Uson and Sheldrick, 1999) (Figure 4-5B). The heavy atom positions were refined and initial 
phases were calculated with Sharp (de la Fortelle and Bricogne, 1997). After density 
modification with Resolve (Terwilliger, 2000), readily interpretable electron density maps 
were obtained, starting from which a partial model could be automatically built using 
ArpWarp6.1 (Perrakis et al., 1999) (Figure 4-5B). Subsequently, five cycles of iterative 
manual model building and refinement (Rfree 26.2 %, Table 4-1) were performed with Coot 
(Emsley and Cowtan, 2004) and Refmac5 (Murshudov et al., 1997), respectively. In order to 
exclude any artifacts that could result from the substitution of methione by SeMet in the 
crystallized proteins, the final SeMet model was then used to solve a native dataset (see 
chapter 4.1), which was almost isomorphous to the MAD data and had a slightly higher 
resolution limit (2.3 Å). Automatic as well as subsequent manual model building were 
performed as described for the SeMet derivative. The structure was refined to a 
crystallographic R-factor of 19.7 % (Rfree 24.4 %, Table 4-1). Interestingly, application of the 
TLS refinement option of Refmac5, which implements anisotropic thermal motions of defined 
protein subdomains into the crystallographic refinement, improved the refinement statistics 
for both the SeMet-substituted and the native structure significantly (see chapter 3.7.3.3). 
Thus, it is likely that the protein domains in the Sse1-Δloop/Hsp70N complex undergo rigid-
body movements with respect to each other.  
For both the SeMet-derivatized and the native crystal, the asymmetric unit contained 
two virtually identical copies of the Sse1-Δloop/Hsp70N complex (r.m.s.d. of Cα atom 
positions 0.714 Å, Figure 4-6A,C). The final model of the native protein complex comprised 
Sse1-Δloop residues 2-500 and 525-654 in chain A as well as residues 2-498 and 526-655 in 
chain C. Interpretable electron density was not present for the non-natural linker sequence 
replacing Sse1p residues 503-524 and for the C-terminal segment of Sse1-Δloop (residues 
656-693). Both elements seem to be unstructured, which was corroborated for the C-terminus 
by the results of limited proteolysis with Proteinase K (see chapter 4.1). Furthermore, the 
model contained Hsp70 residues 4-382 for both chains B and D. Electron density in the ATP 
binding pocket of both Sse1-Δloop molecules could be unambiguously assigned to ATP in 
complex with Mg2+ and K+ ions (Figure 4-6D). In addition, four further Mg2+ ions, one 
glycerol molecule and 661 ordered water molecules were included into the final model. 207 of 
the water molecules were found at equivalent positions in the two copies of the complex. As 
judged by the program Procheck (Laskowski et al., 1993), the model obeyed reasonable 
stereochemistry with 91.8 % of the ψ-ϕ torsion angles lying in the most favored regions of the 
Ramachandran plot, namely the regions of the secondary structure elements α-helix, β-sheet, 
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and left-handed α-helix (Ramachandran et al., 1963) (Table 4-1). 7.6 % of the ψ-ϕ torsion 
angles were found in the additionally allowed, and 0.6 % in the generously allowed region. 
Only one residue, Gln409 of chain A, was declared as Ramachandran outlier. Overall, the 
complex of chains A and B was characterized by slightly lower B-factors than the complex of 
chains C and D, meaning that its electron density map was somewhat better defined (
B). For this reason, the structure of complex AB is discussed in the following. The data 
collection and refinement statistics for the SeMet-derivatized as well as the native crystals are 
summarized in Table 4-1. 
Figure 
4-6
Figure 4-6: Evaluation of the complex structure. 
(A) The asymmetric unit of both the SeMet-derivatized and the native crystal contained two copies of the Sse1-
Δloop/Hsp70N complex. Complex 1 consists of chains A and B, complex 2 of chains C and D. 
(B) A B-factor plot for both complexes is shown. B-factors are represented in rainbow colors: Regions with low
B-factors are colored in blue, regions with high B-factors are shown in red. In both complexes, the C-terminus
and β-sandwich domain of Sse1-Δloop as well as subdomain IIb of Hsp70N are the most flexible regions.
Overall, complex AB is slightly better ordered than complex CD. 
(C) A superposition of complexes AB and CD is shown. The two complexes are virtually identical. The r.m.s.d.
of Cα atom positions was determined to 0.714 Å. 
(D) The nucleotide binding pocket of Sse1-Δloop (chain A) is depicted. ATP is shown in ball-and-stick
representation, and its experimental electron density is colored in cyan. The complexed Mg2+ is represented as a
green sphere.  K+ was only found in the electron density of the native complex. Carbon atoms of Sse1-Δloop are
colored in dark blue, carbon atoms of ATP in yellow. Note the hydrogen bond contact between the amino group
of the adenine base and Q33 of Hsp70N (dark red, chain B) in the right upper corner. Heteroatoms are indicated
as follows: nitrogen in blue, oxygen in red, and phosphorus in magenta. Atoms in the foreground are omitted for
clarity. 
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Table 4-1: Data collection and refinement statistics. 
(*: values in parenthesis for outer resolution shell; **: as defined in Scala (Evans, 1997); ***: as defined in
Procheck (Laskowski et al., 1993)) 
 
dataset peak infl rm native 
beamline SLS, X10SA SLS, X10SA SLS, X10SA SLS, X10SA 
wavelength (Å) 0.9792 0.9795 0.9719 0.9780 
space group P212121   P212121 
cell dimensions,  
a, b, c (Å);  
 
α, β, γ (º) 
 
129.88, 141.47, 
150.44;  
90, 90, 90 
 
 
 
 
 
129.50, 141.90, 
151.68; 
90, 90, 90 
resolution limits (Å)* 80.85 - 2.6  
(2.74 - 2.6) 
80.85 - 2.6  
(2.74 - 2.6) 
80.85 - 2.35  
(2.48 - 2.35) 
75.81 - 2.3 
(2.42 - 2.3) 
Rmerge **,* 0.064 (0.353) 0.064 (0.366) 0.058 (0.472) 0.073 (0.506) 
I/sigma **,* 12.1 (2.5) 12.0 (2.5) 12.0 (2.3) 11.8 (2.5) 
multiplicity * 3.6 (3.1) 3.6 (3.1) 3.7 (3.4) 3.7 (3.5) 
completeness (%) * 99.8 (99.0) 99.8 (99.0) 99.9 (99.7) 100 (100) 
complexes /a.u. 2 2 2 2 
solvent content (%) 56.2    
Wilson B-factor (Å2) 59.91 60.06 50.11 45.99 
Phasing     
sites 25 (Se) -  - 
phasing power ano 0.948 0.493 0.565  
phasing power iso 0.546 0.906 -  
mean FoM   0.378 - 
Refinement     
resolution range - - 20 - 2.35 20 - 2.3 
reflections (test set) - - 109627 (5797) 117858 (6248) 
Rwork - - 0.210 0.197 
Rfree - - 0.262 0.244 
number of atoms - - 15835 16199 
r.m.s.d. bonds (Å) - - 0.012 0.014 
r.m.s.d. angles (º) - - 1.430 1.430 
Ramachandran plot ***     
 % most favored region - - 90.8 91.8 
 % additionally allowed - - 8.5 7.6 
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4.4 Structure of the Sse1-Δloop/Hsp70N complex  
 
4.4.1 Overview of the complex structure 
Figure 4-7: Crystal structure of the Sse1p·ATP/Hsp70N complex. 
(A) The frontal view of the complex illustrates the domain organization of the yeast Hsp110 homolog Sse1p.
Sse1p is shown in ribbon representation with the NBD colored in dark blue, the linker segment in yellow (in the
background), the β-sandwich domain in brown, and the 3HBD in green. The NBD of human Hsp70, Hsp70N, is
shown in surface representation in dark red. The subdomain structure of Hsp70N is indicated. 
(B) A bottom view of the complex in surface representation is shown using the same coloring scheme as in panel
(A). 
(C) Cut-away views on the Sse1p/Hsp70N interface are shown. The position of the interaction partner is
indicated by its outline. Atoms mediating the Sse1p/Hsp70N interaction are colored in orange. Water molecules
connecting the binding partners via hydrogen bonds are indicated as beige spheres. Sse1p-bound ATP is shown
in ball-and-stick representation. The subdomain structures of the NBDs are indicated, and the color code for the
protein domains corresponds to the one introduced in (A). 
(D) Superposition of an Hsp70N·ADP complex (light blue, structure solved by Dr. A. Bracher) with nucleotide-
free Hsp70N (red) crystallized in this study illustrates the 27 ° rotation of Hsp70N subdomain IIb upon binding
of Sse1p. The position of Sse1p is indicated by an outline. The orientation of the structure is the same as in panel
(C). Please note that subdomain IIb of the Hsp70N·ADP complex would clash with Sse1p subdomain IIb. 
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As a member of the Hsp70 superfamily, Sse1p shares the general domain organization of 
canonical Hsp70 proteins, consisting of an N-terminal Hsp70/actin-type NBD, a β-sandwich 
domain and a C-terminal 3HBD (Figure 4-7A). In the crystallized complex, the latter two 
Sse1p domains are arranged along the NBD and point into opposite directions. This domain 
arrangement differs from the one observed for the isolated PBD of DnaK, in which the 3HBD 
forms a lid over the peptide binding cleft of the β-sandwich domain (Figure 2-5; Zhu et al., 
1996). 
All interactions with the NBD of Hsp70 are mediated by the NBD and the 3HBD of 
Sse1p. (In the following description of the crystal structure, Sse1p will be used instead of 
Sse1-Δloop, assuming that all observations made for Sse1-Δloop are also valid for wt Sse1p.) 
Specifically, the NBDs of Sse1p and Hsp70 are oriented towards each other with contacts 
between subdomains IIb and Ib, IIa and Ia, and Ib and IIb of Sse1p and Hsp70, respectively 
(Figure 4-7C). Furthermore, the 3HBD of Sse1p tightly contacts the flank of Hsp70 
subdomain IIb. As a consequence, subdomain IIb of Hsp70 is clamped between the 3HBD 
and the flank of subdomain IIb of Sse1p, and rotated 27 º sideways with respect to the rest of 
the NBD (Figure 4-7A,C,E). In this open conformation, the binding sites for the adenosine 
moiety on subdomain IIb and the catalytic and triphosphate binding residues on lobe I of the 
Hsp70 NBD are moved apart, diminishing the affinity for adenine nucleotides and thus 
facilitating nucleotide exchange. This mechanism of nucleotide exchange resembles the 
conformational switch induced by GrpE in DnaK and by the BAG domain of BAG-1 in 
Hsc70, although the conformational change in the Hsp70 binding partner is less pronounced 
in these complexes (~14 º rotation of subdomain IIb) (Harrison et al., 1997; Sondermann et 
al., 2001). In line with these findings, the Hsp70 NBD is stable against proteolysis in complex 
with Sse1p or BAG, while HspBP1, which operates by a different mechanism, induces a 
partially protease sensitive conformation of the NBD (Figure 4-1E, data not shown and 
Shomura et al., 2005). 
 
4.4.2 Structure of Sse1p·ATP in the complex 
 
Overall, the structure of the Hsp70N-complexed Sse1p·ATP is stabilized by extended and 
intimate domain-domain interactions, which are predominantly hydrophobic in character 
(Figure 4-7A,B). In addition, as indicated by the results of limited proteolysis, ATP binding 
contributes to the stability of the multi-domain protein, which is highly protease-sensitive in 
the absence of nucleotide (Figure 4-2C and Shaner et al., 2004). Notably, the NBD/linker, 
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NBD/β-sandwich domain, and NBD/3HBD interfaces are also highly conserved within 
canonical Hsp70s, despite limited overall sequence similarity between canonical Hsp70s and 
Hsp110s. Thus, it appears plausible that the conformation found for Sse1p·ATP in complex 
with Hsp70N might serve as a good model for the transient ATP state of canonical Hsp70s, 
which is characterized by low-affinity peptide binding (see also chapter 5.1 and Liu and 
Hendrickson, 2007). 
 
4.4.2.1 The ATP-bound Sse1p NBD 
Very similar to the known structures of canonical Hsp70 NBDs, the NBD of Sse1p consists of 
two lobes (lobes I and II), which enclose a central nucleotide binding pocket. The individual 
lobes of Sse1p superimpose well with the respective lobes of an ADP-bound Hsc70 NBD 
(Jiang et al., 2007). For lobe I, 197 of 209 Sse1p Cα atoms could be aligned with an r.m.s.d. 
of 0.933 Å. For lobe II, 170 of 176 Cα atoms were aligned with an r.m.s.d. of 1.19 Å. 
However, the orientations of the lobes with respect to each other differ between the structures. 
Compared to the Hsc70 NBD, the two lobes of the Sse1p NBD are twisted against each other 
by ~23 º around a rotation axis diagonally traversing the NBD (Figure 4-8A). As a 
consequence, the tip of subdomain IIb shifts approximately 8 Å in comparison to the Hsc70 
structure. Since the bound nucleotide is close to the rotation axis, the shifts are not as drastic 
in its vicinity. Only this twisted subdomain topology of the Sse1p NBD appears to enable the 
intricate interactions with Hsp70N (see chapter 4.4.1). The Sse1p lobe arrangement seems to 
be stabilized by extensive inter-domain interactions with the linker segment (residues 385-
399) (chapter 4.4.2.2), the β-sandwich domain (chapter 4.4.2.3), and the N-terminal segment 
of the 3HBD (chapter 4.4.2.4). Additionally, backbone contacts from both lobes to the γ-
phosphate of ATP might contribute to the stabilization of the Sse1p NBD (Figure 4-8B). 
The ATP binding mode observed in the Hsp70N-complexed Sse1p resembles the 
interactions found in previous structures of canonical Hsp70s in complex with nucleotides 
(Figure 4-8B) (Wilbanks and McKay, 1995; O'Brien et al., 1996). Whereas lobe I interacts 
with the triphosphate moiety of ATP, the adenosine moiety is bound by subdomain IIb. 
Furthermore, also Mg2+ and K+ are coordinated in an Hsp70-like manner. The conformations 
of the AMP moieties of Sse1p-bound ATP and Hsc70N-bound ADP are very similar (Figure 
4-8C) (Jiang et al., 2007). However, the catalytic residues Lys69 and Asp174, counterparts to 
Hsc70 residues Lys71 and Glu175, are displaced in Sse1p, explaining how ATP remained 
intact during several weeks at 4 ºC which passed between crystallization set-up and crystal 
mounting. A number of highly conserved Hsp70 residues, which directly interact with the 
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Figure 4-8: The NBD of Sse1p. 
(A) The superposition of the NBDs of Sse1p·ATP and bovine Hsc70·ADP (PDB entry code 1HPM (Wilbanks
and McKay, 1995)) illustrates the twisted lobe arrangement in Sse1p. Sse1p domains are colored as in Figure
4-7, and Hsc70N is represented in white. The rotation axis for reorientation of the lobes in Sse1p is indicated in
red. ATP is shown as red space-filling model. To highlight lobe II and the linker, these two elements are
represented as ribbons; the remaining backbone is shown as Cα trace. 
(B) A stereo representation of ATP bound to Sse1p as observed in the complex with Hsp70N is shown. The
orientation of the structure is the same as in Figure 4-6D. ATP·Mg2+ is shown in ball-and-stick representation. A
potassium ion in contact with the triphosphate moiety is shown as a pink sphere. Hydrogen bond contacts are
indicated by dashed lines. Bridging water molecules are shown as beige spheres. Carbon atoms in lobes I and II
are colored in grey and dark blue, respectively. Carbon atoms of Hsp70N (right upper corner) are shown in red,
carbon atoms of ATP in yellow. Heteroatoms are indicated as follows: magnesium in green, nitrogen in blue,
oxygen in red, and phosphorus in magenta. ATP·Mg2+ contacting residues in the foreground are labeled. The γ-
phosphate is in direct hydrogen-bond contact to the amide groups of residues from both lobes I and II, and to the
sidechains of K69 and S207. Atoms in the foreground and ordered water molecules without direct contact to
ATP·Mg2+ are omitted for clarity. 
(C) Comparison of the nucleotide binding pockets of Sse1p·ATP and of bovine Hsc70N·ADP (PDB entry code
2QWL (Jiang et al., 2007)). The view is the same as in (B). The Sse1p·ATP structure is shown in dark blue,
Hsc70N·ADP in orange. The Hsp70N backbone (right upper corner) is colored in red. Magnesium, potassium,
and magnesium-coordinating water molecules are shown as small crosses. Metal-ligand bonds in Sse1p are
indicated by dashed lines. For the shown representation, the atoms of the AMP moieties of complexed ATP and
ADP molecules were superposed. The reorientation of the two lobes in the NBD of Sse1p in comparison to
Hsc70N gets apparent. Especially, residues from lobe I on the left, such as K69 (K71 in Hsc70), are clearly
shifted to the right and backwards.  
bound nucleotide and some of which were implicated in linking ATP hydrolysis to peptide 
binding (Sousa and McKay, 1998), are not stringently conserved in Hsp110s, suggesting that 
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such allosteric coupling is not critical for Hsp110 function. For example, the following 
substitutions are observed in Sse1p: Thr13Asn, Thr14Asn, Tyr15Asn, Gly202His, Gly203Ser, 
and Thr204Ser (numbering for bovine Hsc70 and substitutions as found in the Sse1p 
sequence, Figure 7-1 (page 151)). Intriguingly, even the catalytic key residue Lys71 (bovine 
Hsc70 numbering) is replaced in several ER-homologs of Sse1p (data not shown). Taken 
together, these observations are consistent with the proposition from Morano and colleagues 
that only ATP binding – but not ATP hydrolysis – is required for Hsp110/Grp170 function 
(Shaner et al., 2004; Raviol et al., 2006a). 
 
4.4.2.2 The Sse1p inter-domain linker 
In the structure of Sse1p as observed in complex with Hsp70, the so-called linker segment 
(residues 385-399) rigidly connects the NBD with the β-sandwich domain. The linker is 
composed of a loop followed by a β-strand, which extends the β-sheet in subdomain IIa of 
Sse1p by aligning in a parallel fashion to β-strand β15 and which pairs with β-strand β23 of 
the β-sandwich domain (Figure 4-9A). Specifically, the sidechains of Phe392 and Phe394 
bind into hydrophobic pockets at the cleft located at the base of the NBD, and the highly 
conserved residue Asp396 forms hydrogen bonds with the sidechains of Thr176 and Asn173, 
which both belong to NBD subdomain Ia (Figure 4-9B).   
Figure 4-9: The Sse1p linker. 
(A) A magnification of the linker region of Sse1p is shown. Sse1p domains are colored as in Figure 4-7.
Whereas Sse1p is shown in ribbon representation, ATP is depicted in stick representation. The linker segment
forms a rigid link between the NBD and the β-sandwich domain, by aligning to β-strands β15 and β23. β23
bridges the two layers of the β-sandwich structure.    
(B) The interactions of the linker with the cleft at the base of the NBD are illustrated in detail. The NBD of
Sse1p is shown in surface representation, the other domains are depicted as ribbons and colored as in Figure 4-7.
For the NBD, a color gradient from red over white to blue indicates decreasing conservation among Hsp70 and
Hsp110 sequences: Residues identical among Hsp70/Hsp110 homologs are colored red, residue positions with
50 % identical residues are shown in white. Regions in cyan are variable. The conserved linker sidechains F392,
F394 and D396 are shown in stick representation. 
 
In the sequences of canonical Hsp70s, this linker region is highly conserved with the 
invariable aspartate residue (Sse1p numbering: Asp396) being preceded by a succession of 
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four hydrophobic residues (Figure 2-5C), while in Hsp110 sequences hydrophobic and polar 
positions alternate (Figure 7-1). Whereas the Hsp70 linker was shown to be flexible and 
exposed in the nucleotide-free as well as in the ADP state of the NBD, it is protected from 
solvent in the ATP state (Rist et al., 2006; Swain et al., 2007; Chang et al., 2008). Since the 
NBD amino acid residues interacting with the linker are conserved among Hsp70 and Hsp110 
sequences (Figure 4-9B), it seems plausible that the linker in Hsp70·ATP assumes a similar 
conformation as in Hsp70N-complexed Sse1p·ATP.  
 
4.4.2.3 The Sse1p β-sandwich domain 
 
 
 
Figure 4-10: The Sse1p β-sandwich domain. 
(A) A ribbon representation of the β-sandwich domain of Sse1p is shown. The ends proximal and distal to the 
NBD are indicated. Furthermore, selected β-strands and loop connections as well as the N- and C-termini are 
labeled. 
(B) A ribbon representation of the β-sandwich domain of DnaK in complex with the substrate peptide 
NRLLLTG is shown (PDB entry code 1DKZ (Zhu et al., 1996)). The peptide is depicted in stick representation. 
The molecule orientation corresponds to the one in (A).  
(C) For comparison, the β-sandwich domains of Sse1p (brown) and DnaK (green) are shown superposed onto 
each other. Intriguingly, the peptide binding cleft is closed in the Sse1p structure as the loops L21,22 and L24,25 
pack against one another.  
 
Despite low sequence homology, the β-sandwich domain of Sse1p shares the general 
secondary structure topology (two stacked β-sheets) with canonical Hsp70s (Figure 4-10). 
However, the final β-strand segment β30 forms hydrogen bond contacts with both β-sheets of 
the Sse1p β-sandwich domain. As a consequence, the β-sandwich domain of Sse1p is more 
barrel-like compared to DnaK (Figure 4-10A,B). Furthermore – probably resulting from the 
low sequence similarity between the β-sandwich domains of Hsp110s and canonical Hsp70s – 
the loop structures at the distal end deviate significantly (Figure 4-10C). Conspicuously, 
Hsp110 homologs are characterized by a variable insertion, which is located between β28 and 
β29 (L28,29) in the structure of Sse1p. In the crystallized Sse1-Δloop construct, this segment 
was replaced by a short peptide linker, which was found to be disordered. Moreover and most 
significantly, the peptide binding cleft, which is formed by two distal loops corresponding to 
L21,22 and L24,25 in the DnaK/peptide complex, is closed in the Hsp70N-complexed Sse1p. The 
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flanking loops (Sse1p nomenclature: L25,26 and L26,27) also differ significantly in length, 
sequence and position from canonical Hsp70s, in which these regions are highly conserved. 
Based on the structural data, it is thus unclear whether Sse1p is able to interact with substrate 
peptides similarly to canonical Hsp70s.   
Figure 4-11: The β-sandwich domain/NBD 
interaction in Sse1p. 
A magnification of the β-sandwich domain/NBD 
interaction region of Sse1p is shown. Sse1p domains 
are colored as in Figure 4-7. Whereas Sse1p is 
shown in ribbon representation, ATP is depicted in
stick representation. The loops L25,26 and L27,28, 
which mediate the interaction, are indicated. β-
strand β23 and the amino acid residues Leu489 and 
His490 are labeled. The molecule is rotated by 70 ° 
compared to the view in Figure 4-9A.    
 
In the structure of Sse1p, the proximal end of the β-sandwich domain and the base of 
the NBD form extensive contacts. The contact between the β-sandwich domain and NBD lobe 
II is exclusively mediated via the linker segment (Figure 4-9 and Figure 4-11). In contrast, the 
contact between the β-sandwich domain and NBD lobe I is direct, with the most intimate 
contacts being formed by two loop connections, L25,26 and L27,28, which are juxtaposed at the 
proximal end of the β-sandwich (Figure 4-11). L27,28 also contacts β23, which interacts tightly 
with the linker. The importance of this segment for Hsp70/Hsp110 function becomes evident 
from its high sequence conservation throughout the entire Hsp70 protein family (Figure 7-1). 
In contrast, the loop connection L25,26, which forms the interface to the 3HBD ("lid") in the 
DnaK/peptide complex, is poorly conserved in Hsp110 homologs. This indicates that a stable 
association between the β-sandwich domain and the 3HBD as observed in the structure of the 
peptide complex of DnaK (Zhu et al., 1996) is dispensable for Hsp110 function. 
 
4.4.2.4 The Sse1p 3HBD 
In the Sse1p/Hsp70N complex, the 3HBD of Sse1p does not form a "lid" over the peptide 
binding pocket as observed in the structure of the DnaK PBD/peptide complex (Figure 2-5B; 
Zhu et al., 1996), but instead interacts with the NBD and points away from the β-sandwich 
domain (Figure 4-7A). The intimate interaction between the N-terminal segment of the 3HBD 
and the flank of NBD lobe I ensures the correct positioning of the 3HBD, and thus is probably 
critical for complex formation with Hsp70N. The core of the extensive interface is formed by 
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buried polar interactions of residue Arg47 with Glu554 and Asp561 (Figure 4-12A). These 
polar residues are flanked by large hydrophobic clusters comprising residues Phe106, Phe113, 
Met121, Ile163, Leu547, Leu550, Ile551, Met557, and Leu558. Interestingly, in the closed lid 
conformation as observed in the peptide complex of DnaK, equivalent residues of the 3HBD 
bind to the β-sandwich domain and thereby ensure tight substrate binding (Zhu et al., 1996).  
Since the chemical character of all the listed 3HBD and NBD lobe I residues is 
conserved among Hsp70/Hsp110 sequences (Figure 4-9B and Figure 7-1), such an interaction 
between the 3HBD and the NBD might contribute to the conformational cycle of canonical 
Hsp70s. One notable exception regarding the degree of conservation is Glu554, which is 
systematically replaced by Ala in canonical Hsp70s and by larger hydrophobic residues, such 
as Leu and Val, in ER-resident Hsp110s ( B and data not shown). On the one hand, 
the replacement of Glu by Ala might weaken the interaction between the 3HBD and the NBD 
in canonical Hsp70s, but on the other hand, the Ala residue seems to be essential for the 
interaction between the 3HBD and the β-sandwich domain in the closed conformation of the 
PBD. Whereas Ala is small enough to be buried at the interface between the 3HBD and the β-
sandwich domain (Zhu et al., 1996), residues with larger sidechains might prevent closure of 
the lid, questioning whether Sse1p can stably assume such a conformation. Taken together, 
the tight interaction of the lid domain with the NBD, which is likely required for efficient 
Figure 4-12: The Sse1p 3HBD. 
(A) The tight interactions between the N-terminal part of the 3HBD and the flank of lobe I in Sse1p are shown.
Sse1p domains are colored as in Figure 4-7. The buried polar interactions at the core of the interface are
indicated by dashed lines. Key interacting residues are labeled. 
(B) A sequence alignment of the 3HBD segment is shown, which contacts the NBD in the Sse1p and the β-
sandwich domain in the DnaK/peptide crystal structures (Zhu et al., 1996). Amino acid sequences of selected
Hsp110, eukaryotic Hsp70 and bacterial DnaK homologs were aligned. Residues indicated in red are invariable,
residues colored in blue are conserved in more than 50 % of the sequences. Residues that contact the NBD of
Sse1p are indicated by blue arrowheads. As indicated by red and blue boxes, the consensus sequences for
Hsp110s and canonical Hsp70s differ systematically at position 554 (Sse1p numbering). An unabridged version
of the alignment is shown in Figure 7-1. 
 
Figure 4-12
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catalysis of nucleotide exchange, and the formation of a stably closed conformation of the 
PBD might be mutually exclusive features of Hsp110 and Hsp70 chaperones, respectively. 
 
4.4.3 Intermolecular interface in the Sse1p/Hsp70 complex 
 
The extensive protein-protein interface in the Sse1p/Hsp70N complex, which buries ~1760 Å2 
of surface on each binding partner, is mostly polar in character, including a large number of 
ordered water molecules in hydrogen bond contact to both proteins. The high Sc value of 0.74, 
an overall measure of surface shape complementarity (Lawrence and Colman, 1993), is 
comparable to that observed in stable protein complexes such as hemoglobin (Sc 0.74).  
The closest interactions are found between the 3HBD of Sse1p and α-helix 9 of Hsp70N 
(Figure 4-13A). The N-terminus of helix α9 is in close contact to the sidechain of Asn572S 
(S indicates Sse1p residues, H Hsp70N residues). The highly conserved adjacent Hsp70 
residue Ala300H mediates an intimate van-der-Waals contact to the Sse1p backbone between 
residues Glu575S and Glu576S, which in turn are engaged in hydrogen bond contacts to 
Hsp70 residues Thr298H and Lys348H, respectively (Figure 4-13A,D). Tyr579S makes 
additional van-der-Waals contacts to Ala300H and Glu304H. Remarkably, Glu304S replaces 
the corresponding Ala300H in Sse1p. This amino acid exchange might contribute to the 
avoidance of non-productive Hsp110 homodimer formation (see also below). 
Interestingly, Hsp70 also makes close contacts to the nucleotide binding pocket of 
Sse1p (Figure 4-13B). Gln33H directly contacts the adenine amino group of ATP. 
Furthermore, Gln33H is in van-der-Waals contact to Ala280S and Ser279S, with the former 
intercalating between Ala54H and Gln33H and the latter forming a tight hydrogen bond to 
ATP. All Hsp110 homologs have a small Ala or Ser residue at position 280 of the NBD, 
enabling rigid backbone contacts with their binding partners (Figure 4-13E). The neighboring 
residue, Asn281S, is in close hydrogen bond contact to Asn57H. Two ordered water molecules 
mediate additional hydrogen bonds between both partners. The sidechain of Arg346S flanks 
the nucleobase of ATP and forms a π-stacking interaction with the peptide bond between 
Gln33H and Gly34H. These close contacts of Hsp70 to the nucleotide and the nucleotide 
binding residues in Sse1p can explain, at least in part, the requirement of nucleotide binding 
for the Sse1p/Hsp70 interaction.  
A further area of close surface complementarity with Hsp70 was found at residues 364-
367 in Sse1p, which contact the backbone of Hsp70 subdomain Ia at residues 133 and 134 as 
well as the sidechain of Tyr134H (Figure 4-13C). At this interface, intramolecular hydrogen 
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bonds of Thr365S and Asn367S appear to shape the surface of Sse1p into a conformation that 
cradles Tyr134H. The contacts between subdomain IIb of Hsp70 and the NBD of Sse1p 
appear to be less well defined. One notable exception is the conserved Lys262S which forms a 
salt bridge with Asp285H. No contacts were found to subdomain IIa of Hsp70N. 
 
Figure 4-13: Key interactions at the Sse1p·ATP/Hsp70N interface. 
(A) The close-up view illustrates the contacts between subdomain IIb of Hsp70N and the 3HBD of Sse1p. 
(B) The contact interface in the vicinity of the Sse1p-bound ATP molecule is shown. 
(C) The region of close surface complementarity between Sse1p and subdomain Ia of Hsp70N is depicted. 
In panels (A)-(C), both protein backbones are shown in ribbon representation with the exception of regions 
involved in intermolecular contacts. These regions and the corresponding sidechains are depicted in stick 
representation. Sse1p is enveloped in a transparent molecular surface to highlight the close surface 
complementarity. The color coding for molecular surfaces, backbone and carbon atoms is identical to that in 
Figure 4-7. Sse1p-bound ATP is represented in a ball-and-stick model with carbon atoms colored in yellow. 
Nitrogen and oxygen atoms are indicated in blue and red, respectively. Ordered water molecules bridging the 
binding partners are shown as beige spheres. Hydrogen bonds are represented as dashed lines. Key interacting 
residues are indicated. In all panels, unrelated obstructing features in the foreground are omitted for clarity. 
(D) Alignment of Hsp110, Hsp70 and DnaK amino acid sequences at the contact region between the 3HBD of 
Sse1p and subdomain IIb of Hsp70N. Contacting residues are marked by arrowheads below the sequence with 
the interacting domain indicated by the color scheme used in Figure 4-7. Notable differences in the consensus 
sequences for Hsp110s and canonical Hsp70s are boxed. For example, Ala300H is only conserved in canonical 
Hsp70s but not in Hsp110 homologs. The complete sequence alignment is shown in Figure 7-1. 
(E) Sequence alignment of residues involved in the contact close to the nucleotide binding pocket of Sse1p. Note 
the high degree of conservation of Gln33H in Hsp70 homologs and of residues 279-281 (Sse1p numbering) in all 
aligned sequences.  
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The pattern of surface residue conservation in Hsp110 homologs generally corresponds 
to the residues important for complex formation with Hsp70, indicating that (i) the 
Sse1p/Hsp70N structure represents a useful model for all Hsp110 homologs and that (ii) 
complex formation and concomitant nucleotide exchange on canonical Hsp70s should be a 
major function of Hsp110s (Figure 4-14A,B). Likewise, the Hsp110-interacting residues in 
canonical eukaryotic Hsp70s are highly conserved, but the contrast against the generally high 
degree of sequence conservation is low ( C,D). Interestingly, most of these 
interacting residues are also conserved in bacterial homologs, indicating their general 
importance for Hsp70 function rather than mere co-evolution with Hsp110 homologs, which 
are absent in bacteria (
Figure 4-14: Surface conservation of the Sse1p/Hsp70 interface. 
(A) A surface representation of Sse1p is shown. Color coding and molecule orientation correspond to that in
Figure 4-7C. Hsp70N-interacting atoms are colored in orange. Water molecules are shown as beige spheres.
Bound ATP is shown in ball-and-stick representation. The subdomain structure of the NBD is indicated.   
(B) The surface conservation of the Sse1p interface is depicted. The degree of sequence identity in an alignment
of Hsp110 homologs (group 1 in Figure 7-1) was plotted onto the surface of Sse1p. The color gradient indicates
decreasing conservation. Residues identical among Hsp110 homologs are colored red, residue positions with
50 % identical residues are shown in white. Regions in cyan are variable.  
(C) A surface representation of Hsp70N is shown. Sse1p-interacting atoms are colored in orange. For further
details, see (A). 
(D) The surface conservation of the Hsp70N interface is depicted. The degree of sequence identity in an
alignment of eukaryotic Hsp70s (group 2 in Figure 7-1) was plotted onto the surface of Hsp70N. For further
details, see (B).  
 
Figure 4-14
Figure 7-1). The high conservation of Hsp110-interacting residues 
explains why Hsp70N can substitute for Ssa1N with respect to Sse1p binding. In contrast, 
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many of these Hsp70N residues are not conserved in Hsp110 homologs, thus presumably 
preventing the formation of non-productive Hsp110 homodimers. 
 
4.5 Biochemical analysis of the cooperation of Hsp110 and Hsp70 
chaperones 
 
4.5.1 Overview of the Sse1p and Ssa1p mutants 
 
In order to relate the structural data to biological function, we designed mutants of Sse1p and 
a cognate yeast Hsp70, Ssa1p, and analyzed them in different functional assays. Considering 
the large complementary interfaces between Sse1p and Hsp70N and the intimate domain-
domain interactions within Sse1p, we preferentially introduced clusters of amino acid 
exchanges instead of single substitutions in order to effectively disrupt the observed 
interaction sites. Amino acid exchanges were chosen to target the three key features of the 
complex (Figure 4-15): The first group of mutations (red group) was meant to affect the 
interaction between Sse1p and Ssa1p. Mutations of the second group (blue group) were 
thought to destroy the interfaces between individual Sse1p domains. The third group of 
mutations (yellow group) was directed at the putative peptide binding site in the β-sandwich 
domain of Sse1p. At the Sse1p/Ssa1p interface, we specifically targeted (i) the contact of the 
Sse1p 3HBD to subdomain IIb of Ssa1p (N572Y, E575A in Sse1p and A300E in Ssa1p; 
Figure 4-13A), (ii) the complementary surfaces close to the nucleotide binding pocket of 
Sse1p (A280T, N281A in Sse1p or Q31A in Ssa1p; Figure 4-13B), and (iii) the contact of the 
Sse1p NBD to subdomain Ia of Ssa1p (T365V, N367S in Sse1p; Figure 4-13C). The Sse1p 
domain-domain interfaces were analyzed by mutating the linker region (F392A, F394A and 
D396A; Figure 4-9B), the conserved residues of the β-sandwich domain (L489A, H490A; 
) and the N-terminal part of the 3HBD (E554A, M557S, L558S; Figure 4-12A). 
All three mutated regions interact with the NBD of Sse1p. The putative peptide binding cleft 
of Sse1p was probed with the mutation pairs L433A, N434P and F439L, M441A. L433 and 
N434 correspond to the E. coli DnaK residues F426 and S427, which are located in the 
peptide binding site of DnaK (
Figure 4-11
Figure 7-1). The single site mutations F426S and S427P were 
both shown to weaken the peptide binding affinity of DnaK (Montgomery et al., 1999). In 
addition, the ATPase deficient Sse1p variant K69M (gray) (Raviol et al., 2006a), the 
crystallized Sse1p construct Sse1-Δloop (black), as well as an Sse1p mutant in which the 
NBD was deleted (Sse1C, red) were tested. Finally, Sse1p mutants were constructed which 
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combined different mutation clusters. Mutations targeting the Sse1p/Ssa1p interaction were 
either combined with other mutations of the same group (A280T, N281A, N572Y, E575A and 
T365V, N367S, N572Y, E575A; both red group) or with mutations meant to affect putative 
peptide binding by Sse1p (L433A, N434P, N572Y, E575A and F439L, M441A, N572Y, 
E575A; both green group). For simplification, mutants are denoted by a number code in the 
following (Figure 4-15). Furthermore, they are color-coded according to their expected 
functional defects in all figures. 
Figure 4-15: Designed Sse1p and Ssa1p mutants. 
An overview of the constructed Sse1p and Ssa1p mutant proteins is shown. For simplicity, the mutants are
denoted by a number code and are color-coded according to their expected functional defects. The location of the
mutations in the Sse1p structure is indicated. Mutated residues are shown in van-der-Waals representation. 
 
All mutant proteins were purified to homogeneity (data not shown). Soluble aggregates 
were effectively removed by size exclusion chromatography immediately before performing 
functional assays. 
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4.5.2 Biophysical characterization of the Sse1p variants 
 
To ensure that the introduced mutations did not affect the secondary structure of the Sse1p 
variants, far-UV CD spectra were recorded for all mutants ( ). Comparison of the 
CD spectra indicates that the secondary structure composition of the mutant proteins was very 
similar to that of the wt protein. The same was found for the Ssa1p and Ssa1N mutants (data 
not shown). 
Figure 4-16
Figure 4-16: CD spectra of the Sse1p variants. 
The CD spectra of the Sse1p mutant proteins (2.5 μM) at 4 ºC in HKM2 buffer containing 0.5 mM ATP are
shown. Each panel contains the CD spectrum of wt Sse1p (gray trace) for comparison. The mutants are number-
and color-coded as in Figure 4-15.    
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To investigate the thermal stability of Sse1p, a thermal transition was measured, 
following the decreasing CD signal at 222 nm upon heating. ATP-complexed Sse1p 
underwent a cooperative structural rearrangement with a transition midpoint at 39.0 ºC, at 
which approximately 15 % of α-helical structure was lost (Figure 4-17A). Remarkably, even 
at temperatures above 60 °C, a significant amount of secondary structure (~60 %) persisted 
(see also Raviol et al., 2006a). In contrast, the secondary structure of Sse1p was almost 
completely lost in 6 M GdnHCl, as illustrated by the CD spectrum of Sse1p measured in 
presence of 6 M GdnHCl (Figure 4-17B) or by the GdnHCl transition (Figure 4-17C). 
Interestingly, the close homolog Sse2p revealed to be thermally more stable than Sse1p 
(Tm = 46.5 °C, Figure 4-17A). Since Sse2p represents the stress-inducible isoform of the 
relatively thermo-labile Sse1p, it seems plausible that Sse2p might be adapted to take over the 
cellular functions of Sse1p at elevated temperatures. 
The Sse1p variants generally exhibited melting curves similar to unmodified Sse1p 
(Figure 4-18), suggesting that the mutants were not significantly compromised in terms of 
structural stability. The transition of the linker mutant Sse1-5 was less cooperative, but – 
similar to the other mutants – Sse1-5 was structured at 30 ºC, the maximum temperature used 
in most of the in vitro assays (chapters 4.5.3-4.5.6). Only the test for the Sse1p holdase 
activity was performed at 42 °C (chapter 4.5.8).  
Figure 4-17: Stability of Sse1p. 
(A) Thermal transitions of Sse1p and Sse2p (both 2.5 µM) are shown. The transition curves were recorded at a
wavelength of 222 nm in HKM2 buffer containing 0.5 mM ATP. The temperatures at the midpoints of the
transitions were 39.0 °C and 46.5 °C for Sse1p (black curve) and Sse2p (red curve), respectively. Note that a
significant amount of secondary structure (~60 %) persisted above 60 °C in both proteins. 
(B) CD spectra of different structural states of Sse1p (2.5 µM) are shown. The solid line shows the CD spectrum
of Sse1p in presence of ATP at 4 ºC. The spectrum of Sse1p at 70 ºC is depicted as dashed line. Under these
conditions, Sse1p maintained a significant amount of structure, which was absent in 6M GdnHCl (dotted line).
HKM2 containing 0.5 mM ATP was used as buffer for all measurements. 
(C) A GdnHCl-induced transition of Sse1p (2.5 µM) is shown. The transition was recorded at 222 nm and 20 °C
in HKM2 buffer. 
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Figure 4-18: Thermal stability of the Sse1p variants. 
The thermal transitions of the Sse1p mutant proteins (2.5 μM, 5.7 μM for Sse1C) recorded at a wavelength of
222 nm in HKM2 buffer containing 0.5 mM ATP are shown. The temperature at the midpoint of the transition is
indicated in ºC (Tm). For comparison, each panel contains the melting curve of wt Sse1p (gray trace). The Tm for
Sse1p was 39.0 ºC under the same conditions. The mutants are number- and color-coded as in Figure 4-15.    
To test the reversibility of the partial unfolding observed for the Sse1p mutants at 42 °C 
(Figure 4-18), temperature-dependent transitions were recorded in both directions. 
Specifically, the protein solutions were heated to 42 °C and then cooled down to 4 °C again 
(temperature gradient of 1 ºC min-1 for both un- and refolding transitions). The transition 
curves (Figure 4-19, left panels) as well as CD spectra recorded at 4 °C before and after 
heating ( , right panels) were in agreement with a reversible structural transition for 
the majority of the mutants. A partial recovery of secondary structure was observed for the 
Sse1p variants Sse1-9 and Sse1-10, in which the putative peptide binding cleft is mutated.  
Figure 4-19
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Figure 4-19: Reversibility of the partial unfolding of selected Sse1p variants. 
For each Sse1p variant, heating and cooling curves recorded in the temperature region from 4 to 42 °C at a
wavelength of 222 nm are shown (left panel). Whereas the unfolding transitions are color-coded as in Figure
4-15, the refolding transitions are colored in green. Furthermore, CD spectra at 4 °C before and after heating and
at 42 °C are depicted for each variant. Spectra recorded at 4 °C before heating are color-coded according to
Figure 4-15, spectra at 42 °C are shown in blue, and spectra measured at 4 °C after cooling of the sample are
colored in green. The partial unfolding of mutants Sse1-9 and Sse1-10 appeared at least in part irreversible.   
 
4.5.3 Complex formation of Sse1p variants and Ssa1p 
 
In an initial biochemical assay, we tested whether the Sse1p variants were still able to form 
complexes with Ssa1N. Specifically, the relative binding efficiencies of the Sse1p mutants for 
Ssa1N were estimated by the amount of Ssa1N coeluting with the respective Sse1p variant in 
size exclusion chromatography experiments. The amount of Ssa1N bound to wt Sse1p was 
used as a reference (Figure 4-20A). Mutations targeting the Sse1p/Hsp70N interface (Sse1-2, 
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Sse1-3, Sse1-4, Ssa1N(Q31A) and Ssa1N(A300E)) reduced binding to a low basal level. This 
suggests that the interface of the endogenous Sse1p/Ssa1p complex is presumably very 
similar to that seen in the structure of the Sse1p/Hsp70N complex. Furthermore, the structural 
integrity of Sse1p appears to be essential for the high-affinity interaction with Hsp70 
Figure 4-20: Mutational analysis of Sse1p/Hsp70 complex formation and nucleotide exchange.  
(A) The complex formation between the Sse1p variants and Ssa1N was analyzed by size exclusion
chromatography. The columns indicate the relative amount of Ssa1N coeluting with the respective Sse1p mutant
(see also Figure 4-1A). The relative complex formation between Ssa1N and wt Sse1p was set to one. Binding of
Ssa1N mutants was studied with wt Sse1p (right panel). The mutants are number- and color-coded as in Figure
4-15.    
(B) The nucleotide exchange activities of the Sse1p variants were analyzed by determining the respective
dissociation rates for MABA-ADP release from Hsp70N. The fluorescent probe MABA-ADP was bound to
2.5 μM Hsp70N, and mixed in a stopped-flow apparatus with a solution containing 250 μM ATP and 2.5 μM
Sse1p variant or no protein (spontaneous). The fluorescence traces of four mixing experiments were averaged,
and the time-dependent decrease in fluorescence was fitted with a mono- or bi-exponential model. The bars
represent the rate constants for the dominating dissociation process in a representative experiment. 
(C) The dissociation rates for MABA-ADP release from Ssa1p triggered by the different ATP-bound Sse1p
mutant proteins are shown (left panel). The rates of spontaneous and Sse1p-triggered MABA-ADP release for
the Ssa1p mutants are shown in the right panel. For comparison, the dissociation rates for Fes1p-triggered
MABA-ADP release are depicted in the right panel. Further details are as described above under (B).   
(D) The nucleotide exchange activity at increased concentrations of Sse1p mutant proteins relative to Ssa1p was
also analyzed. The gray and black columns represent the nucleotide release rates determined by mixing 2.5 μM
MABA-ADP complex of Ssa1p with a solution containing 2.5 μM or 25 μM of the indicated Sse1p mutant,
respectively. Otherwise, experiments were performed as described in the legend to panel (B). 
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homologs, as the Sse1p mutants affecting the domain-domain interfaces, Sse1-5, Sse1-7, and 
Sse1-8, showed significantly diminished complex formation. In contrast, ATP hydrolysis, 
which is abolished in the point mutant Sse1-1 (Raviol et al., 2006a), proved to be dispensable 
for complex formation. Consistent with the structural data, mutations in the β-sandwich 
domain of Sse1p (Sse1-Δloop, Sse1-9 and Sse1-10) did not impair binding to Ssa1N either. 
 
4.5.4 Nucleotide exchange activities of the Sse1p variants 
 
Nucleotide exchange activity was analyzed by determining the rate constants for the 
dissociation of the fluorescent nucleotide MABA-ADP from Hsp70N and Ssa1p upon 
addition of an equimolar concentration of the respective Sse1p variant ( B,C). The 
results for the various mutants showed the same trend irrespective of whether Hsp70N or full-
length Ssa1p was used as the interaction partner, confirming that the interactions in the 
endogenous complex are very similar to those observed in the crystal structure.  
Figure 4-20
Figure 4-20
Figure 4-20
Figure 4-20
Mutants Sse1-2 and Sse1-8 accelerated nucleotide exchange only slightly over the 
spontaneous rate. The same was observed upon interaction of wt Sse1p with the Ssa1p mutant 
A300E (Figure 4-20C). This indicates that the interaction between subdomain IIb of the 
canonical Hsp70 and the 3HBD of Sse1p (Figure 4-13A and ) is critical for 
nucleotide exchange activity, as predicted from the structural analysis. In contrast, Fes1p, 
which presumably contacts a different area of Ssa1p to perform nucleotide exchange (chapter 
Figure 4-15
2.5.6, Dragovic et al., 2006b), can still trigger nucleotide release from Ssa1p(A300E), 
suggesting that this mutant has nucleotide binding properties similar to wt Ssa1p. 
Interestingly, the Sse1p mutations targeting the NBD/NBD interface (Sse1-3 and Sse1-
4) lowered the rate of nucleotide exchange to a lesser extent ( B,C) than expected 
from their greatly reduced Ssa1N binding propensity ( A). Similarly, the mutation 
Q31A in subdomain Ia of Ssa1p (corresponding to Hsp70 Q33), which disrupts the direct 
contact to the Sse1p-bound nucleotide, had a relatively mild effect on the nucleotide exchange 
rate (Figure 4-13B and C). In a control experiment, Fes1p was shown to exchange 
nucleotide on Ssa1(Q31A) as effectively as on wt Ssa1p, consistent with the prediction that 
Fes1p does not directly interact with Q31. In general, stable binding of Hsp70 to Hsp110 
appears to be dispensable for efficient nucleotide exchange, suggesting that complex 
formation provides the basis for additional cooperative functions of Ssa1p and Sse1p in 
protein folding.  
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As shown in Figure 4-20D, the combination mutants Sse1-(2+3) and Sse1-(2+4) have 
similarly low nucleotide exchange activities as mutants Sse1-2 and Sse1-8 when applied at an 
equimolar ratio to Ssa1p, but could be distinguished when used at higher concentrations. 
While a ten-fold molar excess of Sse1-2 or Sse1-8 accelerated nucleotide exchange roughly 
by a factor of ten, a ten-fold excess of Sse1-(2+3) or Sse1-(2+4) did not lead to a significant 
acceleration in MABA-ADP release. Thus, multiple mutations at the binding interface are 
apparently required to efficiently disrupt the distributed interactions in the Sse1p/Ssa1p 
complex. 
Mutation of the linker/NBD interface of Sse1p (Sse1-5, ) also strongly 
attenuated nucleotide exchange (Figure 4-9 and Figure 4-20C,D). Since the respective 
mutation site is remote from the Hsp70 interaction interface, this effect is likely to be indirect. 
The decrease in nucleotide exchange efficiency might be caused by a destabilization of the 
twisted, ATP-bound conformation of the Sse1p NBD. The other domain-domain interface 
mutants (Sse1-6 and Sse1-7) as well as Sse1p variants with mutations directed at the putative 
peptide binding site (Sse1-9 and Sse1-10) exhibited nucleotide exchange activities more 
similar to unmodified Sse1p (Figure 4-20C). Consistently, combining mutations 9 and 10 with 
mutation 2 (Sse1-(2+9) and Sse1-(2+10)) did not significantly aggravate the nucleotide 
exchange defect of Sse1-2 alone ( D). 
Figure 4-15
Figure 4-20
 
4.5.5 Acceleration of Ssa1p peptide release by Sse1p 
 
Hsp70-assisted protein folding is thought to occur in nucleotide-dependent cycles of substrate 
binding and release (Hartl and Hayer-Hartl, 2002; Mayer and Bukau, 2005). In order to assess 
whether nucleotide exchange triggered by Sse1p results in increased substrate turnover by 
Ssa1p, we measured the release of the fluorescently labeled substrate peptide D-NR (dansyl-
NRLLLTGC) from Ssa1p by stopped-flow mixing experiments. Dissociation of D-NR from 
Hsp70 in the presence of excess unlabeled peptide (NR) results in a fluorescence decrease 
(Gässler et al., 2001; Dragovic et al., 2006a). The spontaneous dissociation of D-NR from the 
ADP complex of Ssa1p was very slow ( A). ATP strongly increased the 
dissociation rate, consistent with the ATP-dependent conversion of Ssa1p into a structural 
state with a high off-rate for peptide. Notably, in the presence of Sse1p, dissociation of D-NR 
was further accelerated seven-fold, although nucleotide exchange was accelerated 90-fold 
under the same conditions (Figure 4-20C and A). Accordingly, Sse1p mutants 
with a mild NEF defect were still able to stimulate peptide release like wt Sse1p, as shown 
Figure 4-21
Figure 4-21
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for Sse1-3 ( A). However, in mutants with severely impaired NEF activity, 
nucleotide exchange became rate-limiting for peptide release, despite the substantial intrinsic 
off-rate of ADP from eukaryotic Hsp70s. For these mutants, the rates of MABA-ADP release 
from Ssa1p correlated with the rate of peptide dissociation: for example, Sse1-2 stimulated 
both the MABA-ADP and peptide release about five-fold (Figure 4-20D and Figure 4-21A).  
Figure 4-21
Figure 4-21
Figure 4-21: Effects of Sse1p mutations on Hsp70 substrate release. 
 (A) Sse1p accelerates substrate release from Ssa1p by catalyzing nucleotide exchange. Complexes of Ssa1p with
ADP and the fluorescent peptide probe D-NR (2.5 μM) were mixed in a stopped-flow apparatus with the
indicated reagents. Whereas excesses of the unlabeled peptide probe NR and ATP were used (both 250 µM),
Sse1p variants were used at equimolar ratio. The fractional decrease of fluorescence, reflecting peptide release
from Ssa1p, is shown for selected reactions. The release rates for all analyzed mutants are presented on the right.
The mutants are number- and color-coded as in Figure 4-15. Rates were derived from single exponential analysis
of the average of four fluorescence traces (SD ~2 %). Representative data are shown.     
(B) Peptide release kinetics from apo-Ssa1p·D-NR are shown. An Ssa1p·ADP·D-NR complex was treated with
shrimp alkaline phosphatase, resulting in partial degradation of ADP. The reaction mixture was diluted to a final
concentration of 2.5 µM Ssa1p and then mixed with reagents as indicated using a stopped-flow apparatus.
Further details are as described above under (A). The fractional decrease of fluorescence is shown on the left,
numerical values for the release rates as well as the respective amplitudes are indicated on the right. For
comparison, the ATP-induced peptide release from Ssa1p·ADP·D-NR is shown (see also (A)). 
 
In order to study the peptide dissociation mechanism without the complication by the 
ADP release step, Ssa1p·ADP·D-NR complex was treated with alkaline phosphatase to 
prepare D-NR-bound apo-Ssa1p ( B). The spontaneous release of D-NR occurred 
at the same rate as from the Ssa1p·ADP·D-NR complex, suggesting that apo-Ssa1p has 
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conformational and substrate binding properties close to ADP-bound Ssa1p (Figure 4-21A,B). 
Addition of Sse1p to the apo-Ssa1p·D-NR complex only moderately accelerated substrate 
release compared to the spontaneous dissociation2, indicating that Sse1p binding is not the 
principal trigger for substrate dissociation ( B). In contrast, ATP addition resulted 
in a strong acceleration of D-NR release
Figure 4-21
3, consistent with an ATP-driven structural 
rearrangement of Ssa1p towards a conformation with low substrate binding affinity. 
Interestingly, mixing of apo-Ssa1p·D-NR with both Sse1p and ATP resulted in less 
accelerated substrate release. Thus, the presence of Sse1p might hamper the conformational 
transition of Ssa1p necessary for accelerated substrate dissociation in a plausible, transiently 
occurring quarternary complex of Sse1p, Ssa1p, ATP, and D-NR. 
In summary, the datasets acquired with the Ssa1p·ADP·D-NR and the apo-Ssa1p·D-NR 
complexes indicate that the main purpose of Sse1p is triggering of ADP dissociation from 
Ssa1p·ADP·D-NR, preparing Ssa1p for ATP binding. In contrast, Sse1p binding appears to 
have only minor influence on substrate release from the Ssa1p·ATP·D-NR complex.   
 
4.5.6 Mutational analysis of Sse1p function in protein folding 
 
In order to investigate how Sse1p contributes to Hsp70-assisted protein folding, the thermo-
labile protein firefly luciferase was employed as a model substrate (Dragovic et al., 2006a). 
The folding of firefly luciferase is believed to be a model reaction for the biogenesis of multi-
domain proteins. Luciferase was denatured at 42 ºC in the presence of Ssa1p, and refolding 
was initiated by addition of ATP and Ydj1p at 30 ºC. Within 40 min of incubation, luciferase 
refolded to ~23 % of the value prior to denaturation (Figure 4-22A,B). When sub-
stoichiometric amounts of Sse1p were added together with ATP and Ydj1p, refolding was 
accelerated and the folding yield increased to ~33 % (Figure 4-22A,B). A maximum three-
fold acceleration of folding was reached at a ratio of Sse1p:Ssa1p of 1:6, whereas equimolar 
concentrations of Sse1p inhibited refolding, suggesting that Hsp70 cycling was no longer 
productive (Figure 4-22A). 
The Sse1p mutants were tested under conditions where the wt protein was most efficient 
in luciferase folding (see Figure 4-23 for a comprehensive presentation of the refolding data). 
The most severely nucleotide exchange defective mutants Sse1-(2+3), Sse1-(2+4), and Sse1C 
                                                 
2 The peptide release kinetic was bi-exponential with a major slow and a minor ten-fold faster process. The latter 
could be caused by small quantities of ATP lacking from Sse1p·ATP complexes. 
3 The ATP-induced release of D-NR had a bi-exponential kinetic. The rate of the minor process was in good 
agreement with the rate of ATP-triggered D-NR release from the Ssa1p·ADP·D-NR complex, suggesting that 
residual traces of Ssa1p·ADP·D-NR complex remained after the phosphatase treatment.   
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(the C-terminal fragment of Sse1p corresponding to the PBD of canonical Hsp70s (Dragovic 
et al., 2006a)) did not improve luciferase refolding compared to Ssa1p and Ydj1p alone 
(Figure 4-20D, Figure 4-22C and Figure 4-23). This suggests that catalysis of nucleotide 
exchange and the resulting acceleration of substrate release from Hsp70 is the most important 
function of Sse1p in luciferase refolding. In support of this conclusion, mutants retaining 
weak NEF activity, including Sse1-2, Sse1-8, and Sse1-5 (Figure 4-20D), were still able to 
partially increase the rate and yield of refolding (Figure 4-22C and Figure 4-23), consistent 
with their ability to substantially accelerate peptide release from Ssa1p (Figure 4-21A). Thus, 
Figure 4-22: Effects of Sse1p mutations on luciferase refolding. 
(A) The ratio of Sse1p:Ssa1p was optimized for efficient luciferase refolding. Firefly luciferase at 100 nM was
denatured for 10 min at 42 ºC in presence of 3 µM Ssa1p. Subsequently, protein refolding was initiated by
addition of Sse1p (concentrations as indicated), 3 µM Ydj1p, and 3 mM ATP at 30 ºC. Luciferase activity was
determined at the indicated time points. An equimolar amount of Sse1p relative to Ssa1p was inhibitory
compared to refolding in absence of Sse1p. At a ratio of Sse1p:Ssa1p of 1:6, luciferase refolding was most
efficient. 
(B) The presence of Sse1p enhanced the luciferase refolding rate and recovery. Firefly luciferase was thermally
denatured in presence or absence (bottom curve) of Ssa1p. Refolding was initiated at 30 °C by addition of the
indicated chaperones. 0.5 µM of Sse1p were used, further details are as described in (A). Each curve represents
the average of at least three independent measurements, SDs are shown. 
(C) Refolding of thermally denatured luciferase in the presence of representative Sse1p variants. Firefly
luciferase was thermally denatured and refolded as described in (A). 0.5 μM of the respective Sse1p variant was
used. Each curve represents the average of at least three independent measurements, SDs are shown. Sse1p
mutants are number- and color-coded as in Figure 4-15. The gray traces correspond to the control measurements
in (B). A complete representation of the luciferase refolding curves is depicted in Figure 4-23. The Sse1p
mutants with the most severe nucleotide exchange defects did not improve luciferase refolding compared to
Ssa1p and Ydj1p alone. 
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Figure 4-23: A complete representation of the effects of Sse1p mutations on luciferase refolding. 
The refolding of firefly luciferase (100 nM) following thermal denaturation at 42 °C in the presence of 3 µM
Ssa1p is shown. Refolding was initiated by addition of 0.5 µM Sse1p variant, 3 µM Ydj1p, and 3 mM ATP at
30 °C. Luciferase activity was determined at the indicated time points. Each curve represents the average of at
least three independent measurements, SDs are shown. Sse1p mutants are number- and color-coded as in Figure
4-15. The gray traces correspond to the control measurements in Figure 4-22B. 
 
a small increase in nucleotide exchange over the spontaneous rate may be sufficient to cause a 
noticeable acceleration of protein folding. On the other hand, the combination mutants Sse1-
(2+9) and Sse1-(2+10) were almost inactive in refolding (Figure 4-22C and Figure 4-23), 
although their exchange activity was comparable to that of the partially folding-active mutants 
Sse1-2 and Sse1-8 ( D). Mutations 9 and 10 are located in the β-sandwich domain 
and may affect the ability of Sse1p to interact with non-native luciferase. Substrate 
interactions mediated by the β-sandwich domain of Sse1p may contribute to efficient folding 
in addition to the nucleotide exchange function of Sse1p. In further support of this possibility, 
Figure 4-20
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the fully nucleotide exchange-active mutant Sse1-Δloop (Figure 4-20C), which also affects 
the β-sandwich domain, displayed only partial refolding activity (Figure 4-22C and 
).  
Figure 
4-23
Figure 4-23
All other mutants with normal or mildly reduced NEF activity – namely (i) the ATPase 
deficient mutant Sse1-1, (ii) the Sse1p/Ssa1p interface mutants Sse1-3, Sse1-4, and 
Ssa1(Q31A) (data not shown), (iii) the Sse1p domain-domain interface mutants Sse1-6 and 
Sse1-7, and (iv) the putative peptide binding cleft mutants Sse1-9 and Sse1-10 – supported 
luciferase refolding with similar efficiency as wt Sse1p, indicating that stimulated nucleotide 
exchange was faster than the limiting step in protein folding ( C, Figure 4-22C, and 
). Since Sse1-1 is unable to hydrolyze ATP (Raviol et al., 2006a), nucleotide 
cycling by Sse1p is apparently not required for Sse1p function in cooperative protein folding.  
Figure 4-20
 
4.5.7 Sse1p/peptide interaction 
 
The peptide binding specificity of Sse1p was assessed in a so-called peptide scan, in which an 
array of peptides is covalently linked to a cellulose-PEG membrane. Specifically, the scan 
was performed with peptides covering the entire sequence of firefly luciferase (180 peptides 
in total). The peptides were each 13 amino acids long, and the sequences of neighboring 
peptides overlapped by ten residues. Each heptapeptide motif occurs thus in three consecutive 
spots. After incubation of the membrane with Sse1p, chaperone binding was detected using an 
Sse1p antiserum. Wt Sse1p preferentially interacted with three peptide series sharing the 
sequence motifs 52-TYAEYFE, 262-VVLMYRF, and 292-FSFFAKS (Figure 4-24). These 
findings suggest that Sse1p, similar to canonical Hsp70s, is able to recognize short 
Figure 4-24: The Sse1p/peptide interaction. 
Sse1p binds to specific luciferase sequence segments (red boxes in the left panel). Partially overlapping 13
amino acid peptides covering the sequence of firefly luciferase were synthesized on a cellulose membrane. The
membrane was probed with Sse1p (10 μg/ml), and peptide-bound Sse1p was visualized by immunodetection
with Sse1p antiserum. The peptide sequences in the upper box share the amino acids TYAEYFE, those in the
lower left box the amino acids VVLMYRF, and those in the lower right box the amino acids FSFFAKS. The
peptide scan was performed in triplicate, a representative result is shown. The right panel shows the result of a
control experiment, in which unspecific binding of the Sse1p antiserum to the membrane was tested by probing
the membrane directly with the Sse1p antiserum and the HRP-conjugated secondary antibody. Apart from that,
the membrane was exactly treated as in the left panel. 
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hydrophobic segments in substrate proteins (Rüdiger et al., 1997).  
Anisotropy measurements with the fluorescently labeled peptide LICGFRVVLMYRF 
(LIC-peptide), a generous gift from Dr. J.L. Brodsky, confirmed binding of Sse1p to this 
luciferase sequence segment (KD ≈ 10 nM, data not shown, see also Goeckeler et al., 2008). 
However, neither co-crystallization nor soaking of the Sse1-Δloop/Hsp70N complex with 
unlabeled LIC-peptide, the closely related peptide SGFRVVLMYRFEE or the peptide 
TLFSFFAKST have been successful up to now.  
 
4.5.8 Sse1p prevents protein aggregation at elevated temperatures  
 
Similar to other members of the Hsp110 protein family, Sse1p was reported to efficiently 
prevent the aggregation of heat-denatured luciferase in vitro (Oh et al., 1997; Goeckeler et al., 
2002). We were able to reproduce these findings: As judged by the intensity of scattered light, 
luciferase alone started to form large aggregates after 7 min of incubation at 42 ºC (
A). Presence of a five-fold excess of wt Sse1p reduced the increase in light scattering by 
approximately 43 %.  
Figure 
4-25
Figure 4-25
Additionally, we could demonstrate that Sse1p maintains the denatured protein in a 
refolding competent state. When luciferase was thermally denatured at 42 ºC in the presence 
of Sse1p/ATP, followed by the addition of Ssa1p and Ydj1p at 30 °C, ~27 % of the initial 
luciferase activity was restored (Figure 4-25B, left panel). Using BSA (with ATP) as a 
unspecific control protein, only a small fraction of luciferase (5 %) regained activity upon 
addition of Ssa1p and Ydj1p (Figure 4-25B, right panel). As reported in chapter 4.5.2, 
Sse1p·ATP undergoes a reversible structural rearrangement upon heating with a midpoint at 
~39 ºC, at which ~15 % of α-helical structure is lost ( ,  and (Raviol et 
al., 2006a)). Provided that this transition also occurs in the presence of substrate protein and 
Ssa1p, this conformational change may expose additional regions in Sse1p for substrate 
binding. Consistent with this notion, a less cooperative thermal transition in the mutant Sse1-5 
(Figure 4-18 and Figure 4-19) was accompanied by a loss of function in stabilizing luciferase 
against heat denaturation: Sse1-5 was neither able to reduce the formation of large aggregates 
upon heating at 42 °C (Sse1-5/luciferase light scattering data not shown and Figure 4-25A) 
nor to increase the luciferase refolding yield above the background measured with BSA as 
holdase (Figure 4-25C). All other point mutants studied preserved the cooperative thermal 
transition and were clearly more effective than BSA in stabilizing luciferase in a folding-
competent state (Figure 4-18 and C). Differences in the luciferase refolding yields 
Figure 4-17 Figure 4-19
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Figure 4-25: Analysis of the holdase activity of Sse1p variants. 
(A) Sse1p can reduce the aggregation of heat-denatured luciferase. 100 nM luciferase were incubated in presence
of 3 mM ATP and in absence (black curve) or presence of a five-fold excess of Sse1p (red curve) at 42 °C. The
light scattering signal was followed at a wavelength of 350 nm over time.  
(B) In the left panel, protein refolding after thermal denaturation of luciferase in the presence of Sse1p is shown.
100 nM luciferase were thermally denatured for 25 min at 42 ºC in a buffer containing 3 mM ATP in the
presence or absence of 0.5 µM Sse1p, followed by addition of the indicated protein components (3 µM Ssa1p,
3 µM Ydj1p, 0.5 µM Sse1p) and incubation at 30 ºC. At the presented time points luciferase activity was
analyzed. Each curve represents the average of at least three independent measurements, SDs are indicated.
Presence of Sse1p in the heated sample significantly increased the luciferase refolding yield. In the right panel,
protein refolding after thermal denaturation of luciferase in the presence of bovine serum albumin (BSA) is
shown. In these experiments, luciferase was denatured in the presence of 0.5 µM BSA using otherwise identical
conditions as described for the left panel. Refolding was initiated by addition of the indicated components at
30 ºC. For comparison, the folding reactions after denaturation in the presence of wt Sse1p (top) and
spontaneous recovery (bottom) are shown in gray.   
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in in experiments with different Sse1p variants can be attributed to low nucleotide exchange 
activity (Sse1-2, Sse1-8, Sse1-2+3, Sse1-2+4, Sse1-2+9, Sse1-2+10). The poor refolding 
yields observed for the nucleotide exchange active mutants Sse1-9 and Sse1-10 might be 
rather caused by their inability to revert quantitatively into the NEF-active state after cooling 
(Figure 4-19) than by a limited holdase activity. Interestingly, Sse1C, corresponding to the 
PBD in canonical Hsp70s, failed to reduce the light scattering signal of heat-denatured 
luciferase (data not shown) and could not increase the refolding yield above the background 
level. Importantly, addition of wt Sse1p before refolding did not correct this functional defect, 
indicating that it was not simply caused by the absence of NEF activity in Sse1C (
C). Thus, while possibly contributing to substrate binding in the context of Hsp70-
mediated protein folding (see chapter 
Figure 4-25 continued: Analysis of the holdase activity of Sse1p variants. 
(C) Luciferase refolding after denaturation in the presence of Sse1p mutants is shown. 100 nM luciferase were 
thermally denatured for 25 min at 42 ºC in the presence of 0.5 µM Sse1p mutant protein and 3 mM ATP, 
followed by addition of 3 µM Ssa1p and 3 µM Ydj1p (and 0.5 µM wt Sse1p when indicated) and incubation at 
30 °C. Each curve represents the average of at least three independent measurements, SDs are shown. Sse1p 
mutants are number- and color-coded as in Figure 4-15. The gray traces correspond to the control measurements 
marked in red in (B). 
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4.5.6), this segment of Sse1p does not appear to be 
sufficient for substrate stabilization under heat shock conditions.  
 
4.5.9 In vivo analysis of the Sse1p mutants 
 
To assess the functionality of the Sse1p mutants in vivo, we tested the ability of the mutant 
proteins to complement the lethal phenotype of the combined deletion of SSE1 and SSE2 in 
yeast cells. The Sse1p variants were expressed in a ΔSSE1ΔSSE2 yeast strain containing a 
rescue plasmid coding for wt SSE1 and the URA3 marker. To select for loss of wt SSE1 
expression, cells were grown on medium containing 5-FOA. The non-toxic 5-FOA is 
converted to toxic 5-fluorouracil in yeast strains expressing the functional URA3 gene. 
Consequently, only yeast cells that lost the rescue plasmid and expressed a functional sse1 
mutant could multiply. The experiments showed that only mutants sse1-(2+3) and sse1-(2+4) 
were unable to complement the ΔSSE1ΔSSE2 double deletion under normal growth 
conditions (Figure 4-26A). In these mutants, two contact sites with Hsp70 are disrupted, 
resulting in severely reduced complex formation with Hsp70, consistent with the finding that 
Sse1-(2+3) and Sse1-(2+4) have the lowest NEF activities among all mutants tested in vitro 
(Figure 4-20D). Thus, the NEF activity of Sse1p is likely to be critical for cell survival. To 
exclude that the lethality of sse1-(2+3) and sse1-(2+4) strains resulted from failure to express 
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Figure 4-26: Functionality of Sse1p variants in vivo. 
In all panels, the Sse1p mutants are number- and color-coded as in Figure 4-15. 
(A) The in vivo functionality of Sse1p mutants was assessed in a yeast ΔSSE1ΔSSE2 complementation assay. 
sse1 mutant strains were generated by transforming the respective expression plasmids into an SSE1/SSE2 
deletion strain harboring the wt SSE1 encoding rescue plasmid pCM189-SSE1-URA3. 5-FOA selection against 
the rescue plasmid showed that expression of sse1-(2+3) and sse1-(2+4) did not support growth of the deletion 
strain. All other sse1 mutants analyzed resulted in viable strains. 
(B) The expression levels of Sse1p mutants Sse1-(2+3) and Sse1-(2+4) in an SSE1 deletion strain of S. 
cerevisiae were tested. Yeast cultures were grown to mid-log phase at 30 ºC in YPD medium. Serial dilutions of 
the cultures were spotted on YPD agar plates and incubated at 30 ºC for 24 h. Mutants sse1-(2+3) and sse1-
(2+4) grew slightly slower than a strain expressing wt SSE1. Furthermore, equal cell amounts of the mid-log 
phase cultures were harvested and subjected to alkaline lysis. Cell extracts were separated on 10 % SDS-PAGE 
and probed by Western blotting against Sse1p using a polyclonal antiserum. A strain transformed with an empty 
plasmid served as a control for the endogenous Sse2p level, as the Sse1p antiserum crossreacts with Sse2p. A 
strain transformed with a plasmid coding for wt SSE1 was used as a positive control for the expression of non-
mutated Sse1p. Endogenous phosphoglycerate kinase (PGK) served as a gel loading control. Sse1-(2+3) and 
Sse1-(2+4) were expressed at similar levels as plasmid-borne wt Sse1p.  
(C) The growth of sse1 mutant strains was tested under conditions of heat stress. sse1 mutants were ectopically 
expressed in a SSE1/SSE2 deletion background. Serial dilutions of mid-log phase cultures were spotted on YPD 
agar plates and incubated at 30 (upper panels) or 37 ºC (lower panels) for 48 h. Significant growth differences 
could only be detected at 37 ºC. 
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Figure 4-26 continued: Functionality of Sse1p variants in vivo. 
(D) The expression levels of the Sse1p variant proteins in the mutant strains were determined. Yeast cultures 
were grown to mid-log phase at 30 ºC in YPD medium. Equal amounts of cells were harvested and subjected to 
alkaline lysis. Alternatively, the cells were further incubated for 4 h at 37 ºC, followed by lysis as described 
above. Cell extracts were separated on 10 % SDS-PAGE and probed by Western blotting against Sse1p using a 
polyclonal antiserum. The wt strain YPH499 served as a control for the endogenous Sse1p expression level; 
endogenous PGK was used as a gel loading control. All mutants were expressed at levels similar to endogenous 
Sse1p. 
(E) The in vivo stability of the Sse1p variants was tested in a cycloheximide chase experiment. Yeast cells were 
grown to mid-log phase at 30 ºC in YPD medium. Cells were harvested and resuspended at an OD600 of 5 in 
fresh medium. Translation was terminated by addition of cycloheximide to a final concentration of 0.48 mg/ml. 
Subsequently, the cultures were incubated at 37 ºC. Aliqouts were retrieved at the indicated time points, 
subjected to alkaline lysis and analyzed by Western blotting against Sse1p and PGK. All Sse1p variants 
appeared stable against degradation under the tested conditions. 
 
Sse1 mutant protein, respective expression plasmids were transformed in a ΔSSE1 strain 
(Figure 4-26B). The resulting strains grew similarly slow as a control strain, which was only 
transformed with an empty plasmid. In contrast, a strain expressing plasmid-borne wt SSE1 
grew slightly faster. Western blot analysis of the Sse expression levels with an antiserum 
recognizing both Sse1p and Sse2p showed that ectopical expression of wt and mutant Sse1 
resulted in similar protein amounts (Figure 4-26B). In the control ΔSSE1 strain, the level of 
stress-induced endogenous Sse2p was significantly lower.  
All other Sse1p mutants analyzed supported yeast growth at a level comparable to wt 
Sse1p at 30 ºC and could only be further differentiated at an elevated growth temperature of 
37 ºC (Figure 4-26C). As confirmed by Western blot analysis of whole cell lysates, the mutant 
proteins were present at a level similar to endogenous Sse1p in wt cells under these conditions 
(Figure 4-26D). Furthermore, cycloheximide chase experiments showed that neither wt Sse1p 
nor Sse1p mutants are subjected to rapid protein turnover (Figure 4-26E). At 37 ºC, cells 
expressing Sse1-2 or Sse1-8 exhibited a pronounced growth defect (Figure 4-26C). Both 
mutations are expected to interfere with the crucial interactions between the 3HBD of Sse1p 
and subdomain IIb of Ssa1p (Figure 4-12, Figure 4-13A, and Figure 4-15), strongly impairing 
nucleotide exchange. An even more severe growth defect was observed in the strains 
expressing Sse1-(2+9) or Sse1-(2+10), which combine mutation 2 with mutations 9 and 10 in 
the putative peptide binding domain (Figure 4-26C). As cells expressing mutants Sse1-9 and 
Sse1-10 showed no growth defects, impairment of substrate binding by Sse1p may affect cell 
growth only when combined with a strong defect in the nucleotide exchange function. 
 Finally, we tested whether the absence of functional Sse1p induces general cellular 
stress and thereby activates the heat shock response. In a first approach, we analyzed the 
protein levels of the stress-inducible chaperones Hsp12p, Hsp42p, Hsp104p, Ssa1p, and 
Ydj1p in the cell lysates of the different mutant strains by Western blotting. For none of these 
heat shock proteins apparent expression differences between sse1 mutant and wt cells could 
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be detected under the investigated conditions (30, 34 and 37 °C, data not shown). However, 
the level of the stress-inducible yeast Hsp70 homolog Ssa3p was significantly higher in 
nucleotide exchange and growth defective mutant strains (sse1-2, sse1-8, sse1-2+9, sse1-
2+10, sse1-2+3, and sse1-2+4) than in strains expressing wt Sse1p (data not shown). 
Interestingly, the mutant-specific induction of Ssa3p expression was already observable at 
30 °C. Thus, the heat shock response was already activated at seemingly normal cell growth 
in nucleotide exchange impaired mutants (Figure 4-26C). 
Figure 4-27: Stress induction in sse1 mutant strains. 
Activation of the heat shock response in sse1 mutant yeast strains was tested using a β-galactosidase reporter
assay. Wt YPH499 cells (light gray bars) as well as ΔSSE1ΔSSE2 (dark gray bars) and ΔSSE1 (checked bars)
strains ectopically expressing the indicated mutants (number- and color-coded as introduced in Figure 4-15)
were transformed with a plasmid coding for β-galactosidase under control of the stress-inducible SSA3 promotor
(pYEP-SSA3-lacZ). Cells were grown at 30 °C to mid-log phase, and the β-galactosidase activity was
determined using the artificial substrate ONPG. The β-galactosidase activity of YPH499 cells at 37 °C was
measured after additional incubation of the cultures at 37 °C for 3.5 h. The bars indicate the relative induction of
β-galactosidase activity compared to the activity determined for wt YPH499 cells at 30 °C. Each measurement
was independently repeated for at least three times, SDs are indicated as black bars. According to the β-
galactosidase activities, yeast strains expressing nucleotide exchange defective Sse1p variants experience severe
cellular stress.  
 
In a second approach, β-galactosidase expression under control of the SSA3 promotor 
was used as a sensitive reporter for cellular stress. The results of this assay proved to be 
highly consistent with the observations from the Western blot analysis of Ssa3p expression. 
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The highest β-galactosidase activities were found for ΔSSE1ΔSSE2 strains expressing the 
nucleotide exchange impaired mutants sse1-2, sse1-8, sse1-2+9, and sse1-2+10 (Figure 4-27). 
Strikingly, the β-galactosidase expression determined for sse1-2 at 30 °C was approximately 
two-fold higher than in a wt yeast strain at 37 °C, illustrating that the stress induction caused 
by nucleotide exchange defects of Sse1p was quite severe. The strong activation of the heat 
shock response might be necessary to ensure normal cell growth at 30 °C. The β-galactosidase 
activities determined for ΔSSE1 strains expressing sse1-2+3 and sse1-2+4 were 
approximately five-fold higher than for a ΔSSE1 strain expressing extrachromosomal wt 
SSE1. Surprisingly, the stress response was reproducibly stronger in sse1-2+3 and sse1-2+4 
cells than in a control strain transformed with an empty plasmid. Possibly, the stress-inducible 
Sse1p isoform Sse2p might compensate for Sse1p loss more effectively in absence of any 
Sse1p than in presence of large amounts of defective Sse1p. The Sse1p mutants might 
inactivate Sse2p by unproductive heterodimer formation. 
In summary, the results from the in vivo analysis suggest that the nucleotide exchange 
function of Sse1p is critical for yeast growth. It is likely that nucleotide exchange defects of 
Sse1p lead to a decreased protein flux through the Hsp70 chaperone machinery and 
consequently induce general stress in the cell. Since elevated growth temperatures may 
require an increased protein flux through the Hsp70 chaperone system, the loss of NEF 
function might have more severe consequences under heat stress conditions. 
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5 DISCUSSION 
 
Correct protein folding is crucial for cell survival. Especially the folding of larger proteins 
depends on the assistance of molecular chaperones. In the cell, a large number of different 
chaperones form a sophisticated folding network, the general principles of which are 
conserved from prokaryotes to eukaryotes. In this network, the molecular chaperones of the 
Hsp70 protein family are of particular significance. They not only participate in co- and post-
translational folding of newly synthesized proteins and in protein assembly, but are also 
involved in refolding of stress-denatured proteins, in protein degradation, in protein transport 
across membranes, and in regulation of signal transduction proteins. However, canonical 
Hsp70s do not perform these diverse cellular functions autonomously, but depend on J-
proteins and NEFs, which regulate their ATP cycle and thereby their substrate binding 
affinity, which is low in the ATP and high in the ADP state. In eukaryotes, four different 
classes of NEFs have been found, among which Hsp110 homologs are most abundant. 
Hsp110s apparently originated from canonical Hsp70s – as judged by their conserved domain 
composition – and evolved into NEFs preserving the ability to stabilize misfolded proteins in 
solution.  
In the present study, we performed a structural and biochemical analysis of the complex 
between the yeast Hsp110, Sse1p, and human Hsp70. Our results lead to a model describing 
the functional cooperation between Hsp110 and Hsp70 homologs in the cytosol and ER of 
eukaryotic cells (Figure 5-3B): Central to Hsp110 function is its nucleotide exchange activity 
on Hsp70. Mutations that abolish Hsp110 NEF activity in the yeast cytosol are lethal. 
Concomitant with nucleotide exchange, Sse1p accelerates Hsp70-assisted protein folding and 
perhaps other Hsp70-dependent processes. Furthermore, our data suggest that direct 
interactions of non-native substrate proteins with Sse1p may support Hsp70-assisted protein 
folding in a cooperative process. Interestingly, Sse1p function does not require the nucleotide-
dependent allostery and peptide binding mode of canonical Hsp70s.  
  
5.1 The structure of Sse1p·ATP – a model for the ATP state of Hsp70 
 
The structure of Sse1p·ATP as found in complex with Hsp70N confirmed the proposition that 
– despite low overall sequence similarity – Hsp110s share the general domain organization of 
canonical Hsp70 proteins, consisting of an N-terminal NBD, a β-sandwich domain and a C-
terminal 3HBD (Figure 5-1A and Oh et al., 1999). The tight interactions between these 
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domains were however unanticipated. In the peculiar conformation of Sse1p·ATP, the NBD 
and β-sandwich domain associate intimately with the linker forming an inter-domain β-sheet. 
It appears plausible that NBD binding sites for both the linker and the β-sandwich domain 
become exposed as a consequence of ATP binding to Sse1p, which apparently results in a 
~25 ° twisting of the two NBD lobes against each other compared to the Hsp70 NBD·ADP 
structure (Figure 4-8A and Liu and Hendrickson, 2007). Strikingly, the 3HBD does not form 
a "lid" over the β-sandwich domain as observed in the structure of the DnaK PBD in complex 
with a substrate peptide (Zhu et al., 1996), but instead interacts with the flank of lobe I of the 
NBD and points away from the β-sandwich domain (Figure 5-1A). The same three-
dimensional domain arrangement was found in the crystal structure of Sse1p·ATP alone, 
Figure 5-1: Sse1p·ATP as model for Hsp70·ATP.  
(A) The Sse1p·ATP/Hsp70N complex is compared with the structure of Sse1p·ATP. A frontal and a side view of
the superposed structures are shown in the left and right panel, respectively. Hsp70N-complexed Sse1p is shown
as a Cα trace using the same color scheme as in Figure 4-7; the individual domains and the C-terminus are
labeled. ATP is represented as green sticks. The Sse1p·ATP structure (PDB entry code 2QXL (Liu and
Hendrickson, 2007)) is superposed as a Cα trace in white. Hsp70N is shown in surface representation. Small
differences of the Sse1p conformations are apparent at the Hsp70N interface and at the C-terminus. 
(B) The structure of C-terminally truncated Geobacillus kaustophilus HTA426 DnaK bound to ADP-Pi is shown
in ribbon representation (PDB entry code 2V7Y (Chang et al., 2008)). ADP-Pi is depicted as green sticks. The
DnaK subdomains are labeled and colored as the corresponding Sse1p domains in Figure 4-7. Other than in the
Sse1p·ATP structure, the linker connecting the NBD and the β-sandwich domain adopts an extended and solvent
accessible conformation.    
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which was solved by Hendrickson and coworkers while the work presented herein was in 
progress (Liu and Hendrickson, 2007). For the two structures, an r.m.s.d. of 0.91 Å was 
determined (for 604 Cα positions), indicating that Hsp70N binding causes only minor 
rearrangements in Sse1p (Figure 5-1A).  
Notably, the NBD/linker, NBD/β-sandwich domain, and NBD/3HBD interfaces as 
found in Sse1p·ATP are highly conserved within canonical Hsp70s, despite limited overall 
sequence similarity between canonical Hsp70s and Hsp110s. Thus, it appears plausible that 
the conformation of Sse1p·ATP might serve as a working model for the ATP state of 
canonical Hsp70s, which is characterized by low-affinity peptide binding. This hypothesis is 
supported by extensive mutational analyses of these interfaces in Sse1p, Ssa1p, and DnaK 
(Liu and Hendrickson, 2007). Moreover, it is in line with the results of hydrogen deuterium 
(HD)-exchange and NMR experiments, which suggest that – as in the Sse1p·ATP structure – 
the inter-domain linker is firmly bound and protected from solvent in the ATP state of Hsp70 
(Rist et al., 2006; Swain et al., 2007). In contrast, the ADP state of Hsp70 appears to be 
characterized by a solvent-exposed and protease-accessible linker and a much looser 
attachment of the individual domains (Buchberger et al., 1995; Rist et al., 2006; Swain et al., 
2007). A recent crystal structure of C-terminally truncated ADP-bound DnaK confirmed the 
notion that Hsp70 NBD and PBD are separated in the ADP state (Figure 5-1B; Chang et al., 
2008). The hydrophobic inter-domain linker was found bound in a substrate-like manner by 
an adjoining DnaK molecule with the 3HBD forming a "lid" over the β-sandwich domain. In 
the structure of the corresponding fragment from rat Hsc70, the PBD was disordered, which is 
in line with the proposed flexibility of the linker segment and loose contact between the 
domains (Chang et al., 2008). 
 
5.2 Structure and function of the Hsp110/Hsp70 chaperone system 
 
In the Sse1p/Hsp70N complex structure, the NBD of Hsp70, which is sufficient for Sse1p 
binding and nucleotide exchange, is embraced by the NBD and the 3HBD of Sse1p. Through 
these contacts, Sse1p stabilizes the nucleotide binding cleft of Hsp70 in an open conformation 
with low affinity for ADP, defining the structural framework for the NEF activity of Sse1p. 
The involvement of both the N-terminal NBD and the C-terminal 3HBD of Sse1p in Hsp70 
NBD binding explains the previous finding that essentially full-length Sse1p is needed for 
nucleotide exchange activity (Shaner et al., 2004; Dragovic et al., 2006a). The importance of 
the interaction between the NBD of Hsp70 and the 3HBD of Sse1p is highlighted by the 
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severe growth defects of yeast cells caused by mutations at this interface and by mutations 
that may disturb the positioning of the lid domain (this study and Liu and Hendrickson, 2007). 
A further prerequisite for efficient complex formation and nucleotide exchange is the 
presence of ATP in the nucleotide binding pocket of Sse1p, which contributes to stabilizing a 
conformation of the NBD in which the two lobes are twisted with respect to each other. Only 
this conformation appears to have the proper shape and functional group pattern for 
stabilizing the open, nucleotide-free state of Hsp70N in the complex. Consistently, this 
nucleotide-exchange active conformation is already preformed in isolated Sse1p·ATP (Figure 
5-1A; Liu and Hendrickson, 2007). Several biochemical studies indicated that ATP binding is 
critical for the compact, active conformation of Sse1p (this study; Raviol et al., 2006a; Shaner 
et al., 2006). Subsequently, Bukau and coworkers showed with HD-exchange experiments 
that Sse1p is likely to undergo a two-step compacting reaction upon ATP binding, leading to 
the active conformation (Andréasson et al., 2008b). Sse1p appears to be in fast equilibrium 
between its nucleotide-free, flexible form (state I) and a nucleotide-bound, stabilized, but 
inactive form (state II). While ATP binding favors the conversion into a fully compacted, 
active conformation (state III), ADP-bound Sse1p predominantly populates state II. This is in 
line with the finding that Sse1p·ADP accelerates nucleotide exchange on Hsp70 much less 
efficiently than Sse1p·ATP (this study and Andréasson et al., 2008b). 
 In principle, Hsp110 proteins could contribute to Hsp70-assisted protein folding through 
different mechanisms, dependent on the nature of their interaction with Hsp70: A transient 
interaction that merely triggers nucleotide exchange would enable the rapid conformational 
cycling of Hsp70 and thus support efficient substrate binding and release for folding. 
Alternatively, the two chaperones could provide a platform for the conformational remodeling 
of substrates. While a model of cooperative folding remains plausible, at least for certain 
substrates, our mutational analysis stresses the significance of the NEF activity of Sse1p. The 
Sse1p mutants with severely reduced NEF activity failed to complement the synthetic 
lethality of the ΔSSE1ΔSSE2 deletion, and did not accelerate luciferase refolding. Mutations 
with a milder NEF impairment still supported normal growth of yeast at 30 ºC but not 37 ºC 
and were only partially functional in refolding in vitro. Importantly, the reduced NEF activity 
of these mutants resulted in induction of the cellular stress response in the respective yeast 
strains already at 30 °C, suggesting a limited substrate flux through the Hsp70 system. This 
finding is in line with an earlier observation that deletion of SSE1 causes a stress response at 
30 ºC, which was confirmed in this study (Liu et al., 1999). Interestingly, the heat shock 
response became manifest only in the increased expression of Ssa3p. In contrast, the 
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expression levels of other stress-inducible chaperones (Hsp12p, Hsp42p, Hsp104p, Ssa1p, and 
Ydj1p) were not upregulated. Similarly, the deletion of SSE1 was reported to have no 
significant effects on the expression of Ssa1/2p, Ssb1/2p, Hsp104p, Sis1p, Sti1p, and Hsp90 
(Fan et al., 2007). A further finding pointing towards nucleotide exchange as the major 
function of Sse1p is that overexpression of Fes1p can rescue a ΔSSE1ΔSSE2 strain at least 
partially (Raviol et al., 2006b; Sadlish et al., 2008). Equivalent results were obtained, when 
the BAG domain of the membrane-anchored yeast BDP Snl1p was overexpressed, whereas 
upregulation of Ssa1p or Ssb1p was insufficient to restore viability, indicating that a potential 
chaperone-like function of Sse1p is secondary to its nucleotide exchange activity (Sadlish et 
al., 2008). Finally, the finding that optimal luciferase refolding occurs only at sub-
stoichiometric concentrations of Sse1p relative to Ssa1p underlines the dynamic character of 
the interaction between Hsp110 and Hsp70 and thus the significance of the NEF activity of 
Sse1p. Consistently, the in vivo concentrations of Sse1p are also much lower than those of 
Ssa1p (Ssa1/2p : Sse1/2p : Ydj1p = 16 : 2 : 3) (Ghaemmaghami et al., 2003). In contrast, high 
concentrations of Sse1p that favor a constitutive complex with Ssa1p inhibit refolding in 
vitro, in agreement with a slow growth phenotype caused by overexpression of Sse1p (Shaner 
et al., 2004).  
The inhibitory effect of high concentrations of Sse1p might be a consequence of 
preventing efficient Hsp70 cycling. Possibly, high Sse1p levels lead to an increased erroneous 
binding of the NEF to canonical Hsp70s in the ATP state. Assuming that the Hsp70·ATP state 
is not strictly defined but rather represents a rapid equilibrium of distinct conformations, the 
recognized Hsp70·ATP conformation could be more Hsp70·ADP- than Sse1p·ATP-like. 
Increased Sse1p binding to substrate-free Hsp70·ATP might hold the chaperone off binding 
unfolded proteins, whereas increased binding to substrate-loaded Hsp70·ATP may delay 
substrate release after completed nucleotide exchange. The notion that Sse1p could recognize 
ATP-bound Hsp70 at least with low affinity is supported by our finding that presence of 
Sse1p slows the release of substrate from the Ssa1p·ATP·D-NR complex. 
 
5.3 Sse1p interaction with unfolded proteins 
 
Sse1p efficiently stabilized thermally denatured luciferase in a folding-competent state, 
demonstrating the ability of Hsp110 to productively interact with unfolded proteins as a 
chaperone. It seems possible that elevated temperature activates this holdase function of 
Sse1p by exposing additional substrate interaction surfaces, as ATP-bound Sse1p undergoes a 
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cooperative conformational transition with a midpoint at ~39 ºC in vitro. Interestingly, in 
contrast to Sse1p, the secondary structure of the mammalian homolog Apg-2 appears 
unaltered under these conditions (Raviol et al., 2006a). It is tempting to speculate that yeast – 
an immotile organism, which is prone to be confronted with elevated temperature – possibly 
adapted to cope with extreme living conditions. While the physiological significance of the 
Sse1p conformational change remains to be experimentally investigated, our analysis of 
Sse1p mutants indicated that parts of Sse1p outside the β-sandwich domain contribute to 
substrate binding under these conditions: Thus, the mutants Sse1-9 (L433A/N434P) and Sse1-
10 (F439L/M441A) designed to block the binding of hydrophobic peptide sequences to the 
putative peptide binding cleft in the β-sandwich domain showed holdase activities comparable 
to wt Sse1p, suggesting that thermally denatured luciferase is bound by a different mechanism 
Figure 5-2: Hypothetical substrate interaction sites on the surface of Sse1p. 
(A) A stereo representation of the surface of Sse1p in complex with Hsp70N is shown. A large surface channel
running along the structure is indicated by arrows. The domain structure is indicated. Disordered side chains
were modeled. 
(B) The surface hydrophobicity of the Sse1p surface is shown. Carbon atoms are colored in magenta, polar
groups in white, negatively and positively charged atoms in red and blue, respectively. 
(C) The surface conservation of Sse1p is shown. The sequence identity from the alignment of Hsp110 sequences
represented in Figure 7-1 was plotted onto the surface of Sse1p. Note the poor conservation of the β-sandwich
domain. 
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to Sse1p. Moreover, the C-terminal fragment of Sse1p, which comprises the PBD of 
canonical Hsp70s, failed to keep thermally denatured luciferase in a folding-competent state. 
It should be noted that Sse1C and Hsp110C were previously reported to work as holdases (Oh 
et al., 1999; Goeckeler et al., 2002). The reason for this discrepancy is unclear. However, in 
contrast to earlier work, we showed that our preparation of Sse1C was structured. The low 
degree of conservation found for the β-sandwich domain of Hsp110 proteins – in comparison 
to the highly conserved PBD of canonical Hsp70s – would be surprising in light of the β-
sandwich domain being the exclusive substrate binding site of Hsp110s (Figure 5-2C). In fact, 
the β-sandwich domain of Hsp110 proteins might not contain a typical Hsp70-like peptide 
binding region, considering that no obvious peptide binding cleft could be identified in the 
crystal structures of Sse1p·ATP (this study and Liu and Hendrickson, 2007).  
On the other hand, indirect evidence for a role of the β-sandwich domain in interacting 
with substrate was provided by the finding that mutations in this region aggravated the 
functional defect of partially NEF-deficient Sse1p mutants in vitro and in vivo. Moreover, the 
fully nucleotide exchange-active mutant Sse1-Δloop, which also affects the β-sandwich 
domain, displayed only partial refolding activity. A negative effect on luciferase refolding had 
previously been reported for a similar construct of mammalian Hsp110 (Oh et al., 1999). 
Thus, it is likely that the β-sandwich domain contributes to the binding of unfolded substrate 
proteins, however, by a mechanism distinct from the proposed model. 
With the exception of the Hsp70 interface, surface residues are not well conserved 
among Hsp110 family members (Figure 5-2C), but we note that the Sse1p structure provides 
a groove-like indention running between domain protrusions that could possibly 
accommodate exposed α-helices or β-hairpins in partially unfolded substrates (Figure 5-2A). 
Preliminary binding studies suggest that Sse1p/substrate interactions are dynamic and do not 
result in stable complex formation (data not shown). 
 
5.4 Does Sse1p function require conformational cycling? 
 
In the case of canonical Hsp70s, ATP binding and hydrolysis drive well-defined 
conformational transitions (Rist et al., 2006; Swain et al., 2007). Since Sse1p has been 
reported to have an intrinsic ATPase activity similar to canonical Hsp70 proteins, which can 
be stimulated by the essential Hsp40 cochaperone Sis1p (Raviol et al., 2006a), Sse1p might 
undergo Hsp70-like, nucleotide-dependent conformational rearrangements. Moreover, the 
ATPase activities of the Hsp110 homologs Lhs1p and mouse Hsp105α were reported to be 
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stimulated in complex with their cognate Hsp70 partners, Kar2p and Hsc70, respectively 
(Steel et al., 2004; Yamagishi et al., 2004), opening interesting possibilities for the functional 
cooperation of the two proteins. However, in strong contrast, the nucleotide binding pocket of 
Sse1p in complex with Hsp70N has been found occupied with intact ATP, indicating that at 
least under the employed crystallization conditions and in absence of the Hsp70 PBD Sse1p-
bound ATP is not hydrolyzed. The crystallized ATP state of Sse1p might reflect the 
conformation of the ATP-complexed Hsp70 NBD at a precatalytic stage. Moreover, we and 
others could show that mutations predicted to abolish ATPase activity and conformational 
cycling did not impair Sse1p function in vitro and in vivo (this study; Shaner et al., 2004; 
Raviol et al., 2006b; Shaner et al., 2008). Specifically, we analyzed an Sse1p linker point 
mutant D396A (Sse1-6) corresponding to DnaK mutant D393A, which is known to have 
severe defects in domain-domain communication (Vogel et al., 2006b). However, Sse1-6 
behaved wt-like in all functional assays. Similarly, the ATPase inactive Sse1p mutant K69M 
was fully active in luciferase refolding and supported yeast growth like the wt protein (this 
study; Raviol et al., 2006a; Raviol et al., 2006b). The occurrence of Leu or Gln residues at the 
corresponding position in several ER homologs of Hsp110 suggests that these proteins are 
naturally ATPase-deficient. ATP hydrolysis and associated allosteric rearrangements thus 
seem dispensable for Sse1p function. This implicates that – in contrast to what was suggested 
by Morano and colleagues (Shaner et al., 2006) – Hsp110 dissociation from Hsp70 does not 
depend on ATP hydrolysis by Sse1p either (see also Andréasson et al., 2008b). Nevertheless, 
the conformational state of Sse1p is strongly dependent on its nucleotide state (this study; 
Raviol et al., 2006a; Shaner et al., 2006; Andréasson et al., 2008b). 
 
5.5 Model for cooperative protein folding by Hsp110 and Hsp70 
chaperones 
 
In the accepted model of the Hsp70 reaction cycle, unfolded proteins are recognized and 
recruited to Hsp70 with the help of J-proteins (Hsp40s). As anchor point, J-proteins appear to 
employ a binding site on Hsp70 distinct from that of Hsp110s ( A). Both, substrate 
and J-domain binding are known to trigger ATP hydrolysis on Hsp70 (Mayer and Bukau, 
2005). As a consequence, Hsp70 undergoes a dramatic structural rearrangement leading to a 
conformation in which the PBD adopts a closed state that binds substrate tightly ( B, 
step 1). Subsequent association of Hsp110 with Hsp70 induces ADP release from Hsp70 (step 
2). Upon binding to Hsp70, Hsp110 might interact with the unfolded substrate protein 
directly, provided it is of sufficient size and exposes structural elements that are recognized by 
Figure 5-3
Figure 5-3
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Hsp110. Simultaneous association of substrate protein with both chaperones might further 
promote Hsp70/Hsp110 complex formation. In the ternary complex, the folding of larger 
multi-domain proteins with a propensity to undergo intramolecular misfolding may be 
Figure 5-3: Model for cooperative protein folding by Hsp110 and Hsp70 chaperones. 
(A) A superposition of the Sse1p/Hsp70N complex and the crystal structure of the auxilin J-domain cross-linked
to the NBD/linker construct of Hsc70·ADP-Pi is shown (PDB code 2QWO (Jiang et al., 2007)). For aligning the
structures, only the NBD of Hsp70 was considered. The orientation of the molecules corresponds to the side
view of the Sse1p/Hsp70N complex shown in Figure 4-7. Both structures are represented as Cα traces. Sse1p and
Hsp70N are colored following the scheme introduced in Figure 4-7; Sse1p-bound ATP is depicted as green
sticks. Hsc70N is colored gray and the J-domain light blue. Residues implicated in DnaJ binding by the bacterial
Hsp70, DnaK, are shown in space-filling mode (Suh et al., 1998). 
(B) A schematic model for the cooperation of Hsp110 and Hsp70 chaperones in protein folding is depicted.
Hsp70 and Hsp110 are indicated in red and dark blue, respectively. Recruitment of Hsp70 to unfolded substrate
protein (green) as well as Hsp70 ATP hydrolysis are assisted by J-domain proteins (Hsp40, orange; step 1).
Complex formation between Hsp70 and Hsp110 displaces ADP from the Hsp70 partner (step 2). Direct substrate
binding to Hsp110 may provide an anchor aiding the unfolding of kinetically trapped intermediates through
thermal motions of the substrate binding domain of Hsp70. Finally, upon binding of ATP to Hsp70, the
Hsp70/Hsp110 complex dissociates and the substrate protein is released for folding (step 3). The green circle
indicates natively folded substrate protein. 
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facilitated. Large-scale thermal motions of the Hsp70 PBD, which is linked loosely to the 
NBD in the ADP-bound and presumably also in the nucleotide-free state (Rist et al., 2006; 
Swain et al., 2007; Chang et al., 2008), might aid the remodeling of misfolded or kinetically-
trapped substrates held by Hsp110. Finally, ATP would rebind to Hsp70. Sousa and 
colleagues suggested in an independent structural study on the Hsp110/Hsp70 complex that 
ATP might enter through an electropositive pore connecting the nucleotide binding sites of 
both Hsp70 and Hsp110 with the solvent (Schuermann et al., 2008). ATP binding would 
promote extensive structural rearrangements within Hsp70, including the closure of the NBD 
around the nucleotide. The closed conformation of the NBD appears incompatible with 
Hsp110 binding, since Hsp70 and Hsp110 subdomains IIb would clash (this study; 
Andréasson et al., 2008b; Schuermann et al., 2008). Thus, the Hsp70·ATP/substrate complex 
would dissociate from Hsp110 and the substrate would be released from Hsp70 for folding 
(Figure 5-3B, step 3). The substrate protein would either reach its native structure or – if still 
only partially folded – rebind to Hsp70 for a new folding cycle (step 1).  
 
5.6 Evolution of Hsp70 NEFs 
 
Whereas prokaryotes and eukaryotes possess Hsp70 and Hsp40 proteins, which have clearly 
common ancestry, their NEF families are evolutionary unrelated. Thus, GrpE homologs have 
only been identified in bacteria and organelles of bacterial origin. Conversely, Hsp110 
homologs, BDPs, and HspBP1 homologs have exclusively been found in eukaryotes. This 
observation could be explained with the absence of Hsp70 NEFs in the last common ancestor 
of bacteria and eukaryotes. Alternatively, bacteria might have evolved the DnaK system only 
after divergence of the bacterial and the archaeal/eukaryotic branches. Archaea and 
eukaryotes would have acquired Hsp70 and Hsp40 later through horizontal gene transfer from 
bacteria. The latter hypothesis is consistent with the absence of Hsp70-homologous genes in 
most archaeal genomes, which is difficult to reconcile with the Hsp70/Hsp40 system being 
already present in the last common ancestor of all three kingdoms of life. Furthermore, the 
genes for DnaK and DnaJ are frequently encoded as one operon in prokaryotic genomes and 
are thus likely to be transferred simultaneously.  
Sequence homology of Hsp110 and Hsp70 homologs suggests that Hsp110 proteins 
presumably derive from canonical Hsp70s. In this context, it is tempting to speculate that 
primordial Hsp70 proteins were mutually able to catalyze nucleotide exchange in an 
intermolecular reaction: ATP-bound Hsp70 proteins may have been able to accelerate ADP 
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dissociation from peptide-charged Hsp70 molecules, using an Hsp110-like nucleotide 
exchange mechanism. Homodimer formation might have enabled tight coordination between 
Hsp70 molecules during collaborative folding of larger, possibly multi-domain protein 
substrates. Specifically, a peptide-charged Hsp70 molecule might have recruited an ATP-
bound Hsp70 molecule, sensing its nucleotide-dependent conformation. While nucleotide 
exchange would have resulted in substrate dissociation from the same Hsp70 molecule, 
unmasked hydrophobic peptide segments could have efficiently been rebound by the adjacent 
accessible peptide binding cleft of the second Hsp70 molecule. Thus, two Hsp70 molecules 
would have been coupled in the hypothetical homodimeric Hsp70 complex similar to a two-
stroke engine. Intriguingly, most key residues mediating the interactions between Sse1p and 
Hsp70 are conserved among sequences of canonical Hsp70s. However, using our MABA-
ADP dissociation assay, we were not able to find evidence for an NEF function of canonical 
Hsp70s (data not shown). Possibly, present canonical Hsp70s have lost this function after the 
emergence of specialized NEFs and the concomitant relief of evolutionary restraints. 
Hsp110/Grp170 family proteins appear to have specialized for their nucleotide exchange 
function: The systematic substitution of the 3HBD residue 554 from Ala in canonical Hsp70s 
to Glu in Hsp110s appears to reinforce the interaction between the 3HBD and the NBD, 
which is crucial for nucleotide exchange. Glu554 forms a salt bridge to Arg47 of the NBD. 
Furthermore, residues implicated in ATP hydrolysis and conformational cycling in canonical 
Hsp70s – both features which are dispensable for Hsp110 function – are less conserved in 
Hsp110 sequences. Moreover, residues which might promote unproductive homodimeric 
association (e.g. Ala300, human Hsp70 numbering) differ from canonical Hsp70 sequences.  
Both the BAG domain of BDPs and HspBP1/Fes1p homologs have generic folds, 
namely a three helix bundle and a succession of Armadillo repeats. These structural scaffolds 
are employed in many different functional contexts in eukaryotes, indicating their great 
adaptability for distinct protein-protein interactions. 
 
5.7 Diversity of NEFs in eukaryotes 
 
In Figure 5-4, the crystal structures and Hsp70 nucleotide exchange mechanisms of 
representatives of the distinct NEF families are compared. Despite different binding modes, 
most NEF families (GrpE, BDPs and Hsp110 homologs) appear to use similar nucleotide 
release mechanisms. Specifically, they stabilize the Hsp70 NBD in an open conformation by 
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Figure 5-4: Comparison of the NEFs of Hsp70. 
For better comparison, the Hsp70 NBDs of the different NEF/Hsp70 complexes (this study; Harrison et al.,
1997; Shomura et al., 2005; Sondermann et al., 2001; Xu et al., 2008) were superposed on the NDB of bovine
Hsc70 in the ADP state (Flaherty et al., 1994). In the ribbon representations of the NEFs on the left, the N- and
C-termini are labeled. In the complex structures, the NEFs are shown in surface representation. The Hsp70
molecules are colored as in Figure 2-5; the second Hsp70 molecule in the BAG-2/Hsc70N complex is colored in
gray tones. Please note that the left end of BAG-1 points towards the reader, while it is oriented to the back in
BAG-2. In the right column, the structural transitions of the Hsp70 NBD upon complex formation with the
respective NEF in comparison to the ADP-bound conformation of the Hsc70 NBD are shown.  
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tilting subdomain IIb. HspBP1 homologs however seem to utilize a different technique to 
exchange nucleotide on Hsp70: They might stabilize an outward rotation of subdomain IIb as 
well, but mainly seem to induce local unfolding in Hsp70 lobe I (Shomura et al., 2005; 
Andréasson et al., 2008a).  
The recently published crystal structure of the BAG-2/Hsc70 complex revealed that 
BAG-2 applies a nucleotide exchange mechanism similar to the ones of GrpE, BAG-1, and 
Sse1p, although being characterized by a "new" Hsp70 binding mode (Xu et al., 2008): The 
NEF domain of BAG-2 forms a dimer, with each monomer contacting an Hsc70 NBD by 
binding to sudomains Ib and IIb in an end-on fashion (Figure 5-4), resulting in an opening of 
subdomain IIb. In contrast, the BAG domain of BAG-1 binds along the cleft between 
sudomains Ib and IIb. In addition to its nucleotide exchange function, the NEF domain of 
BAG-2 is able to interact with unfolded substrate proteins, its binding preferences being 
similar to those of Hsc70. Since the substrate and Hsc70 binding sites on the catalytic domain 
of BAG-2 overlap, BAG-2 might coordinately transfer substrate peptides to the PBD of 
Hsc70 (Arndt et al., 2005; Xu et al., 2008). Alternatively, the substrate binding activity of 
BAG-2 might be used to recruit the NEF to Hsp70/client complexes.  
Why do eukaryotic cells have such a plethora of Hsp70 NEFs? Does the large number 
of NEFs ensure the robustness of the Hsp70 system, the central cellular chaperone machine, 
by sheer multiplicity? Or have the different NEFs adapted to specific targets during the 
evolution of eukaryotic cells?  
The first hypothesis is supported by the redundancy of many NEFs. Thus, 
overexpression of Fes1p or Snl1ΔN can rescue a ΔSSE1ΔSSE2 strain (Raviol et al., 2006b; 
Sadlish et al., 2008). While Fes1p is the HspBP1 homolog, Snl1ΔN represents the catalytic 
domain of the unique, membrane-anchored BDP in S. cerevisiae. Furthermore, 
overexpression of Fes1p was shown to reverse the morphology defects of ΔSSE1ΔSWI6 cells 
similarly well as overexpression of Sse1p (Shaner et al., 2008). The proteins Swi6p and 
Swi4p form a heterodimeric transcription factor. Moreover, overexpression of the ER 
HspBP1 homolog Sil1p is sufficient to suppress the growth defect of a ΔIRE1ΔLHS1 yeast 
strain, with Lhs1p being the yeast ER Hsp110 homolog and Ire1p a transmembrane 
kinase/nuclease, which is essential for the transduction of the UPR (unfolded protein 
response) (Tyson and Stirling, 2000). 
However, the redundancy of the different NEFs is only partial, indicating a 
specialization of the different NEFs, which is claimed in the second hypothesis. Especially the 
BDPs do not seem to be general regulators of productive protein folding by the Hsp70 
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machinery, but appear to assist specific Hsp70 functions (Takayama and Reed, 2001; Alberti 
et al., 2003; Kabbage and Dickman, 2008). This notion is based on their modular domain 
architecture. Apart from the BAG domain, which is a common feature of all BDPs, the 
domain composition is unique for each BDP and allows individual family members to interact 
with distinct target proteins. Thus, BDPs are likely to recruit Hsp70 chaperones to specific 
substrates or cellular localizations. In this scenario, the local concentrations of the individual 
BDPs, which are thought to be expressed at low cellular levels, might suffice for efficient 
promotion of Hsp70-mediated substrate folding (Tzankov et al., 2008). Interestingly, even the 
BAG domain seems to have diversified in BDPs. Thus, as mentioned above, the BAG domain 
of BAG-2 can directly bind misfolded proteins and prevent their aggregation in contrast to the 
BAG domains of other BDPs (Arndt et al., 2005; Xu et al., 2008). Consequently, BAG-2 and 
Hsp70 may cooperate in chaperoning select Hsp70 clients. Furthermore, the three helix 
bundle in BAG-4 is considerably shorter than in BAG-1 (Brockmann et al., 2004).  
In contrast to BDPs, GrpE as well as both HspBP1 and Hsp110 homologs appear to 
serve as general NEFs. However, the functions of HspBP1 and Hsp110 homologs still seem to 
be only partially overlapping: First, overexpression of Fes1p cannot support the growth of a 
ΔSSE1ΔSSE2 yeast strain as effectively as expression of Sse1p. Furthermore, deletion of the 
ER Hsp110 homolog Grp170 is lethal in mice, indicating that its function cannot be replaced 
by the ER-lumenal HspBP1 homolog Sil1. Conversely, mutations in SIL1 appear not to be 
generally compensated by Grp170, because mutations disrupting Sil1 function result in the 
Marinesco-Sjögren syndrome (a rare autosomal recessive neurodegenerative disorder) in 
humans and an ataxia phenotype in mice, which is characterized by abnormal accumulation of 
ubiquitinated proteins in the ER and nucleus of cerebellar Purkinje cells (Anttonen et al., 
2005; Senderek et al., 2005; Zhao et al., 2005a). Strikingly, although SIL1 is widely 
expressed in the brain, protein aggregation and subsequent degeneration was only observed 
for Purkinje cells in certain lobules of the brain (Zhao et al., 2005a). Presumably, Grp170 
compensates loss of Sil1 function in the unaffected regions.  
The partial functional redundancy of HspBP1 and Hsp110 homologs might have several 
reasons, which will be discussed in the following three paragraphs. According to our MABA-
ADP release assay, human Hsp110 and yeast Sse1p appear to be much more efficient NEFs 
than human HspBP1 and yeast Fes1p, at least in vitro (this study; Shomura et al., 2005; 
Dragovic et al., 2006a). Moreover, Hsp110 and Sse1p were shown to enhance Hsp70/Hsp40-
mediated refolding of firefly luciferase in vitro, while HspBP1 inhibited the Hsp70 refolding 
function (this study and Tzankov et al., 2008). Consistent with an inhibitor function of 
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HspBP1, overexpression of this NEF was reported to block the anti-apoptotic function of 
Hsp70, which is upregulated in a wide variety of tumor cells (Tanimura et al., 2007). On the 
other hand, the yeast HspBP1 homolog Fes1p was shown to be necessary for efficient Hsp70-
mediated luciferase folding in vivo, at least under heat stress conditions (Shomura et al., 2005; 
Raviol et al., 2006b). Fes1p and HspBP1 might thus have diverged in substrate specifity, or 
the in vitro folding reaction with HspBP1 may miss crucial components such as holdases, 
which keep non-native proteins in solution. Built-in holdase activity might make Hsp110s 
more autonomous than HspBP1 homologs and consequently much better suited for minimal 
folding reactions.   
A further difference between HspBP1 and Hsp110 homologs might be adaptation of the 
Hsp70/NEF complexes to different substrate pools. For example, Hsp110s might recognize 
specific substrates with their β-sandwich domain and assist Hsp70 in remodeling of the client 
protein. Moreover, individual substrates might require unique Hsp70 interaction intervals for 
efficient folding, which might possibly be governed by different average life times of the 
Hsp70/NEF/substrate complexes.  
Another reason for the limited redundancy of HspBP1 and Hsp110 homologs might be 
their specialization for interaction with specific Hsp70 chaperones and cochaperones. Thus, 
HspBP1 was shown to bind Hsp70 in cells with much higher affinity than the constitutively 
expressed Hsc70 (Tanimura et al., 2007). Similarly, other Hsp70 cochaperones might be able 
to discern complexes of Hsp70 with HspBP1 and Hsp110 proteins, perhaps by recognizing 
the distinct Hsp70 NBD conformations. For example, the J-domain containing factor RAC 
was shown to compete with Fes1p for the binding to the ribosome-associated yeast Hsp70 
homolog (Dragovic et al., 2006b), while Hsp110 binding should not interfere with the binding 
of a J-domain (Figure 5-3A, this study and Jiang et al., 2007). Furthermore, yeast Hsp90 was 
frequently found associated with Sse1p but not Fes1p in substrate complexes. Assuming that 
the Hsp90 interaction occurs indirectly via Hsp70, the conformation of the NBD might form 
the basis for this distinction (Zhao et al., 2005b).  
The large variety of eukaryotic NEFs illustrates impressively the complexity of the 
eukaryotic Hsp70 machinery. Hsp110 homologs appear to be the most important cellular 
NEFs and are likely to assist the general Hsp70 chaperoning function. The additional 
eukaryotic NEFs might confer robustness to the Hsp70 system and enable specialized 
functions of Hsp70. 
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7 APPENDICES 
 
7.1 List of primers 
 
Table 7-1: Primers utilized for sequencing.  
The constructs sequenced with the help of the shown primers are listed in the last column. 
Primer Sequence (5'→3') 
Sequenced 
constructs 
pProEx for GAGCGGATAACAATTTCACACAGG pProEx constructs 
pProEx rev CTGTTTTATCAGACCGCTTCTGCG pProEx constructs 
Sse1_100 rev CCAAAACCAACAACAGATGGGGTGGAACG sse1 constructs 
Sse1-750 GAACATTTCGCCGATGAGTTC sse1 constructs 
Sse1-1500 AAGAACCTATTCCATTACCAG sse1 constructs 
SP1001 CCTGTAAGGATTGTCAACGATGTGACTGCAGC SSE2 construct 
Sse2_Dloop2rev CGCGGATCCGGCCGTTGTGTAAGCGTTCTCGATAATATGCAAGC SSE2 construct 
 
 
Table 7-2: Primers utilized for cloning of the sse1-Δloop construct.  
While the N-terminal part of the Sse1-Δloop construct was amplified with the help of primers Ehe1_SSE1ORF 
and Sse1_BamHIrev, the C-terminal part was amplified with the help of primers Sse1_BamHIfor and 
SSE1ORF_Xho1. The introduced BamHI restricition site was used for the ligation of the two fragments. In Sse1-
Δloop, aminoacid residues 503-524 are replaced by the peptide linker AGSD. Nucleotides that code for the 
tetrapeptide are highlighted in red. The endonuclease restriction sites are underlined, and the respective 
endonucleases are listed in the last column. 5'-phosphorylation of the Ehe1_SSE1ORF primer is indicated by Ê.       
 Primer Sequence (5'→3') Endo-nuclease 
Ehe1_SSE1ORF Ê-GCCATGAGTACTCCATTTGGTTTAGATTTAGGTAACAATAACTCT EheI 
SSE1ORF_Xho1 GCATCTCGAGTTAGTCCATGTCAACATCACCTTCAGTGTCCTTC XhoI 
Sse1_BamHIfor CGCGGATCCGACACTAAAACTGTAAAGAAGGATGACTTAACCATCG BamHI 
Sse1_BamHIrev CGCGGATCCGGCTTCAATATCTTCAATAGTGTAAGCCTCTTCAATTGTG BamHI 
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Table 7-3: Primers utilized for site-directed mutagenesis on SSE1. 
Point mutants of SSE1 were produced via a PCR-based mutagenesis strategy, which relies on the amplification 
of the full-length plasmid using blunt end primers that contain the required nucleotide alterations (Weiner et al., 
1994). Nucleotides that diverge from the wt SSE1 DNA sequence were always introduced in the forward (fw) 
primer and are shown in red. The corresponding amino acid exchanges are indicated in the primer names and 
highlighted in red. The respective Sse1p variant names are listed in the last column. 5'-phosphorylation of 
reverse (rev) primers is indicated by Ê.  
Primer Sequence (5'→3') Sse1p  variant 
E_K69Mfw ACTGTCGCCAACTTGATGAGAATTATTGGTTTGGATTACC 
Sse1-1 
E_K69MrevP Ê-GTTCTTGATGTTGGAAGTCTGCTTGTTCTTACC 
E_N572YE575Afw ACAGAAGACCGTAAGTACACTCTTGCAGAGTACATCTACACATTGCG 
Sse1-2 
E_N572YE575ArevP Ê-TCAGCAACTAGCTTATCTTGAGCAAGCATTTCATTTTC 
E_A280TN281Afw AAGAAAGTTTTGTCTACTGCTACTAATGCCCCATTCTCTGTTG 
Sse1-3 
E_A280TN281ArevP Ê-CAACTTTTCAGCAGCAGTTAGAATTCTGTTGTAAGC 
E_T365VN367Sfw CCATTGTCCACCGTTTTGAGCCAAGATGAAGCCATCG 
Sse1-4 
E_T365VN367SrevP Ê-CTTGCCGAAGGCTTCAGAAATGGATTGTTTCAATG 
E_F392AF394Afw CTAAGAGTTAGACCAGCCAAGGCTGAGGATATCCATCCTTAC 
Sse1-5 
E_F392AF394ArevP Ê-AGTTGGAGAGTGAATGGCGCAAATAAAGGCG 
E_D396Afw CCATTCAAGTTTGAGGCTATCCATCCTTACTCTGTC 
Sse1-6 
E_D396ArevP Ê-TCTAACTCTTAGAGTTGGAGAGTGAATGGCGC 
E_L489AH490Afw TGCGACCCCTCTGGTGCAGCCACAATTGAAGAGGC 
Sse1-7 
E_L489AH490ArevP Ê-TCTCAACTTTAACTTAACAGGAACAGAGTCTTGACC 
E_E554AM557SL558Sfw GAAAAAGCAAATGAAAGCAGTGCTCAAGATAAGCTAGTTGCTGAGACAGAAGACCG 
Sse1-8 
E_E554AM557SL558SrevP Ê-ATTAATTCATTCAACTTTTTAGCGTCTAGGCCAAAGGTGTGTGC 
E_L433AN434Pfw CTACTAAATTGATCACTGCGCCCCGTACGGGTGACTTTTC 
Sse1-9 
E_L433AN434PrevP Ê-ATGGGAAGGATGAACCAGCTGGGAAAACTTC 
E_F439LM441Afw GTACGGGTGACTTGTCAGCGGCTGCTAGCTACACTG 
Sse1-10 
E_F439LM441ArevP Ê-TTCAAAGTGATCAATTTAGTAGATGGGAAGGATGAACC 
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Table 7-4: Primers utilized for cloning of the ssa1N construct (amino acid residues 1-378).  
The endonuclease restriction sites are underlined, and the respective endonucleases are listed in the last column. 
The introduced stop codon is highlighted in blue.   
Primer Sequence (5'→3') 
Endo-
nuclease
Ssa1N_BamHIfor CGCGGATCCAAAGCTGTCGGTATTGATTTAGGTACAACATAC BamHI 
AB11r CCGCTCGAGTCAAGTCAAAATAGCAGCTTGAACAGCAGC XhoI 
 
 
 
 
 
 
Table 7-5: Primers utilized for site-directed mutagenesis on SSA1 and ssa1N. 
Nucleotides that diverge from the wt SSA1 DNA sequence are shown in red. The corresponding amino acid 
exchanges are indicated in the primer names and highlighted in red. The respective Ssa1p variant names are 
listed in the last column. 5'-phosphorylation of reverse (rev) primers is indicated by Ê.  
Primer Sequence (5'→3') Ssa1p variant 
A_Q31Afw ATTATTGCCAACGATGCAGGTAACAGAACCACTCC Ssa1(Q31A) and Ssa1N(Q31A)   
A_Q31ArevP Ê-GTCCACACGATCATTAGCAAAGTGAGCAAC Ssa1(Q31A) and Ssa1N(Q31A) 
A_A300Efw ACTTCCATCACCAGAGAAAGATTCGAAGAATTGTGTGC Ssa1(A300E) and Ssa1N(A300E) 
A_A300ErevP Ê-GTAGAAATCGATACCTTCGAACAAAGAGTCAATTTC Ssa1(A300E) and Ssa1N(A300E) 
 
 
 
 
 
 
 
Table 7-6: Primers utilized for cloning of the SSE2 construct.  
The endonuclease restriction sites are underlined, and the respective endonucleases are listed in the last column. 
5'-phosphorylation of the EheISse2ORF primer is indicated by Ê. 
Primer Sequence (5'→3') Endo-nuclease
EheISse2ORF Ê-GCCATGAGCACTCCATTTGGCTTAGATTTAGGTAACAATAACTCA EheI 
Sse2ORFXhoI GCATCTCGAGTTAATCAAGGTCCATGTTTTCATCATTGTTGTCA XhoI 
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7.2 Amino acid sequence alignment of selected Hsp110 and Hsp70 
homologs  
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Figure 7-1: Amino acid sequence alignment of selected Hsp110 and Hsp70 homologs. 
Amino acid sequences of selected Hsp110, eukaryotic Hsp70 and bacterial DnaK homologs (groups 1, 2 and 3, 
respectively) were aligned using the MultAlin server. Residues indicated in red are invariable, and residues 
indicated in blue are conserved in more than 50 % of the sequences. Residues which are conserved in Hsp110 
homologs but dissimilar in canonical Hsp70s are boxed in red. A consensus sequence using the standard symbols 
of the MultAlin analysis program (Corpet, 1988) is given in the bottom row of the alignment. The secondary 
structure elements and the residue numbering for Sse1p are indicated above the sequences. The colors of the 
secondary structure elements reflect the domain structure; the same colors as in Figure 4-7 of the main text are 
used. Contact residues are indicated below the consensus sequence. Residues in contact with ATP are labeled by 
green asterisks. Horizontal arrowheads indicate residues involved in domain-domain interactions in Sse1p.  
Vertical arrowheads indicate contact residues in the Sse1p/Hsp70N complex (downward pointing arrowheads 
indicate residues in Sse1p, upward pointing arrowheads residues in Hsp70N). The arrowhead color indicates the 
domain in contact. SwissProt accession numbers of the sequences shown are as follows: Saccharomyces 
cerevisiae Sse1p (P32589), Neurospora crassa Hsp88 (O74225), Schizosaccharomyces pombe Pss1 (O59838), 
Dictyostelium discoideum Hsp88 (Q6TMK3), Arabidopsis thaliana Hsp110 (Q9SAB1), Caenorhabditis elegans 
Hsp110 (Q05036), Drosophila melanogaster Hsp110 (Q9XZT5), Xenopus laevis Hsp110 (Q1PAH4), Homo 
sapiens Hsp110 (Q92598), Saccharomyces cerevisiae Ssa1p (P10591), Saccharomyces cerevisiae Ssb1p 
(P11484), Neurospora crassa Hsp70 (Q01233), Schizosaccharomyces pombe Ssa1 (Q10265), Dictyostelium 
discoideum Hsp70 (Q55C64), Arabidopsis thaliana Hsc70.1 (P22953), Caenorhabditis elegans Hsp70A 
(P09446), Drosophila melanogaster Hsp70 (P82910), Xenopus laevis Hsp70 (A1L3K5), Homo sapiens Hsp70.1 
(P08107), Escherichia coli DnaK (P0A6Z0), Clostridium tetani DnaK (Q892R0), Thermus thermophilus DnaK 
(Q72IK5), and Deinococcus radiodurans DnaK (Q9RY23). 
 
 
   
7.3 List of abbreviations 
 
Units are expressed according to the international system of units (SI). For the amino acids, 
one and three letter codes were used. 
 
A   amplitude 
AA    acrylamide 
AAA   ATPases associated with various cellular activities 
ADA   N-(carbamoylmethyl)iminodiacetic acid 
ADP    adenosine 5'-diphosphate 
Amp    ampicillin 
AMP   adenosine 5'-monophosphate 
AMP-PNP  adenylyl imidodiphosphate 
Apg   A: ATP binding domain, p: peptide binding domain, g: germ cell derived 
apoB   apolipoprotein B 
APS    ammonium peroxodisulfate 
ATP    adenosine 5'-triphosphate 
BAG   Bcl2-associated athanogene 
BAP    BiP-associated protein 
BDP   BAG domain protein 
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BiP   binding immunoglobin protein 
bp    base pairs 
BSA    bovine serum albumin 
c   concentration 
CCD   charge coupled device 
CD   circular dichroism 
CD   C-terminal domain 
CFTR  cystic fibrosis transmembrane conductance regulator 
CHIP   C-terminus of heat shock cognate 70 stress protein-interacting protein 
CHO   chinese hamster ovary 
CLIP   chaperones linked in protein synthesis 
Clp   caseinolytic protease 
Cm   chloramphenicol 
CTD   carboxy terminal domain 
CV   column volume 
DEAE  diethylaminoethyl   
∆ (delta)   deletion 
DMF   dimethylformamide 
DNA   deoxyribonucleic acid 
DnaJ   bacterial Hsp40 chaperone 
DnaK   bacterial Hsp70 chaperone 
D-NR  dansyl-NRLLLTGC 
dNTPs  deoxyribonucleotides 
DTT    dithiothreitol 
ECL   enhanced chemiluminescence 
E. coli   Escherichia coli 
EDTA   ethylenediaminetetraacetic acid 
ER   endoplasmic reticulum 
ESRF  European Synchrotron Radiation Facility 
Fes1p  factor exchange for Ssa1p 
FFF-MALS field flow fractionation - multiangle light scattering 
FFT   fast fourier transformation 
5-FOA  5-fluoroorotic acid 
GdnHCl   guanidinium hydrochloride 
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GroEL   large growthE gene product  
GroES   small growthE gene product 
Grp   glucose-regulated protein 
GrpE   Growth P-like gene E 
3HBD  three helix bundle domain 
HD   hydrogen deuterium 
Hdj   human DnaJ-like protein  
HEPES   N-(2-hydroxyethyl)piperazin-N'-2-ethanesulfonic acid 
HIP   Hsp70 interacting protein 
His6    histidine tag 
HOP   Hsp organizing protein 
HRP    horseradish peroxidase 
Hsc    heat shock cognate protein 
HSF   heat shock factor    
Hsp    heat shock protein 
HspBP1  Hsp70 binding protein 1 
IPTG   isopropyl-β-D-1-thiogalactopyranoside 
Ire1p   high inositol-requiring protein 1 
k   rate 
KAc   potassium acetate 
Kar2p  karyogamy 2 protein 
KD   dissociation constant 
kDa    kilodalton 
LB    Luria Bertani 
LDL   low density lipoprotein 
Lhs1p  lumenal hsp seventy protein 1 
LiAc   lithiumacetate 
MABA-ADP N8-(4N′-methylanthraniloylaminobutyl)-8 aminoadenosine 5′-diphosphate 
MAD  multiple wavelength anomalous diffraction 
MD   middle domain 
MES   2-morpholinoethanesulfonic acid 
MOPS   3-(N-morpholino)propanesulfonic acid 
MPP11  M-phase phosphoprotein 11 
MS    mass spectrometry 
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MW    molecular weight 
MWCO   molecular weight cut off 
n   refractive index 
NAC   nascent chain-associated complex 
NBD   nucleotide binding domain 
ND    N-terminal domain 
NEF   nucleotide exchange factor 
NLS  nuclear localization signal 
NMR  nuclear magnetic resonance 
OAc    acetate 
OD    optical density 
ONPG  o-nitrophenyl-β-D-galactopyranoside 
Orp   oxygen-regulated protein 
PAGE   polyacrylamide gel electrophoresis 
PBD   peptide binding domain 
PCR    polymerase chain reaction 
PDB   protein data bank 
PEG    polyethylene glycol 
PFD   prefoldin 
Pfu    Pyrococcus furiosus 
PGK   phosphoglycerate kinase 
PMSF   phenyl-methyl-sulfonyl fluoride 
RAC    ribosome-associated complex 
Raf-1   rapidly growing fibrosarcoma kinase 1 
r.m.s.d.  root mean square deviation 
RNA   ribonucleic acid 
ROI   region of interest 
rpm    revolutions per minute 
RT    room temperature 
Sba1   sensitive to benzoquinoid ansamycins protein 1 
SC   synthetic complete 
S. cerevisiae Saccharomyces cerevisiae 
SD   standard deviation 
SDS    sodium dodecylsulfate 
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SeMet   selenomethionine 
sHsp   small heat shock protein 
Sil1p   suppressor of the ΔIRE1ΔLHS1 double mutant number 1 
Sis1p   sit4 suppressor number 1 
SLS    Swiss Synchrotron Light Source 
Sls1p   synthetic lethal mutation with the 7S RNA mutation protein 1 
Snl1p   suppressor of nucleoporin 116-C lethal number 1 
SODD   silencer of death domains 
Ss   Stress seventy 
Sti1p   stress inducible protein 1 
Swi   switching 
Taq   Thermus aquaticus 
TCA    trichloroacetic acid 
TEMED   N,N,N',N'-tetramethylethylenediamine 
TEV    tobacco etch virus 
TF    trigger factor 
Tgo   Thermococcus gorgonarius 
TLS   translation libration screw 
TNFR1  tumor necrosis factor receptor 1 
TOM   translocase of the outer mitochondrial membrane 
TPR    tetratricopeptide repeat  
TRiC   tailless complex peptide 1 (TCP1) ring complex  
Tris    trishydroxymethylaminomethan 
UPR   unfolded protein response 
URA3  orotine-5'-monophosphate decarboxylase 
UV   ultraviolet 
v/v    volume per volume 
wt   wildtype 
w/v    weight per volume 
Ydj1p  yeast DnaJ-like protein 1  
YPD    yeast extract peptone dextrose 
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